PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ayombil, F; Petrillo, T; Kim, H; Camire, RM				Ayombil, Francis; Petrillo, Teodolinda; Kim, Haein; Camire, Rodney M.			Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPI alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR VA; BOVINE FACTOR-V; FACTOR-XA; BLEEDING DISORDER; BINDING-SITE; INACTIVATION; RESISTANCE; COFACTOR; CLEAVAGE; MUTATION	Activated protein C (APC) is an important anticoagulant protein that regulates thrombin generation through inactiva-tion of factor V (FV) and activated factor V (FVa). The rate of APC inactivation of FV is slower compared to FVa, although proteolysis occurs at the same sites (Arg306, Arg506, and Arg679). The molecular basis for FV resistance to APC is unknown. Further, there is no information about how FV-short, a phys-iologically relevant isoform of FV with a shortened B-domain, is regulated by APC. Here, we identify the molecular determinants which differentially regulate APC recognition of FV versus FVa and uncover how FV-short can be protected from this anticoagulant pathway. Using recombinant FV derivatives and B-domain fragments, we show that the conserved basic region (BR; 963-1008) within the central portion of the B-domain plays a major role in limiting APC cleavage at Arg506. Derivatives of FV lacking the BR, including FV-short, were subject to rapid cleavage at Arg506 and were inactivated like FVa. The addition of a FV-BR fragment reversed this effect and delayed APC inactivation. We also found that anticoagulant glycoprotein TFPI alpha, which has a C-terminal BR homologous to FV-BR, protects FV-short from APC inactivation by delaying cleavage at Arg506. We conclude that the FV-BR plays a major role in protecting FV from APC inactivation. Using a similar mechanistic strategy, TFPI alpha also shields FV-short from APC. These findings clarify the resis-tance of FV to APC, advance our understanding of FV/FVa regulation, and establish a mechanistic framework for manip-ulating this reaction to alter coagulation.	[Ayombil, Francis; Petrillo, Teodolinda; Kim, Haein; Camire, Rodney M.] Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Div Hematol, Philadelphia, PA 19104 USA; [Camire, Rodney M.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Petrillo, Teodolinda] Univ Maryland, Baltimore, MD 21201 USA; [Kim, Haein] JDRF T1D Fund, 50 Milk St, 16th floor, Boston, MA 02109 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University System of Maryland; University of Maryland Baltimore	Camire, RM (corresponding author), Childrens Hosp Philadelphia, Raymond G Perelman Ctr Cellular & Mol Therapeut, Div Hematol, Philadelphia, PA 19104 USA.; Camire, RM (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	rcamire@pennmedicine.upenn.edu	Ayombil, Francis/AAE-2889-2020	Ayombil, Francis/0000-0001-6011-1931	US National Institutes of Health (NIH);  [P01 HL139420];  [T32 HL007971]	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	Funding and additional information - This work was supported by US National Institutes of Health (NIH) grant P01 HL139420, Project 2 (RM Camire) and T32 HL007971 (F Ayombil) . The con- tent of this manuscript is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the NIH.	Aparicio C, 1996, BIOCHEM J, V313, P467, DOI 10.1042/bj3130467; BAKKER HM, 1992, EUR J BIOCHEM, V208, P171, DOI 10.1111/j.1432-1033.1992.tb17171.x; Barhoover MA, 2011, BLOOD COAGUL FIBRIN, V22, P317, DOI 10.1097/MBC.0b013e3283456c4e; Betz A, 1998, J BIOL CHEM, V273, P10709, DOI 10.1074/jbc.273.17.10709; Bos MHA, 2012, J BIOL CHEM, V287, P26342, DOI 10.1074/jbc.M112.377168; Bradford HN, 2019, J BIOL CHEM, V294, P2422, DOI 10.1074/jbc.RA118.006510; Bradford HN, 2013, J BIOL CHEM, V288, P27789, DOI 10.1074/jbc.M113.502005; BROZE GJ, 1994, BLOOD COAGUL FIBRIN, V5, P551; Bunce MW, 2013, J BIOL CHEM, V288, P30151, DOI 10.1074/jbc.M113.506840; Camire RM, 2009, J THROMB HAEMOST, V7, P1951, DOI 10.1111/j.1538-7836.2009.03622.x; CAMIRE RM, 1995, J BIOL CHEM, V270, P20794, DOI 10.1074/jbc.270.35.20794; Cunha MLR, 2015, BLOOD, V125, P1822, DOI 10.1182/blood-2014-08-592733; Dahlback B, 1997, HAEMATOLOGICA, V82, P91; Dahlback B, 1997, THROMB HAEMOSTASIS, V78, P483; DAHLBACK B, 1995, THROMB HAEMOSTASIS, V73, P739; DAHLBACK B, 1994, P NATL ACAD SCI USA, V91, P1396, DOI 10.1073/pnas.91.4.1396; Dahlback B, 2018, RES PRACT THROMB HAE, V2, P114, DOI 10.1002/rth2.12057; Eaton SL, 2014, JOVE-J VIS EXP, DOI 10.3791/52099; Esmon C, 2000, CRIT CARE MED, V28, pS44, DOI 10.1097/00003246-200009001-00010; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON CT, 1982, J BIOL CHEM, V257, P7944; Gale AJ, 2002, J BIOL CHEM, V277, P28836, DOI 10.1074/jbc.M204363200; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Heeb MJ, 1996, PROTEIN SCI, V5, P1883, DOI 10.1002/pro.5560050914; HIGGINS DL, 1983, J BIOL CHEM, V258, P6503; Kalafatis M, 1996, BLOOD, V87, P4695, DOI 10.1182/blood.V87.11.4695.bloodjournal87114695; KALAFATIS M, 1993, METHOD ENZYMOL, V222, P224; KALAFATIS M, 1993, J BIOL CHEM, V268, P27246; KALAFATIS M, 1995, J BIOL CHEM, V270, P4053, DOI 10.1074/jbc.270.8.4053; KALAFATIS M, 1994, J BIOL CHEM, V269, P31869; Kalafatis M, 1997, CRIT REV EUKAR GENE, V7, P241, DOI 10.1615/CritRevEukarGeneExpr.v7.i3.40; KANE WH, 1990, BIOCHEMISTRY-US, V29, P6762, DOI 10.1021/bi00481a003; KATZMANN JA, 1981, P NATL ACAD SCI-BIOL, V78, P162, DOI 10.1073/pnas.78.1.162; Kuang SQ, 2001, BLOOD, V97, P1549, DOI 10.1182/blood.V97.6.1549; Kumar S., 2015, BLOOD, V126, P121; Kumar S., 2011, BLOOD, V118, P375; Kumar S, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.253.253; Mann KG, 2003, BLOOD, V101, P20, DOI 10.1182/blood-2002-01-0290; Mann KG, 1997, J BIOL CHEM, V272, P20678, DOI 10.1074/jbc.272.33.20678; MANN KG, 1990, BLOOD, V76, P1; NESHEIM ME, 1979, J BIOL CHEM, V254, P952; NICOLAES GAF, 1995, J BIOL CHEM, V270, P21158, DOI 10.1074/jbc.270.36.21158; Norstrom EA, 2003, J BIOL CHEM, V278, P24904, DOI 10.1074/jbc.M303829200; ODEGAARD B, 1987, J BIOL CHEM, V262, P11233; Peterson JA, 2022, J THROMB HAEMOST, V20, P565, DOI 10.1111/jth.15612; Petrillo T, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016341; Ruben EA, 2021, BLOOD, V137, P3137, DOI 10.1182/blood.2021010684; Segers K, 2008, J BIOL CHEM, V283, P22573, DOI 10.1074/jbc.M801724200; SHEN L, 1994, J BIOL CHEM, V269, P18735; Steen M, 2008, J BIOL CHEM, V283, P20805, DOI 10.1074/jbc.M802703200; Thorelli E, 1999, BLOOD, V93, P2552, DOI 10.1182/blood.V93.8.2552.408k15_2552_2558; Thorelli E, 1998, J BIOL CHEM, V273, P16140, DOI 10.1074/jbc.273.26.16140; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; TRACY PB, 1982, BLOOD, V60, P59; Vincent LM, 2013, J CLIN INVEST, V123, P3777, DOI 10.1172/JCI69091; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110; Yegneswaran S, 2007, J BIOL CHEM, V282, P28353, DOI 10.1074/jbc.M704316200; Zhu H, 2007, J BIOL CHEM, V282, P15033, DOI 10.1074/jbc.M701315200; Zimowski KL, 2021, J THROMB HAEMOST, V19, P1653, DOI 10.1111/jth.15314	59	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102558	10.1016/j.jbc.2022.102558	http://dx.doi.org/10.1016/j.jbc.2022.102558			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36183835	Green Published, gold			2022-12-26	WOS:000886086000008
J	Makombu, JG; Cheruiyot, EK; Stomeo, F; Thuo, DN; Oben, PM; Oben, BO; Zango, P; Mialhe, E; Ngueguim, JR; Mujibi, FDN				Makombu, Judith G.; Cheruiyot, Evans K.; Stomeo, Francesca; Thuo, David N.; Oben, Pius M.; Oben, Benedicta O.; Zango, Paul; Mialhe, Eric; Ngueguim, Jules R.; Mujibi, Fidalis D. N.			Species-informative SNP markers for characterising freshwater prawns of genus Macrobrachium in Cameroon	PLOS ONE			English	Article							DECAPODA PALAEMONIDAE; LITOPENAEUS-VANNAMEI; POPULATION; CRUSTACEA; RIVER; COMPONENT; ANCESTRY; PACKAGE	Single Nucleotide Polymorphisms (SNPs) are now popular for a myriad of applications in animal and plant species including, ancestry assignment, conservation genetics, breeding, and traceability of animal products. The objective of this study was to develop a customized cost-effective SNP panel for genetic characterisation of Macrobrachium species in Cameroon. The SNPs identified in a previous characterization study were screened as viable candidates for the reduced panel. Starting from a full set of 1,814 SNPs, a total of 72 core SNPs were chosen using conventional approaches: allele frequency differentials, minor allele frequency profiles, and Wright's Fst statistics. The discriminatory power of reduced set of informative SNPs were then tested using the admixture analysis, principal component analysis, and discriminant analysis of principal components. The panel of prioritised SNP markers (i.e., N = 72 SNPs) distinguished Macrobrachium species with 100% accuracy. However, large sample size is needed to identify more informative SNPs for discriminating genetically closely related species, including M. macrobrachion versus M. vollenhovenii and M. sollaudii versus M. dux. Overall, the findings in this study show that we can accurately characterise Macrobrachium using a small set of core SNPs which could be useful for this economically important species in Cameroon. Given the results obtained in this study, a larger independent validation sample set will be needed to confirm the discriminative capacity of this SNP panel for wider commercial and research applications.	[Makombu, Judith G.; Oben, Pius M.; Oben, Benedicta O.] Univ Buea, Fac Agr & Vet Med, Dept Fisheries & Aquat Resources Management, Buea, Cameroon; [Cheruiyot, Evans K.; Mujibi, Fidalis D. N.] USOMI Ltd, Nairobi, Kenya; [Stomeo, Francesca] Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya; [Thuo, David N.] CSIRO, Natl Res Collect Australia, Australian Natl Wildlife Collect, Canberra, ACT, Australia; [Zango, Paul] Univ Douala, Inst Fisheries & Aquat Sci, Yabassi, Cameroon; [Mialhe, Eric] Concepto Azul, Guayaquil, Ecuador; [Ngueguim, Jules R.] Inst Agr Res Dev IRAD, Kribi, Cameroon; [Cheruiyot, Evans K.] Univ Queensland, Brisbane, Qld, Australia; [Stomeo, Francesca] European Mol Biol Lab EMBL, Heidelberg, Germany	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland; European Molecular Biology Laboratory (EMBL)	Mujibi, FDN (corresponding author), USOMI Ltd, Nairobi, Kenya.	fmujibi@gmail.com		Thuo, David/0000-0003-0067-6580	Bill and Melinda Gates Foundation [OPP:1075938]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	JGM was supported by Bill and Melinda Gates Foundation, Grant number:BMGF [OPP:1075938]. https://www.gatesfoundation.org/.NO - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Alkalay AS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003060; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2011, CARIDEORUM CATALOGUS; Bertolini F, 2015, J ANIM BREED GENET, V132, P346, DOI 10.1111/jbg.12155; Bowles DE, 2000, J CRUSTACEAN BIOL, V20, P158, DOI 10.1651/0278-0372(2000)020[0158:MDCPIT]2.0.CO;2; Browder Joan A., 1994, P379; Cheruiyot EK, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00607; Divu D, 2008, AQUACULTURE, V284, P281, DOI 10.1016/j.aquaculture.2008.07.023; Doume C. D., 2013, International Journal of Biological and Chemical Sciences, V7, P584; Gebrehiwot NZ, 2021, GENET SEL EVOL, V53, DOI 10.1186/s12711-021-00615-4; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Holthuis L.B., 1980, FAO Fisheries Synopsis, pi; Jin SB, 2021, GIGASCIENCE, V10, DOI 10.1093/gigascience/giaa160; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Konan MK, 2008, J NAT HIST, V42, P2095, DOI 10.1080/00222930802254730; Li C, 2020, AQUACULT REP, V18, DOI 10.1016/j.aqrep.2020.100423; Makombu JG, 2019, ECOL EVOL, V9, P14217, DOI 10.1002/ece3.5854; Makombu Judith G., 2015, Journal of Biodiversity and Environmental Sciences, V7, P67; March JG, 2002, FRESHWATER BIOL, V47, P377, DOI 10.1046/j.1365-2427.2002.00808.x; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; MONOD T., 1980, FLORE FAUNE AQUATIQU, VI, P369; MORISATO D, 1994, CELL, V76, P677, DOI 10.1016/0092-8674(94)90507-X; Murphy NP, 2003, J CRUSTACEAN BIOL, V23, P169, DOI 10.1651/0278-0372(2003)023[0169:MTAPOS]2.0.CO;2; Nguyen NN, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-00342-9; NEW M. B., 2009, FRESHWATER PRAWNS BI; Okogwu Okechukwu I., 2010, Acta Zoologica Lituanica, V20, P98, DOI 10.2478/v10043-010-0011-x; Oliveira R, 2015, HEREDITY, V115, P195, DOI 10.1038/hdy.2015.25; Pakstis AJ, 2007, HUM GENET, V121, P305, DOI 10.1007/s00439-007-0342-2; PARDY C, 2011, BMC P, P1; Pfaffelhuber P, 2020, FORENSIC SCI INT-GEN, V46, DOI 10.1016/j.fsigen.2020.102259; Phillips C, 2007, FORENSIC SCI INT-GEN, V1, P273, DOI 10.1016/j.fsigen.2007.06.008; POWELL C, 1980, GENUS MACROBRACHIUM; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Saengphan N, 2019, ZOOTAXA, V4664, P274, DOI 10.11646/zootaxa.4664.2.9; Saung MHH, 2021, ZOOL ANZ, V293, P112, DOI 10.1016/j.jcz.2021.05.010; Savaya-Alkalay A, 2018, AQUACULT ENV INTERAC, V10, P487, DOI 10.3354/aei00285; Schiavo G, 2020, ANIMAL, V14, P223, DOI 10.1017/S1751731119002167; Shriver MD, 1997, AM J HUM GENET, V60, P957; Simeon Tchakonte, 2014, Journal of Biodiversity and Environmental Sciences, V4, P183; Vergamini FG, 2011, CONTRIB ZOOL, V80, P67, DOI 10.1163/18759866-08001003; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-45; Wowor D, 2009, MOL PHYLOGENET EVOL, V52, P340, DOI 10.1016/j.ympev.2009.01.002; Zhang Qing-yi, 2009, Zoological Research, V30, P613, DOI 10.3724/SP.J.1141.2009.06613; Zhao ZY, 2009, J VIROL, V83, P347, DOI 10.1128/JVI.00707-08	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2022	17	10							e0263540	10.1371/journal.pone.0263540	http://dx.doi.org/10.1371/journal.pone.0263540			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6W1FK	36190939	Green Published, Green Submitted, gold			2022-12-26	WOS:000895480500001
J	Bommisetti, P; Young, A; Bandarian, V				Bommisetti, Praneeth; Young, Anthony; Bandarian, Vahe			Elucidation of the substrate of tRNA-modifying enzymes MnmEG leads to in vitro reconstitution of an evolutionarily conserved uridine hypermodification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSFER-RNAS; MODIFIED NUCLEOSIDE; BINDING PROTEIN; BIOSYNTHESIS; GIDA; GENE; METHYLTRANSFERASE; IDENTIFICATION; INSIGHTS; FLAVIN	The evolutionarily conserved bacterial proteins MnmE and MnmG collectively install a carboxymethylaminomethyl (cmnm) group at the fifth position of wobble uridines of several tRNA species. While the reaction catalyzed by MnmEG is one of the central steps in the biosynthesis of the methyl-aminomethyl (mnm) posttranscriptional tRNA modification, details of the reaction remain elusive. Glycine is known to be the source of the carboxy methylamino moiety of cmnm, and a tetrahydrofolate (THF) analog is thought to supply the one carbon that is appended to the fifth position of U. However, the nature of the folate analog remains unknown. This article reports the in vitro biochemical reconstitution of the MnmEG reaction. Using isotopically labeled methyl and methylene THF analogs, we demonstrate that methylene THF is the true substrate. We also show that reduced FAD is required for the reaction and that DTT can replace the NADH in its role as a reductant. We discuss the implications of these methylene-THF and reductant requirements on the mechanism of this key tRNA modification catalyzed by MnmEG.	[Bommisetti, Praneeth; Bandarian, Vahe] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Young, Anthony] Soliome Inc, San Francisco, CA USA	Utah System of Higher Education; University of Utah	Bandarian, V (corresponding author), Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA.	vahe@chem.utah.edu		Young, Anthony/0000-0003-2273-346X	National Institutes of General Medical Sciences of the National Institutes of Health (NIH);  [R35 GM126956]	National Institutes of General Medical Sciences of the National Institutes of Health (NIH); 	Funding and additional information-The research reported in this publication was supported by the National Institutes of General Medical Sciences of the National Institutes of Health (NIH) under the award number R35 GM126956. The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Benitez-Paez A, 2010, RNA, V16, P2131, DOI 10.1261/rna.2245910; Bjork G. R., 2014, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus.esp-0007-2013, DOI 10.1128/ECOSALPLUS.ESP-0007-2013]; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Bommisetti P, 2022, ACS OMEGA, V7, P4011, DOI 10.1021/acsomega.1c05071; Bou-Nader C., 2017, ANGEW CHEM INT EDIT, V129, P12697; Bregeon D, 2001, GENE DEV, V15, P2295, DOI 10.1101/gad.207701; Bujnicki JM, 2004, RNA, V10, P1236, DOI 10.1261/rna.7470904; CARBON J, 1968, SCIENCE, V161, P1146, DOI 10.1126/science.161.3846.1146; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; Esberg B, 1999, J BACTERIOL, V181, P7256, DOI 10.1128/JB.181.23.7256-7265.1999; Armengod ME, 2014, RNA BIOL, V11, P1495, DOI 10.4161/15476286.2014.992269; Fislage M, 2014, NUCLEIC ACIDS RES, V42, P5978, DOI 10.1093/nar/gku213; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Green Jacalyn M, 2007, EcoSal Plus, V2, DOI 10.1128/ecosalplus.3.6.3.6; Grosjean H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004363; HAGERVALL TG, 1984, MOL GEN GENET, V196, P201, DOI 10.1007/BF00328051; Hamdane D, 2013, BIOCHEMISTRY-US, V52, P8949, DOI 10.1021/bi4013879; Hamdane D, 2012, J AM CHEM SOC, V134, P19739, DOI 10.1021/ja308145p; Hamdane D, 2011, J BIOL CHEM, V286, P36268, DOI 10.1074/jbc.M111.256966; Jager G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153488; Kambampati R, 2003, BIOCHEMISTRY-US, V42, P1109, DOI 10.1021/bi026536+; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610; KOBAYASHI Y, 1991, AM J HUM GENET, V49, P590; Lee YJ, 2022, NUCLEIC ACIDS RES, V50, P3001, DOI 10.1093/nar/gkab781; McCarty RM, 2009, BIOCHEMISTRY-US, V48, P3847, DOI 10.1021/bi900400e; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Miles ZD, 2011, P NATL ACAD SCI USA, V108, P7368, DOI 10.1073/pnas.1018636108; Monleon D, 2007, PROTEINS, V66, P726, DOI 10.1002/prot.21186; Morscher RJ, 2018, NATURE, V554, P128, DOI 10.1038/nature25460; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; OKADA N, 1979, J BIOL CHEM, V254, P3061; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507; Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09; Shippy DC, 2013, MICROB PATHOGENESIS, V57, P1, DOI 10.1016/j.micpath.2013.01.004; Shippy DC, 2011, MICROB PATHOGENESIS, V50, P303, DOI 10.1016/j.micpath.2011.02.004; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SLANY RK, 1993, BIOCHEMISTRY-US, V32, P7811, DOI 10.1021/bi00081a028; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Szczupak P, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11091522; Thoden JB, 2005, J BIOL CHEM, V280, P32784, DOI 10.1074/jbc.M505730200; Urbonavicius J, 2005, NUCLEIC ACIDS RES, V33, P3955, DOI 10.1093/nar/gki703; Urbonavicius J, 2007, METHOD ENZYMOL, V425, P103; VONMEYENBURG K, 1982, MOL GEN GENET, V188, P240, DOI 10.1007/BF00332682; Waller JC, 2010, P NATL ACAD SCI USA, V107, P10412, DOI 10.1073/pnas.0911586107; WANG BY, 1989, BIOCHEMISTRY-US, V28, P1148, DOI 10.1021/bi00429a032; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P498, DOI 10.1038/nsmb1242; White DJ, 2001, MOL MICROBIOL, V42, P503, DOI 10.1046/j.1365-2958.2001.02659.x; WITTWER AJ, 1986, ARCH BIOCHEM BIOPHYS, V248, P540, DOI 10.1016/0003-9861(86)90507-2; YAMADA Y, 1981, NUCLEIC ACIDS RES, V9, P1933, DOI 10.1093/nar/9.8.1933; Young AP, 2018, METHOD ENZYMOL, V606, P119, DOI 10.1016/bs.mie.2018.04.024; Young AP, 2013, CURR OPIN CHEM BIOL, V17, P613, DOI 10.1016/j.cbpa.2013.05.035	61	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102548	10.1016/j.jbc.2022.102548	http://dx.doi.org/10.1016/j.jbc.2022.102548			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36181794	Green Published, gold			2022-12-26	WOS:000882627400005
J	Filiberto, AC; Ladd, Z; Leroy, V; Su, G; Elder, CT; Pruitt, EY; Hensley, SE; Lu, GY; Hartman, JB; Zarrinpar, A; Sharma, AK; Upchurch, GR				Filiberto, Amanda C.; Ladd, Zachary; Leroy, Victoria; Su, Gang; Elder, Craig T.; Pruitt, Eric Y.; Hensley, Sara E.; Lu, Guanyi; Hartman, Joseph B.; Zarrinpar, Ali; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.			Resolution of inflammation via RvD1/FPR2 signaling mitigates Nox2 activation and ferroptosis of macrophages in experimental abdominal aortic aneurysms	FASEB JOURNAL			English	Article						abdominal aortic aneurysms; ferroptosis; formyl peptide receptor 2; HMGB1; macrophages; resolvin D1	RESOLVING LIPID MEDIATORS; PROTEIN-COUPLED RECEPTOR; OXIDATIVE STRESS; D1; MECHANISMS; LIGAND; RESPONSES; MODEL	Abdominal aortic aneurysm (AAA) formation is characterized by inflammation, leukocyte infiltration, and vascular remodeling. Resolvin D1 (RvD1) is derived from omega-3 polyunsaturated fatty acids and is involved in the resolution phase of chronic inflammatory diseases. The aim of this study was to decipher the protective role of RvD1 via formyl peptide receptor 2 (FPR2) receptor signaling in attenuating abdominal aortic aneurysms (AAA). The elastase-treatment model of AAA in C57BL/6 (WT) mice and human AAA tissue was used to confirm our hypotheses. Elastase-treated FPR2(-/-) mice had a significant increase in aortic diameter, proinflammatory cytokine production, immune cell infiltration (macrophages and neutrophils), elastic fiber disruption, and decrease in smooth muscle cell alpha-actin expression compared to elastase-treated WT mice. RvD1 treatment attenuated AAA formation, aortic inflammation, and vascular remodeling in WT mice, but not in FPR2(-/-) mice. Importantly, human AAA tissue demonstrated significantly decreased FPR2 mRNA expression compared to non-aneurysm human aortas. Mechanistically, RvD1/FPR2 signaling mitigated p47(phox) phosphorylation and prevented hallmarks of ferroptosis, such as lipid peroxidation and Nrf2 translocation, thereby attenuating HMGB1 secretion. Collectively, this study demonstrates RvD1-mediated immunomodulation of FPR2 signaling on macrophages to mitigate ferroptosis and HMGB1 release, leading to resolution of aortic inflammation and remodeling during AAA pathogenesis.	[Filiberto, Amanda C.; Ladd, Zachary; Leroy, Victoria; Su, Gang; Elder, Craig T.; Pruitt, Eric Y.; Hensley, Sara E.; Lu, Guanyi; Hartman, Joseph B.; Zarrinpar, Ali; Sharma, Ashish K.; Upchurch, Gilbert R., Jr.] Univ Florida, Dept Surg, POB 100286, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Upchurch, GR (corresponding author), Univ Florida, Dept Surg, POB 100286, Gainesville, FL 32610 USA.	gib.upchurch@surgery.ufl.edu		Leroy, Victoria/0000-0002-1025-1888; Sharma, Ashish/0000-0002-1234-6039	American College of Surgeons (ACS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI) [HL153341, HL138931]	American College of Surgeons (ACS); HHS \ NIH \ National Heart, Lung, and Blood Institute (NHLBI)	American College of Surgeons (ACS); HHS vertical bar NIH vertical bar National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL153341 and HL138931	Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Arnardottir H, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142883; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Bhamidipati CM, 2012, SURGERY, V152, P238, DOI 10.1016/j.surg.2012.02.010; Boada-Romero E, 2020, NAT REV MOL CELL BIO, V21, P398, DOI 10.1038/s41580-020-0232-1; Chakraborty A, 2022, J MOL CELL CARDIOL, V163, P67, DOI 10.1016/j.yjmcc.2021.09.010; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; Conte MS, 2018, J CLIN INVEST, V128, P3727, DOI 10.1172/JCI97947; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Cullen JM, 2019, J VASC SURG, V70, P252, DOI 10.1016/j.jvs.2018.09.057; Dufton N, 2010, J IMMUNOL, V184, P2611, DOI 10.4049/jimmunol.0903526; Elder CT, 2021, FASEB J, V35, DOI 10.1096/fj.202100484R; Fashandi AZ, 2018, SURGERY, V163, P397, DOI 10.1016/j.surg.2017.10.003; Fredman G, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00205; Gerlach BD, 2020, CELL DEATH DIFFER, V27, P525, DOI 10.1038/s41418-019-0370-1; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Honkanen Petri, 2014, Surg Neurol Int, V5, P74, DOI 10.4103/2152-7806.132960; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kuivaniemi H, 2015, EXPERT REV CARDIOVAS, V13, P975, DOI 10.1586/14779072.2015.1074861; Laser A, 2012, J SURG RES, V178, P1038, DOI 10.1016/j.jss.2012.04.073; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Liu GJ, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01918-x; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Lu GY, 2017, J VASC SURG, V66, P232, DOI 10.1016/j.jvs.2016.07.105; Martensson J, 2021, J INNATE IMMUN, V13, P242, DOI 10.1159/000514887; Maschalidi S, 2022, NATURE, V606, P776, DOI 10.1038/s41586-022-04754-6; Maskrey BH, 2011, ARTERIOSCL THROM VAS, V31, P1001, DOI 10.1161/ATVBAHA.110.213850; Meital LT, 2017, PROSTAG LEUKOTR ESS, V118, P1, DOI 10.1016/j.plefa.2017.02.001; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Petri MH, 2018, JACC-BASIC TRANSL SC, V3, P719, DOI 10.1016/j.jacbts.2018.08.005; Piechota-Polanczyk Aleksandra, 2015, Front Cardiovasc Med, V2, P19, DOI 10.3389/fcvm.2015.00019; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Ramon S, 2014, EUR J IMMUNOL, V44, P357, DOI 10.1002/eji.201343316; Rymut N, 2020, FASEB J, V34, P597, DOI 10.1096/fj.201902126R; Sawada H, 2015, ARTERIOSCL THROM VAS, V35, P1507, DOI 10.1161/ATVBAHA.115.305586; Sekheri M, 2020, P NATL ACAD SCI USA, V117, P7971, DOI 10.1073/pnas.1920193117; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; Shannon AH, 2020, J SURG RES, V251, P239, DOI 10.1016/j.jss.2020.01.028; Sharma AK, 2016, ARTERIOSCL THROM VAS, V36, P908, DOI 10.1161/ATVBAHA.116.307373; Sharma AK, 2012, CIRCULATION, V126, pS38, DOI 10.1161/CIRCULATIONAHA.111.083451; Spinosa M, 2018, J VASC SURG, V68, p93S, DOI 10.1016/j.jvs.2018.05.253; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Halade GV, 2022, EBIOMEDICINE, V79, DOI 10.1016/j.ebiom.2022.103992; Vinchi F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00094; Wales KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112816; Wiernicki B, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31218-2; Yang Y, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04775-z; Zhang Y, 2022, BIOMED PHARMACOTHER, V145, DOI 10.1016/j.biopha.2021.112423	53	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22579	10.1096/fj.202201114R	http://dx.doi.org/10.1096/fj.202201114R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A6KZ	36183323				2022-12-26	WOS:000862995400001
J	Irwin, S; Karr, C; Furman, C; Tsai, JNF; Gee, P; Banka, D; Wibowo, AS; Dementiev, AA; O'Shea, M; Yang, JY; Lowe, J; Mitchell, L; Ruppel, S; Fekkes, P; Zhu, P; Korpal, M; Larsen, NA				Irwin, Sean; Karr, Craig; Furman, Craig; Tsai, Jennifer; Gee, Patricia; Banka, Deepti; Wibowo, Ardian S.; Dementiev, Alexey A.; O'Shea, Morgan; Yang, Joyce; Lowe, Jason; Mitchell, Lorna; Ruppel, Sabine; Fekkes, Peter; Zhu, Ping; Korpal, Manav; Larsen, Nicholas A.			Biochemical and structural basis for the pharmacological inhibition of nuclear hormone receptor PPAR? by inverse agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA; CANCER; ANTAGONIST; LIGAND; RECRUITMENT; ACTIVATION; REVEALS; POTENT	Recent studies have reported that the peroxisome proliferator- activated receptor gamma (PPAR gamma) pathway is activated in approximately 40% of patients with muscle-invasive bladder can-cer. This led us to investigate pharmacological repression of PPAR gamma as a possible intervention strategy. Here, we characterize PPAR gamma antagonists and inverse agonists and find that the former behave as silent ligands, whereas inverse agonists (T0070907 and SR10221) repress downstream PPAR gamma target genes leading to growth inhibition in bladder cancer cell lines. To understand the mechanism, we determined the ternary crystal structure of PPAR gamma bound to T0070907 and the corepressor (co-R) peptide NCOR1. The structure shows that the AF-2 helix 12 (H12) rearranges to bind inside the ligand-binding domain, where it forms stabilizing interactions with the compound. This dramatic movement in H12 unveils a large interface for co-R binding. In contrast, the crystal structure of PPAR gamma bound to a SR10221 analog shows more subtle structural differences, where the compound binds and pushes H12 away from the ligand-binding domain to allow co-R binding. Interestingly, we found that both classes of compound promote recruitment of co-R proteins in biochemical assays but with distinct conformational changes in H12. We validate our structural models using both site-directed mutagenesis and chemical probes. Our findings offer new mechanistic insights into pharmacological modulation of PPAR gamma signaling.	[Irwin, Sean; Karr, Craig; Furman, Craig; Tsai, Jennifer; Gee, Patricia; Banka, Deepti; O'Shea, Morgan; Yang, Joyce; Lowe, Jason; Mitchell, Lorna; Ruppel, Sabine; Fekkes, Peter; Zhu, Ping; Korpal, Manav; Larsen, Nicholas A.] H3 Biomed, Dept Drug Discovery, Cambridge, MA 02139 USA; [Wibowo, Ardian S.; Dementiev, Alexey A.] Shamrock Struct LLC, Chicago, IL USA; [Tsai, Jennifer] Monta Rosa Therapeut, Boston, MA USA; [Wibowo, Ardian S.] Helix Biostruct, Indianapolis, IN USA; [Dementiev, Alexey A.] Schrodinger Inc, Natick, MA USA; [O'Shea, Morgan] C4 Therapeut, Watertown, MA USA; [Yang, Joyce] Blueprint Med, Cambridge, MA USA; [Lowe, Jason] Foghorn Therapeut, Cambridge, MA USA; [Mitchell, Lorna] Certa Therapeut, Melbourne, Vic, Australia; [Ruppel, Sabine] Ikena Oncol, Boston, MA USA; [Fekkes, Peter] 54 Gene, Washington, DC USA		Larsen, NA (corresponding author), H3 Biomed, Dept Drug Discovery, Cambridge, MA 02139 USA.	nick.a.larsen@gmail.com						Audenet F, 2018, UROL ONCOL-SEMIN ORI, V36, P313, DOI 10.1016/j.urolonc.2018.02.017; Brust R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07133-w; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Davidson MA, 2018, CRIT REV TOXICOL, V48, P52, DOI 10.1080/10408444.2017.1351420; Felsenstein KM, 2018, NAT REV UROL, V15, P92, DOI 10.1038/nrurol.2017.179; Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7; Goldstein JT, 2017, CANCER RES, V77, P6987, DOI 10.1158/0008-5472.CAN-17-1701; Halstead AM, 2017, ELIFE, V6, DOI 10.7554/eLife.30862; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Korpal M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00147-w; Lamotte Y, 2010, BIOORG MED CHEM LETT, V20, P1399, DOI 10.1016/j.bmcl.2009.12.107; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee G, 2002, J BIOL CHEM, V277, P19649, DOI 10.1074/jbc.M200743200; Marciano DP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8443; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mohanty P, 2004, J CLIN ENDOCR METAB, V89, P2728, DOI 10.1210/jc.2003-032103; Nishiu J, 2006, DIABETES OBES METAB, V8, P508, DOI 10.1111/j.1463-1326.2005.00536.x; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Rochel N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08157-y; Rodriguez-Vida Alejo, 2018, Cancer Treat Res, V175, P259, DOI 10.1007/978-3-319-93339-9_12; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Shang JS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14750-x; Sweis RF, 2016, CANCER IMMUNOL RES, V4, P563, DOI 10.1158/2326-6066.CIR-15-0274; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Warrick JI, 2016, SCI REP-UK, V6, DOI 10.1038/srep38531; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Witjes JA, 2014, EUR UROL, V65, P778, DOI 10.1016/j.eururo.2013.11.046; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a	30	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102539	10.1016/j.jbc.2022.102539	http://dx.doi.org/10.1016/j.jbc.2022.102539			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36179791	gold, Green Published			2022-12-26	WOS:000886086000005
J	Marques, C; Pocas, J; Gomes, C; Faria-Ramos, I; Reis, CA; Vives, RR; Magalhaes, A				Marques, Catarina; Pocas, Juliana; Gomes, Catarina; Faria-Ramos, Isabel; Reis, Celso A.; Vives, Romain R.; Magalhaes, Ana			Glycosyltransferases EXTL2 and EXTL3 cellular balance dictates heparan sulfate biosynthesis and shapes gastric cancer cell motility and invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LINKAGE REGION; SYNDECAN-1 EXPRESSION; CHONDROITIN SULFATE; N-ACETYLGLUCOSAMINE; REDUCED EXPRESSION; TUMOR SUPPRESSORS; BREAST-CARCINOMA; FAMILY; XYLOSE; ROLES	Heparan sulfate (HS) proteoglycans (HSPGs) are abundant glycoconjugates in cells' glycocalyx and extracellular matrix. By acting as scaffolds for protein-protein interactions, HSPGs modulate extracellular ligand gradients, cell signaling networks, and cell-extracellular matrix crosstalk. Aberrant expression of HSPGs and enzymes involved in HSPG biosynthesis and processing has been reported in tumors, with impact in cancer cell behavior and tumor microenvironment properties. However, the roles of specific glycosyltransferases in the deregulated biosynthesis of HSPGs are not fully understood. In this study, we established glycoengineered gastric cancer cell models lacking either exostosin-like glycosyltransferase 2 (EXTL2) or EXTL3 and revealed their regulatory roles in both HS and chondroitin sulfate (CS) biosynthesis and structural features. We showed that EXTL3 is key for initiating the synthesis of HS chains in detriment of CS biosynthesis, intervening in the fine-tuned balance of the HS/CS ratio in cells, while EXTL2 functions as a negative regulator of HS biosynthesis, with impact over the glycoproteome of gastric cancer cells. We demonstrated that KO of EXTL2 enhanced HS levels along with concomitant upregulation of Syndecan-4, which is a major cell surface carrier of HS. This aberrant HS expression profile promoted a more aggressive phenotype, characterized by higher cellular motility and invasion, and impaired activation of Ephrin type-A 4 cell surface receptor tyrosine kinase. Our findings uncover the biosynthetic roles of EXTL2 and EXTL3 in rant HS/CS balance in cellular malignant features.	[Marques, Catarina; Pocas, Juliana; Gomes, Catarina; Faria-Ramos, Isabel; Reis, Celso A.; Magalhaes, Ana] Univ Porto, i3S Inst Invest & Inovacao Saude, Porto, Portugal; [Marques, Catarina; Pocas, Juliana; Gomes, Catarina; Faria-Ramos, Isabel; Reis, Celso A.; Magalhaes, Ana] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, Porto, Portugal; [Pocas, Juliana] Inst Ciencias Biomed Abel Salazar ICBAS, Programa Doutoral Biol Mol & Celular MCbiol, Porto, Portugal; [Pocas, Juliana; Reis, Celso A.; Magalhaes, Ana] Univ Porto, ICBAS Inst Ciencias Biomed Abel Salazar, Porto, Portugal; [Reis, Celso A.] FMUP Fac Med Univ Porto, Porto, Portugal; [Vives, Romain R.] Univ Grenoble Alpes, CNRS, CEA, IBS, Grenoble, France	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Magalhaes, A (corresponding author), Univ Porto, i3S Inst Invest & Inovacao Saude, Porto, Portugal.; Magalhaes, A (corresponding author), Univ Porto, IPATIMUP Inst Patol & Imunol Mol, Porto, Portugal.; Magalhaes, A (corresponding author), Univ Porto, ICBAS Inst Ciencias Biomed Abel Salazar, Porto, Portugal.	amagalhaes@ipatimup.pt	; Reis, Celso/B-9969-2008	Gomes, Catarina/0000-0002-0352-6783; Pocas Almeida, Juliana/0000-0003-2877-473X; Reis, Celso/0000-0002-0286-6639; Magalhaes, Ana/0000-0003-4863-6668	FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE [POCI-01-0145-FEDER-007274, POCI-01-0145-FEDER-028489, POCI-01-0145-FEDER-029780]; Foundation for Science and Technology (FCT) [PTDC/MED-ONC/28489/2017, PTDC/MED-QUI/29780/2017, UID/BIM/4293, 2020.06412.BD, SFRH/BD/137319/2018]; Norte Portugal Operational Regional Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF) [NORTE-01-0145-FEDER-000051]; COST Action [CA18103, CA18103-45514]; CNRS; GDR GAG [GDR 3739]; "Investissements d'avenir" program Glyco@Alps [ANR-15-IDEX-02]; Agence Nationale de la Recherche [ANR-17-CE11-0040]	FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE; Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Norte Portugal Operational Regional Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); COST Action(European Cooperation in Science and Technology (COST)); CNRS(Centre National de la Recherche Scientifique (CNRS)); GDR GAG; "Investissements d'avenir" program Glyco@Alps(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE (POCI-01-0145-FEDER-007274, POCI-01-0145-FEDER-028489 and POCI-01-0145-FEDER-029780) and National Funds through the Foundation for Science and Technology (FCT), under the projects: PTDC/MED-ONC/28489/2017 (to A. M.), PTDC/MED-QUI/29780/2017 (to C. G.), UID/BIM/4293 and the project NORTE-01-0145-FEDER-000051, supported by Norte Portugal Operational Regional Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF). COST Action CA18103 INNOGLY: INNOvation with Glycans new frontiers from synthesis to new biological targets (ECOST-STSM-Request-CA18103-45514). C. M. and J. P. acknowledge FCT PhD scholarships 2020.06412.BD and SFRH/BD/137319/2018, respectively. This work was also supported by the CNRS and the GDR GAG (GDR 3739), the "Investissements d'avenir" program Glyco@Alps (ANR-15-IDEX-02), by a grant from the Agence Nationale de la Recherche (ANR-17-CE11-0040). IBS acknowledges integration into the Interdisciplinary Research Institute of Grenoble (IRIG, CEA).	Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Annaval T, 2020, MOLECULES, V25, DOI 10.3390/molecules25184215; Arai T, 1999, INT J ONCOL, V15, P915; Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Busse-Wicher M, 2014, MATRIX BIOL, V35, P25, DOI 10.1016/j.matbio.2013.10.001; Chen YH, 2018, NAT METHODS, V15, P881, DOI 10.1038/s41592-018-0086-z; Corti F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09605-z; Crespo A, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4597-x; DAVID G, 1992, J CELL BIOL, V118, P961, DOI 10.1083/jcb.118.4.961; Depau L, 2020, J MED CHEM, V63, P15997, DOI 10.1021/acs.jmedchem.0c01848; El Masri R, 2017, GLYCOCONJUGATE J, V34, P285, DOI 10.1007/s10719-016-9736-5; Faria-Ramos I, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020136; Fernandez-Vega I, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1724-9; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Furuhashi S, 2021, ANTICANCER RES, V41, P1733, DOI 10.21873/anticanres.14938; Gao W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137664; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gopal S, 2010, J BIOL CHEM, V285, P14247, DOI 10.1074/jbc.M109.056945; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Hagner-McWhirter A, 2000, BIOCHEM J, V347, P69, DOI 10.1042/0264-6021:3470069; Hassan N, 2021, CELL SIGNAL, V77, DOI 10.1016/j.cellsig.2020.109822; Henriet E, 2017, BBA-GEN SUBJECTS, V1861, P2250, DOI 10.1016/j.bbagen.2017.06.006; Holmborn K, 2012, J BIOL CHEM, V287, P33905, DOI 10.1074/jbc.M112.401646; Hwang JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079634; Inokuchi M, 2018, ANTICANCER RES, V38, P1685, DOI 10.21873/anticanres.12402; Irie F, 2008, P NATL ACAD SCI USA, V105, P12307, DOI 10.1073/pnas.0801302105; Izumikawa T, 2015, J BIOL CHEM, V290, P5438, DOI 10.1074/jbc.M114.603266; Jin Y, 2017, ONCOL LETT, V14, P6191, DOI 10.3892/ol.2017.6944; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Karibe T, 2008, J PATHOL, V216, P32, DOI 10.1002/path.2377; Katta K, 2015, J BIOL CHEM, V290, P13168, DOI 10.1074/jbc.M114.631754; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kim BT, 2001, P NATL ACAD SCI USA, V98, P7176, DOI 10.1073/pnas.131188498; Kim SY, 2015, INT J MED SCI, V12, P92, DOI 10.7150/ijms.10497; Kitagawa H, 1999, J BIOL CHEM, V274, P13933, DOI 10.1074/jbc.274.20.13933; Koike T, 2014, J BIOL CHEM, V289, P6695, DOI 10.1074/jbc.M113.520536; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Lanzi C, 2020, BIOCHEM PHARMACOL, V178, DOI 10.1016/j.bcp.2020.114084; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; Li JP, 2016, INT REV CEL MOL BIO, V325, P215, DOI 10.1016/bs.ircmb.2016.02.009; Li N, 2020, J HISTOCHEM CYTOCHEM, V68, P841, DOI 10.1369/0022155420933709; Li N, 2018, TRENDS CANCER, V4, P741, DOI 10.1016/j.trecan.2018.09.004; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Lim HC, 2014, BBA-GEN SUBJECTS, V1840, P2482, DOI 10.1016/j.bbagen.2014.01.018; Lonowski LA, 2017, NAT PROTOC, V12, P581, DOI 10.1038/nprot.2016.165; Magalhaes A, 2009, FEMS IMMUNOL MED MIC, V56, P223, DOI 10.1111/j.1574-695X.2009.00569.x; Marques C, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.778752; Matsumoto A, 1997, INT J CANCER, V74, P482, DOI 10.1002/(SICI)1097-0215(19971021)74:5<482::AID-IJC2>3.0.CO;2-#; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mereiter S, 2019, CANCER CELL, V36, P6, DOI 10.1016/j.ccell.2019.06.006; Merry C. L. R., 2022, PROTEOGLYCANS SULFAT; Miyazaki K, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-19; Nadanaka S, 2020, FASEB J, V34, P8385, DOI 10.1096/fj.201902076R; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; Narimatsu Y, 2018, GLYCOBIOLOGY, V28, P295, DOI 10.1093/glycob/cwx101; Neelamegham S, 2019, GLYCOBIOLOGY, V29, P620, DOI 10.1093/glycob/cwz045; Nikitovic D, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00069; Ohkawa Y, 2021, MOL CANCER RES, V19, P150, DOI 10.1158/1541-7786.MCR-20-0420; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Oki M, 2008, WORLD J GASTROENTERO, V14, P5650, DOI 10.3748/wjg.14.5650; Ponighaus C, 2007, J BIOL CHEM, V282, P5201, DOI 10.1074/jbc.M611665200; Purnomo E, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000405; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Sembajwe LF, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180770; Shi XJ, 2011, ACTA BIOCH BIOPH SIN, V43, P849, DOI 10.1093/abbs/gmr084; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Thacker BE, 2014, MATRIX BIOL, V35, P60, DOI 10.1016/j.matbio.2013.12.001; Theocharis AD, 2003, INT J BIOCHEM CELL B, V35, P376, DOI 10.1016/S1357-2725(02)00264-9; Wen JZ, 2014, P NATL ACAD SCI USA, V111, P15723, DOI 10.1073/pnas.1417993111; Weyers A, 2013, GLYCOCONJUGATE J, V30, P701, DOI 10.1007/s10719-013-9476-8; Wilson LFL, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31048-2; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314	77	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102546	10.1016/j.jbc.2022.102546	http://dx.doi.org/10.1016/j.jbc.2022.102546			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36181793	Green Published, gold			2022-12-26	WOS:000882627400004
J	Doolittle, WKL; Park, S; Lee, SG; Jeong, S; Lee, G; Ryu, D; Schoonjans, K; Auwerx, J; Lee, J; Jo, YS				Doolittle, Woo Kyung Lee; Park, Sunmi; Lee, Seul Gi; Jeong, Seonhyang; Lee, Gibbeum; Ryu, Dongryeol; Schoonjans, Kristina; Auwerx, Johan; Lee, Jandee; Jo, Young Suk			Non-genomic activation of the AKT-mTOR pathway by the mitochondrial stress response in thyroid cancer	ONCOGENE			English	Article							GENE-EXPRESSION; METABOLISM; PHOSPHORYLATION; PERSPECTIVE; SURVIVAL; WARBURG; PROTEOSTASIS; SUPPRESSION; HOMEOSTASIS; RESISTANCE	Cancer progression is associated with metabolic reprogramming and causes significant intracellular stress; however, the mechanisms that link cellular stress and growth signalling are not fully understood. Here, we identified a mechanism that couples the mitochondrial stress response (MSR) with tumour progression. We demonstrated that the MSR is activated in a significant proportion of human thyroid cancers via the upregulation of heat shock protein D family members and the mitokine, growth differentiation factor 15. Our study also revealed that MSR triggered AKT/S6K signalling by activating mTORC2 via activating transcription factor 4/sestrin 2 activation whilst promoting leucine transporter and nutrient-induced mTORC1 activation. Importantly, we found that an increase in (mt)DNA played an essential role in MSR-induced mTOR activation and that crosstalk between MYC and MSR potentiated mTOR activation. Together, these findings suggest that the MSR could be a predictive marker for aggressive human thyroid cancer as well as a useful therapeutic target.	[Doolittle, Woo Kyung Lee] NCI, Lab Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Park, Sunmi; Jeong, Seonhyang; Jo, Young Suk] Yonsei Univ, Dept Internal Med, Open NBI Convergence Technol Res Lab, Coll Med, Seoul 03722, South Korea; [Lee, Seul Gi] Eulji Univ, Dept Surg, Sch Med, Daejeon 34824, South Korea; [Lee, Gibbeum; Lee, Jandee] Yonsei Univ, Severance Hosp, Yonsei Canc Ctr, Dept Surg,Coll Med,Open NBI Convergence Technol R, Seoul 03722, South Korea; [Ryu, Dongryeol] Sungkyunkwan Univ, Dept Mol Cell Biol, Lab Mol & Integrat Biol, Sch Med, Suwon 16419, South Korea; [Schoonjans, Kristina] Ecole Polytech Fed Lausanne, Lab Metab Signaling, CH-1015 Lausanne, Switzerland; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat Syst Physiol, CH-1015 Lausanne, Switzerland; [Doolittle, Woo Kyung Lee] Case Western Reserve Univ, Univ Hosp Cleveland Med Ctr, Dept Med, Cleveland, OH 44106 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yonsei University; Yonsei University Health System; Eulji University; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Case Western Reserve University; University Hospitals of Cleveland	Jo, YS (corresponding author), Yonsei Univ, Dept Internal Med, Open NBI Convergence Technol Res Lab, Coll Med, Seoul 03722, South Korea.; Lee, J (corresponding author), Yonsei Univ, Severance Hosp, Yonsei Canc Ctr, Dept Surg,Coll Med,Open NBI Convergence Technol R, Seoul 03722, South Korea.	jandee@yuhs.ac; joys@yuhs.ac	Doolittle, Woo Kyung Lee/CAJ-0252-2022	Doolittle, Woo Kyung Lee/0000-0002-6737-3173; Jo, Young Suk/0000-0001-9926-8389; Ryu, Dongryeol/0000-0001-5905-6760; Lee, Jandee/0000-0003-4090-0049; Schoonjans, Kristina/0000-0003-1247-4265	National Research Foundation of Korea grant - Korean government [NRF-2018R1A2B6004179, NRF-2021R1H1A2012035, NRF-2020R1A2C1006047, NRF-2020R1I1A1A01069524]; National Research Foundation of Korea GRL grant [NRF-2017K1A1A2013124]; Ecole Polytechnique Federale de Lausanne; European Research Council [ERC-AdG-787702]; Swiss Cancer Research [KFS-4226-08-2017]; Swiss National Science Foundation, Sinergia [CRSII3_160798]	National Research Foundation of Korea grant - Korean government(National Research Foundation of Korea); National Research Foundation of Korea GRL grant; Ecole Polytechnique Federale de Lausanne; European Research Council(European Research Council (ERC)European Commission); Swiss Cancer Research; Swiss National Science Foundation, Sinergia(Swiss National Science Foundation (SNSF))	We received funding from the National Research Foundation of Korea grant, funded by the Korean government NRF-2018R1A2B6004179 and NRF-2021R1H1A2012035 (YSJ); NRF-2020R1A2C1006047 (JL); NRF-2020R1I1A1A01069524 (SP); National Research Foundation of Korea GRL grant NRF-2017K1A1A2013124 (JA); Ecole Polytechnique Federale de Lausanne (JA and KS); European Research Council ERC-AdG-787702 (JA); Swiss Cancer Research KFS-4226-08-2017 (KS); and Swiss National Science Foundation, Sinergia CRSII3_160798 (KS).	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bao XT, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03505-1; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Byun JK, 2017, CELL REP, V20, P586, DOI 10.1016/j.celrep.2017.06.066; Chae YC, 2016, CANCER CELL, V30, P257, DOI 10.1016/j.ccell.2016.07.004; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; D'Amico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002; Ding L, 2018, CELL, V173, P305, DOI 10.1016/j.cell.2018.03.033; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Garaeva AA, 2016, CELL CYCLE, V15, P64, DOI 10.1080/15384101.2015.1120929; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Ishida S, 2013, P NATL ACAD SCI USA, V110, P19507, DOI 10.1073/pnas.1318431110; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Knippler CM, 2019, ENDOCR-RELAT CANCER, V26, P699, DOI 10.1530/ERC-19-0188; Kowalsky AH, 2020, J BIOL CHEM, V295, P1769, DOI 10.1074/jbc.RA119.010857; Lee MH, 2011, J CLIN ENDOCR METAB, V96, pE19, DOI 10.1210/jc.2010-1071; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martinez-Reyes I, 2012, BIOCHEM J, V444, P249, DOI 10.1042/BJ20111829; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004; MATTS RL, 1983, P NATL ACAD SCI-BIOL, V80, P2559, DOI 10.1073/pnas.80.9.2559; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Nacarelli T, 2015, EXP GERONTOL, V68, P66, DOI 10.1016/j.exger.2014.11.004; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; O'Malley J, 2020, TRENDS CANCER, V6, P688, DOI 10.1016/j.trecan.2020.04.009; Park HW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5233; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peng M, 2015, HUM MOL GENET, V24, P4829, DOI 10.1093/hmg/ddv207; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Peng XX, 2018, CELL REP, V23, P255, DOI 10.1016/j.celrep.2018.03.077; Porporato PE, 2018, CELL RES, V28, P265, DOI 10.1038/cr.2017.155; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Quiros PM, 2016, NAT REV MOL CELL BIO, V17, P213, DOI 10.1038/nrm.2016.23; Ringel MD, 2001, CANCER RES, V61, P6105; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saxton RA, 2016, SCIENCE, V351, P53, DOI 10.1126/science.aad2087; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vasko V, 2007, P NATL ACAD SCI USA, V104, P2803, DOI 10.1073/pnas.0610733104; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Yi HS, 2018, J MOL ENDOCRINOL, V61, pR91, DOI 10.1530/JME-18-0005; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yu J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3248-y; Yu M, 2007, TOXICOL LETT, V170, P83, DOI 10.1016/j.toxlet.2007.02.013; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zheng XD, 2016, ELIFE, V5, DOI 10.7554/eLife.13378; Zhou Q, 2015, TOXICOL SCI, V143, P81, DOI 10.1093/toxsci/kfu211	70	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2022	41	44					4893	4904		10.1038/s41388-022-02484-7	http://dx.doi.org/10.1038/s41388-022-02484-7		OCT 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5U1RX	36195659				2022-12-26	WOS:000864233500001
J	Kim, S; Jeong, WK; Choi, JH; Kim, JH; Chun, M				Kim, Sihwan; Jeong, Woo Kyoung; Choi, Jin Hwa; Kim, Jong Hyo; Chun, Minsoo			Development of deep learning-assisted overscan decision algorithm in low-dose chest CT: Application to lung cancer screening in Korean National CT accreditation program	PLOS ONE			English	Article							CUMULATIVE RADIATION-EXPOSURE; COMPUTED-TOMOGRAPHY; OPTIMIZATION; REDUCTION; PROTOCOL	We propose a deep learning-assisted overscan decision algorithm in chest low-dose computed tomography (LDCT) applicable to the lung cancer screening. The algorithm reflects the radiologists' subjective evaluation criteria according to the Korea institute for accreditation of medical imaging (KIAMI) guidelines, where it judges whether a scan range is beyond landmarks' criterion. The algorithm consists of three stages: deep learning-based landmark segmentation, rule-based logical operations, and overscan determination. A total of 210 cases from a single institution (internal data) and 50 cases from 47 institutions (external data) were utilized for performance evaluation. Area under the receiver operating characteristic (AUROC), accuracy, sensitivity, specificity, and Cohen's kappa were used as evaluation metrics. Fisher's exact test was performed to present statistical significance for the overscan detectability, and univariate logistic regression analyses were performed for validation. Furthermore, an excessive effective dose was estimated by employing the amount of overscan and the absorbed dose to effective dose conversion factor. The algorithm presented AUROC values of 0.976 (95% confidence interval [CI]: 0.925-0.987) and 0.997 (95% CI: 0.800-0.999) for internal and external dataset, respectively. All metrics showed average performance scores greater than 90% in each evaluation dataset. The AI-assisted overscan decision and the radiologist's manual evaluation showed a statistically significance showing a p-value less than 0.001 in Fisher's exact test. In the logistic regression analysis, demographics (age and sex), data source, CT vendor, and slice thickness showed no statistical significance on the algorithm (each p-value > 0.05). Furthermore, the estimated excessive effective doses were 0.02 +/- 0.01 mSv and 0.03 +/- 0.05 mSv for each dataset, not a concern within slight deviations from an acceptable scan range. We hope that our proposed overscan decision algorithm enables the retrospective scan range monitoring in LDCT for lung cancer screening program, and follows an as low as reasonably achievable (ALARA) principle.	[Kim, Sihwan; Kim, Jong Hyo] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Appl Bioengn, Seoul, South Korea; [Kim, Sihwan; Kim, Jong Hyo] ClariPi Res, Seoul, South Korea; [Jeong, Woo Kyoung] Sungkyunkwan Univ, Dept Radiol, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Choi, Jin Hwa] Chung Ang Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Kim, Jong Hyo] Adv Inst Convergence Technol, Ctr Med IT Convergence Technol Res, Suwon, South Korea; [Kim, Jong Hyo] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Kim, Jong Hyo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jong Hyo; Chun, Minsoo] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea; [Chun, Minsoo] Chung Ang Univ, Dept Radiat Oncol, Gwang Myeong Hosp, Seoul, Gyeonggi Do, South Korea	Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Chung Ang University	Chun, M (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea.; Chun, M (corresponding author), Chung Ang Univ, Dept Radiat Oncol, Gwang Myeong Hosp, Seoul, Gyeonggi Do, South Korea.	ms1236@caumc.or.kr	; Chun, Minsoo/C-4493-2014	Kim, Sihwan/0000-0001-9444-0303; Chun, Minsoo/0000-0001-8578-9976; Jeong, Woo Kyoung/0000-0002-0676-2116	Korea Medical Device Development Fund - Korean government (the Ministry of Science and ICT) [1711138600, 1711138601, KMDF_PR_20200901_0267]; Korea Medical Device Development Fund - Korean government (Ministry of Trade, Industry and Energy) [1711138600, 1711138601, KMDF_PR_20200901_0267]; Korea Medical Device Development Fund - Korean government (Ministry of Health Welfare) [1711138600, 1711138601, KMDF_PR_20200901_0267]; Korea Medical Device Development Fund - Korean government (Ministry of Food and Drug Safety) [1711138600, 1711138601, KMDF_PR_20200901_0267]	Korea Medical Device Development Fund - Korean government (the Ministry of Science and ICT); Korea Medical Device Development Fund - Korean government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korean government (Ministry of Health Welfare); Korea Medical Device Development Fund - Korean government (Ministry of Food and Drug Safety)	This work was supported by the Korea Medical Device Development Fund grant funded by the Korean government (the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, the Ministry of Food and Drug Safety) (Project Numbers: 1711138600, 1711138601, KMDF_PR_20200901_0267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2021, NPJ DIGIT MED, V4, DOI 10.1038/s41746-021-00438-z; Altman D., 2013, STAT CONFIDENCE CONF; Chun M, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0271724; Chun M, 2015, PHYS MED BIOL, V60, P9107, DOI 10.1088/0031-9155/60/23/9107; Cinar U, 2003, LARYNGOSCOPE, V113, P1813, DOI 10.1097/00005537-200310000-00028; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Cohen SL, 2020, CLIN IMAG, V62, P76, DOI 10.1016/j.clinimag.2019.11.020; Colevray M, 2019, DIAGN INTERV IMAG, V100, P177, DOI 10.1016/j.diii.2018.11.001; Cullell-Dalmau M, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.644327; Demircioglu A, 2021, RADIOL-ARTIF INTELL, V3, DOI 10.1148/ryai.2021200211; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Haubenreisser H, 2015, EUR J RADIOL, V84, P1608, DOI 10.1016/j.ejrad.2015.04.018; International Organization for Standardization (ISO), 572511994EN ISO; Isensee F, 2021, NAT METHODS, V18, P203, DOI 10.1038/s41592-020-01008-z; Johnson JN, 2014, CIRCULATION, V130, P161, DOI 10.1161/CIRCULATIONAHA.113.005425; Kijowski R, 2020, J MAGN RESON IMAGING, V52, P1607, DOI 10.1002/jmri.27001; Kim Hee Jung, 2017, [PROGRESS in MEDICAL PHYSICS, 의학물리], V28, P27, DOI 10.14316/pmp.2017.28.1.27; Kim Hyae Young, 2019, [Journal of the Korean Society of Radiology (JKSR), 대한영상의학회지], V80, P826, DOI 10.3348/jksr.2019.80.5.826; Korea Institute of Associated Medical Imaging (KIAMI), STAND GUID LOW DOS C; Kubo T, 2016, EUR J RADIOL OPEN, V3, P86, DOI 10.1016/j.ejro.2016.04.001; Kuo Pei-Lun, 2022, Acad Radiol, V29, P1552, DOI 10.1016/j.acra.2022.02.017; Larson DB, 2013, RADIOLOGY, V269, P177, DOI 10.1148/radiol.13122321; Lee W -J, 2012, J RADIAT PROT RES, V37, P84, DOI [10.14407/jrp.2012.37.2.084, DOI 10.14407/JRP.2012.37.2.084]; Li XH, 2019, MED PHYS, V46, P1575, DOI 10.1002/mp.13431; Liu C -F, 2021, COMMUNITY MED, V1, P1, DOI [10.1038/s43856-021-00062-8, DOI 10.1101/2021.10.19.21257543, DOI 10.1038/S43856-021-00062-8]; Malone J, 2009, P INT WORKSHOP INT A, P79; McCollough C, 2008, MEASUREMENT REPORTIN, V23, P1, DOI [10.37206/97, DOI 10.37206/97]; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Ministry of Health and Welfare Republic of Korea, 2021, RUL INST OP SPEC MED; Morgan N, 1989, ADV NEURAL INF PROCE; Niemann T, 2008, AM J ROENTGENOL, V191, P396, DOI 10.2214/AJR.07.3414; Ohno Y, 2012, AM J ROENTGENOL, V199, pW477, DOI 10.2214/AJR.11.8275; Oudkerk M, 2021, NAT REV CLIN ONCOL, V18, P135, DOI 10.1038/s41571-020-00432-6; Poletti PA, 2007, AM J ROENTGENOL, V188, P927, DOI 10.2214/AJR.06.0793; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sagara Y, 2010, AM J ROENTGENOL, V195, P713, DOI 10.2214/AJR.09.2989; Sakane H, 2020, RADIOLOGY, V295, P439, DOI 10.1148/radiol.2020190389; Salimi Y, 2021, INSIGHTS IMAGING, V12, DOI 10.1186/s13244-021-01105-3; Schwartz F, 2018, EUR J RADIOL, V102, P49, DOI 10.1016/j.ejrad.2018.03.005; Shah DJ, 2012, BRIT J RADIOL, V85, pE1166, DOI 10.1259/bjr/25026140; Siva S, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-248; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Suntharalingam S, 2018, ACAD RADIOL, V25, P153, DOI 10.1016/j.acra.2017.08.011; Tolles J, 2016, JAMA-J AM MED ASSOC, V316, P533, DOI 10.1001/jama.2016.7653; Trattner S, 2014, J AM COLL RADIOL, V11, P271, DOI 10.1016/j.jacr.2013.10.016; Trevethan R, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00307; Wu PP, 2020, COMPUT INTEL NEUROSC, V2020, DOI 10.1155/2020/8975078; Yang H, 2016, ARXIV; Yang Q, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3298981; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu Lifeng, 2009, Imaging Med, V1, P65, DOI 10.2217/iim.09.5; Zarb F, 2010, RADIOGRAPHY, V16, P147, DOI 10.1016/j.radi.2009.10.002; Zhang SJ, 2021, J HEALTHC ENG, V2021, DOI 10.1155/2021/5524769; Zhang WG, 2021, INT J GEN MED, V14, P1033, DOI 10.2147/IJGM.S293173; Zinsser D, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0304-x	57	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2022	17	9							e0275531	10.1371/journal.pone.0275531	http://dx.doi.org/10.1371/journal.pone.0275531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6Q4SK	36174098	gold, Green Published			2022-12-26	WOS:000891603400001
J	Maiques-Diaz, A; Nicosia, L; Basma, NJ; Romero-Camarero, I; Camera, F; Spencer, GJ; Amaral, FMR; Simeoni, F; Wingelhofer, B; Williamson, AJK; Pierce, A; Whetton, AD; Somervaille, TCP				Maiques-Diaz, Alba; Nicosia, Luciano; Basma, Naseer J.; Romero-Camarero, Isabel; Camera, Francesco; Spencer, Gary J.; Amaral, Fabio M. R.; Simeoni, Fabrizio; Wingelhofer, Bettina; Williamson, Andrew J. K.; Pierce, Andrew; Whetton, Anthony D.; Somervaille, Tim C. P.			HMG20B stabilizes association of LSD1 with GFI1 on chromatin to confer transcription repression and leukemia cell differentiation block	ONCOGENE			English	Article							TRANS-RETINOIC ACID; SNAG DOMAIN; DEMETHYLASE; INHIBITION; COREST; DEACETYLASE; COMPLEX; MLL; PROLIFERATION; NEUTROPENIA	Pharmacologic inhibition of LSD1 induces molecular and morphologic differentiation of blast cells in acute myeloid leukemia (AML) patients harboring MLL gene translocations. In addition to its demethylase activity, LSD1 has a critical scaffolding function at genomic sites occupied by the SNAG domain transcription repressor GFI1. Importantly, inhibitors block both enzymatic and scaffolding activities, in the latter case by disrupting the protein:protein interaction of GFI1 with LSD1. To explore the wider consequences of LSD1 inhibition on the LSD1 protein complex we applied mass spectrometry technologies. We discovered that the interaction of the HMG-box protein HMG20B with LSD1 was also disrupted by LSD1 inhibition. Downstream investigations revealed that HMG20B is co-located on chromatin with GFI1 and LSD1 genome-wide; the strongest HMG20B binding co-locates with the strongest GFI1 and LSD1 binding. Functional assays demonstrated that HMG20B depletion induces leukemia cell differentiation and further revealed that HMG20B is required for the transcription repressor activity of GFI1 through stabilizing LSD1 on chromatin at GFI1 binding sites. Interaction of HMG20B with LSD1 is through its coiled-coil domain. Thus, HMG20B is a critical component of the GFI1:LSD1 transcription repressor complex which contributes to leukemia cell differentiation block.	[Maiques-Diaz, Alba; Nicosia, Luciano; Basma, Naseer J.; Romero-Camarero, Isabel; Camera, Francesco; Spencer, Gary J.; Amaral, Fabio M. R.; Simeoni, Fabrizio; Wingelhofer, Bettina; Somervaille, Tim C. P.] Univ Manchester, Canc Res UK Manchester Inst, Leukaemia Biol Lab, Manchester Canc Res Ctr Bldg,555 Wilmslow Rd, Manchester M20 4GJ, Lancs, England; [Williamson, Andrew J. K.; Pierce, Andrew; Whetton, Anthony D.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Wolfson Mol Imaging Ctr, Stem Cell & Leukaemia Prote Lab, 27 Palatine Rd, Manchester M20 3LJ, Lancs, England; [Pierce, Andrew] Fron Heulog Bangor Univ, Coll Human Sci, Sch Med & Hlth Sci, Bangor LL57 2TH, Gwynedd, Wales; [Whetton, Anthony D.] Univ Surrey, Sch Vet Med, VSM Bldg, Guildford GU2 7AL, Surrey, England; [Whetton, Anthony D.] Univ Surrey, Sch Biosci & Med, VSM Bldg, Guildford GU2 7AL, Surrey, England	Cancer Research UK; University of Manchester; University of Manchester; University of Surrey; University of Surrey	Somervaille, TCP (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, Leukaemia Biol Lab, Manchester Canc Res Ctr Bldg,555 Wilmslow Rd, Manchester M20 4GJ, Lancs, England.	tim.somervaille@cruk.manchester.ac.uk		Nicosia, Luciano/0000-0003-3016-931X; Romero-Camarero, Isabel/0000-0002-2859-7641; Simeoni, Fabrizio/0000-0002-5543-6413; Maiques-Diaz, Alba/0000-0002-3365-3775	Cancer Research UK [C5759/A20971, C5759/A27412]; Kay Kendall Leukaemia Fund Junior Research Fellowship [KKL1185]; Blood Cancer UK [13005, 19007]; Imago Biosciences; Leukaemia UK [2020/JGF/005]	Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund Junior Research Fellowship; Blood Cancer UK; Imago Biosciences; Leukaemia UK	This work was supported by Cancer Research UK grant numbers C5759/A20971 and C5759/A27412 (AM-D, LN, FC, IR-C, GJS, BW, FMRA, FS, TCPS); a Kay Kendall Leukaemia Fund Junior Research Fellowship (KKL1185) (to IR-C); Blood Cancer UK grant numbers 13005 and 19007 (to AP, AJKW, ADW); an educational grant from Imago Biosciences (to NJB); and Leukaemia UK grant number 2020/JGF/005 (to BW). We are grateful to Jeff Barry, Wolfgang Breitwieser, Gillian Newton, Duncan Smith, John Weightman for technical support; and to Andrew Porter for pre-submission review of the manuscript. Cancer Research UK grant numbers C5759/A20971 and C5759/A27412; Kay Kendall Leukaemia Fund Junior Research Fellowship KKL1185; Blood Cancer UK grant numbers 13005 and 19007; Leukaemia UK grant number 2020/JGF/005.	Barth J, 2019, LEUKEMIA, V33, P1411, DOI 10.1038/s41375-018-0375-7; Carmichael CL, 2020, BLOOD, V136, P957, DOI 10.1182/blood.2019002548; Deb G, 2020, LEUKEMIA, V34, P1266, DOI 10.1038/s41375-019-0659-6; Esteghamat F, 2011, HAEMATOL-HEMATOL J, V96, P1252, DOI 10.3324/haematol.2011.045211; Fiskus W, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00487-3; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Ishikawa Y, 2017, MOL CANCER THER, V16, P273, DOI 10.1158/1535-7163.MCT-16-0471; Karsunky H, 2002, NAT GENET, V30, P295, DOI 10.1038/ng831; Lee C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08269-5; Leiendecker L, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012525; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maiques-Diaz A, 2018, CELL REP, V22, P3641, DOI 10.1016/j.celrep.2018.03.012; Maiques-Diaz A, 2016, EPIGENOMICS-UK, V8, P1103, DOI 10.2217/epi-2016-0009; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Marneth AE, 2018, HAEMATOLOGICA, V103, pE395, DOI 10.3324/haematol.2017.180844; McClellan D, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00020-19; McGrath JP, 2016, CANCER RES, V76, P1975, DOI 10.1158/0008-5472.CAN-15-2333; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moroy T, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00824; Nicosia L, 2022, ONCOGENE, V41, P878, DOI 10.1038/s41388-021-02123-7; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Pettit K, 2019, BLOOD, V134, DOI 10.1182/blood-2019-123244; Ravasio R, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax2746; Rivero S, 2015, ONCOGENE, V34, P5264, DOI 10.1038/onc.2014.446; Salamero O, 2020, J CLIN ONCOL, V38, P4260, DOI 10.1200/JCO.19.03250; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Song Y, 2020, CELL REP, V30, P2699, DOI 10.1016/j.celrep.2020.01.091; Sumoy L, 2000, CYTOGENET CELL GENET, V88, P62, DOI 10.1159/000015486; Takagi S, 2017, CANCER RES, V77, P4652, DOI 10.1158/0008-5472.CAN-16-3502; Tayari MM, 2021, CLIN CANCER RES, V27, P1893, DOI 10.1158/1078-0432.CCR-20-4054; van Bergen MGJM, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01027; Wass M, 2021, LEUKEMIA, V35, P701, DOI 10.1038/s41375-020-0892-z; Welcker JE, 2013, DEVELOPMENT, V140, P4947, DOI 10.1242/dev.097642; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Yamamoto Ryusuke, 2018, Oncotarget, V9, P21007, DOI 10.18632/oncotarget.24774; Yang MJ, 2006, MOL CELL, V23, P377, DOI 10.1016/j.molcel.2006.07.012; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	47	0	0	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2022	41	44					4841	4854		10.1038/s41388-022-02471-y	http://dx.doi.org/10.1038/s41388-022-02471-y		SEP 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5U1RX	36171271	hybrid, Green Published			2022-12-26	WOS:000861196200001
J	Farmer, JP; Mistry, SN; Laughton, CA; Holliday, ND				Farmer, James P.; Mistry, Shailesh N.; Laughton, Charles A.; Holliday, Nicholas D.			Development of fluorescent peptide G protein-coupled receptor activation biosensors for NanoBRET characterization of intracellular allosteric modulators	FASEB JOURNAL			English	Article						beta 2-Adrenoceptor; Allosteric modulators; Biosensors; CXCR2; GPCRs; Prostanoid receptor EP2	SYNTHETIC PEPTIDES; BINDING-SITE; ANTAGONISTS; SELECTIVITY; KINETICS; GUIDE; G(S)	G protein-coupled receptors (GPCRs) are widely therapeutically targeted, and recent advances in allosteric modulator development at these receptors offer further potential for exploitation. Intracellular allosteric modulators (IAM) represent a class of ligands that bind to the receptor-effector interface (e.g., G protein) and inhibit agonist responses noncompetitively. This potentially offers greater selectivity between receptor subtypes compared to classical orthosteric ligands. However, while examples of IAM ligands are well described, a more general methodology for assessing compound interactions at the IAM site is lacking. Here, fluorescent labeled peptides based on the G alpha peptide C terminus are developed as novel binding and activation biosensors for the GPCR-IAM site. In TR-FRET binding studies, unlabeled peptides derived from the G alpha s subunit were first characterized for their ability to positively modulate agonist affinity at the beta(2)-adrenoceptor. On this basis, a tetramethylrhodamine (TMR) labeled tracer was synthesized based on the 19 amino acid G alpha s peptide (TMR-G alpha s19cha18, where cha = cyclohexylalanine). Using NanoBRET technology to detect binding, TMR-G alpha s19cha18 was recruited to Gs coupled beta(2)-adrenoceptor and EP2 receptors in an agonist-dependent manner, but not the Gi-coupled CXCR2 receptor. Moreover, NanoBRET competition binding assays using TMR-G alpha s19cha18 enabled direct assessment of the affinity of unlabeled ligands for beta(2)-adrenoceptor IAM site. Thus, the NanoBRET platform using fluorescent-labeled G protein peptide mimetics offers novel potential for medium-throughput screens to identify IAMs, applicable across GPCRs coupled to a G protein class. Using the same platform, Gs peptide biosensors also represent useful tools to probe orthosteric agonist efficacy and the dynamics of receptor activation.	[Farmer, James P.; Holliday, Nicholas D.] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Med Sch, Nottingham NG7 2UH, England; [Farmer, James P.] Univ Birmingham, Ctr Membrane Prot & Receptors, Nottingham, England; [Farmer, James P.] Univ Nottingham, Nottingham, England; [Mistry, Shailesh N.; Laughton, Charles A.] Univ Nottingham, Sch Pharm, Nottingham, England; [Holliday, Nicholas D.] Biocity, Excellerate Biosci, Nottingham, England	University of Nottingham; University of Birmingham; University of Nottingham; University of Nottingham	Farmer, JP; Holliday, ND (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Life Sci, Med Sch, Nottingham NG7 2UH, England.	mbyjf3@nottingham.ac.uk; mbzndh@nottingham.ac.uk		Holliday, Nicholas/0000-0002-2900-828X; Farmer, James/0000-0002-4224-9299	British Pharmacological Society AJ Clark studentship	British Pharmacological Society AJ Clark studentship	This work was funded by The British Pharmacological Society AJ Clark studentship. The authors would like to thank Dr Desislava Nesheva for supplying CXCR2 cell membranes and Dr Nicola Dijon for providing initial EP2 constructs.	A.Kaur, 2020, bioRxiv, DOI 10.1101/2020.08.05.237982; Agasid MT, 2021, J AM CHEM SOC, V143, P4085, DOI 10.1021/jacs.0c11837; Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; Andrews G, 2008, MOL PHARMACOL, V73, P855, DOI 10.1124/mol.107.039321; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2011, J MED CHEM, V54, P6874, DOI 10.1021/jm2008562; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Dijon NC, 2021, METHODS MOL BIOL, V2268, P249, DOI 10.1007/978-1-0716-1221-7_17; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Gilchrist A, 1999, J BIOL CHEM, V274, P6610, DOI 10.1074/jbc.274.10.6610; Gilchrist A, 2001, J BIOL CHEM, V276, P25672, DOI 10.1074/jbc.M100914200; Gilchrist Annette, 2002, Sci STKE, V2002, ppl1, DOI 10.1126/stke.2002.118.pl1; Gonsiorek W, 2007, J PHARMACOL EXP THER, V322, P477, DOI 10.1124/jpet.106.118927; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hilger D, 2018, NAT STRUCT MOL BIOL, V25, P4, DOI 10.1038/s41594-017-0011-7; Hoare SRJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67844-3; Jiang CX, 2020, ACS CHEM NEUROSCI, V11, P1436, DOI 10.1021/acschemneuro.0c00078; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Kim K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017201118; Liu XY, 2017, NATURE, V548, P480, DOI 10.1038/nature23652; Lu HF, 2018, J MED CHEM, V61, P2518, DOI 10.1021/acs.jmedchem.7b01854; Mannes M, 2021, ANGEW CHEM INT EDIT, V60, P10247, DOI 10.1002/anie.202100180; Mazzoni MR, 2000, MOL PHARMACOL, V58, P226, DOI 10.1124/mol.58.1.226; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Qu CX, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf1268; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Soave M, 2020, BRIT J PHARMACOL, V177, P978, DOI 10.1111/bph.14953; Stoddart LA, 2018, TRENDS PHARMACOL SCI, V39, P136, DOI 10.1016/j.tips.2017.10.006; Stoddart LA, 2016, BRIT J PHARMACOL, V173, P3028, DOI 10.1111/bph.13316; Stoddart LA, 2015, NAT METHODS, V12, P661, DOI [10.1038/NMETH.3398, 10.1038/nmeth.3398]; Stott LA, 2016, BIOCHEM PHARMACOL, V101, P1, DOI 10.1016/j.bcp.2015.10.011; Sykes DA, 2019, MOL CELL ENDOCRINOL, V485, P9, DOI 10.1016/j.mce.2019.01.018; Sykes DA, 2018, METHODS MOL BIOL, V1824, P177, DOI 10.1007/978-1-4939-8630-9_10; Sykes DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00716-z; Sykes DA, 2012, BRIT J PHARMACOL, V165, P2672, DOI 10.1111/j.1476-5381.2011.01639.x; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P31973, DOI 10.1074/jbc.M112.348565; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010	44	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22576	10.1096/fj.202201024R	http://dx.doi.org/10.1096/fj.202201024R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A6NY	36183332	Green Published			2022-12-26	WOS:000863003200001
J	Cobo, NL; Sibinelli-Sousa, S; Biboy, J; Vollmer, W; Bayer-Santos, E; Prehna, G				Cobo, Neil Lorente; Sibinelli-Sousa, Stephanie; Biboy, Jacob; Vollmer, Waldemar; Bayer-Santos, Ethel; Prehna, Gerd			Molecular characterization of the type VI secretion system effector Tlde1a reveals a structurally altered fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN STRUCTURE; PROTEIN; BIOSYNTHESIS; FEATURES	The type VI secretion system (T6SS) is a molecular machine that Gram-negative bacteria have adapted for multiple func-tions, including interbacterial competition. Bacteria use the T6SS to deliver protein effectors into adjacent cells to kill rivals and establish niche dominance. Central to T6SS-mediated bacterial competition is an arms race to acquire diverse effec-tors to attack and neutralize target cells. The peptidoglycan has a central role in bacterial cell physiology, and effectors that biochemically modify peptidoglycan structure effectively induce cell death. One such T6SS effector is Tlde1a from Salmonella Typhimurium. Tlde1a functions as an LD-carboxypeptidase to cleave tetrapeptide stems and as an LD-transpeptidase to exchange the terminal D-alanine of a tetrapeptide stem with a noncanonical D-amino acid. To un-derstand how Tlde1a exhibits toxicity at the molecular level, we determined the X-ray crystal structure of Tlde1a alone and in complex with D-amino acids. Our structural data revealed that Tlde1a possesses a unique LD-transpeptidase fold consisting of a dual pocket active site with a capping subdomain. This in-cludes an exchange pocket to bind a D-amino acid for exchange and a catalytic pocket to position the D-alanine of a tetrapeptide stem for cleavage. Our toxicity assays in Escherichia coli and in vitro peptidoglycan biochemical assays with Tlde1a variants correlate Tlde1a molecular features directly to its biochemical functions. We observe that the LD-carboxypeptidase and LD-transpeptidase activities of Tlde1a are both structurally and functionally linked. Overall, our data highlight how an LD-transpeptidase fold has been structurally altered to create a toxic effector in the T6SS arms race.	[Cobo, Neil Lorente; Prehna, Gerd] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada; [Sibinelli-Sousa, Stephanie; Bayer-Santos, Ethel] Univ Sao Paulo, Biomed Sci Inst, Dept Microbiol, Sao Paulo, Brazil; [Biboy, Jacob; Vollmer, Waldemar] Newcastle Univ, Biosci Inst, Ctr Bacterial Cell Biol, Newcastle Upon Tyne, England	University of Manitoba; Universidade de Sao Paulo; Newcastle University - UK	Prehna, G (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.	gerd.prehna@umanitoba.ca		Sibinelli de Sousa, Stephanie/0000-0003-4875-8737; Prehna, Gerd/0000-0001-5539-7533; Lorente Cobo, Neil/0000-0001-5783-8988; Bayer-Santos, Ethel/0000-0003-3832-3449	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2018-04968]; Canadian Foundation for Innovation award (CFI) [37841]; UKRI Strategic Priorities Fund [EP/T002778/1]; Sao Paulo Research Foundation [2017/02178-2]; FAPESP Fellowship [2021/09162-0]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation award (CFI); UKRI Strategic Priorities Fund(UK Research & Innovation (UKRI)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP Fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) grants RGPIN-2018-04968 to G. P. and a Canadian Foundation for Innovation award (CFI) 37841 to G. P. This research was also funded by the UKRI Strategic Priorities Fund (https:// www.ukri.org) EP/T002778/1 to W. V. and a Sao Paulo Research Foundation grant 2017/02178-2 to E. B-S. Additionally, S.S.S. was funded by a FAPESP Fellowship (2021/09162-0) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahmad S, 2020, ELIFE, V9, DOI 10.7554/eLife.62816; Aliashkevich A, 2022, FEBS J, V289, P4718, DOI 10.1111/febs.16066; Allsopp LP, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13153; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bayer-Santos E, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007651; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Bui NK, 2009, J BACTERIOL, V191, P494, DOI 10.1128/JB.00608-08; Catherwood AC, 2020, J AM CHEM SOC, V142, P5034, DOI 10.1021/jacs.9b08822; Caveney NA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09507-0; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Chow J, 2010, CELL HOST MICROBE, V7, P265, DOI 10.1016/j.chom.2010.03.004; Cianfanelli FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005735; DeShazer D, 2019, MICROBIOL RES, V226, P48, DOI 10.1016/j.micres.2019.05.007; Durand E, 2015, NATURE, V523, P555, DOI 10.1038/nature14667; Egan AJF, 2018, MOL MICROBIOL, V110, P335, DOI 10.1111/mmi.14082; Egan AJF, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0031; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Flaugnatti N, 2020, EMBO J, V39, DOI 10.15252/embj.2019104129; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Hachani A, 2016, CURR OPIN MICROBIOL, V29, P81, DOI 10.1016/j.mib.2015.11.006; Han YY, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008198; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hernandez SB, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107578; Ho BT, 2014, CELL HOST MICROBE, V15, P9, DOI 10.1016/j.chom.2013.11.008; Holm L, 2020, METHODS MOL BIOL, V2112, P29, DOI 10.1007/978-1-0716-0270-6_3; Jana B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11546-6; Jiang F, 2014, CELL HOST MICROBE, V15, P600, DOI 10.1016/j.chom.2014.04.010; Jurenas D, 2021, NUCLEIC ACIDS RES, V49, P8384, DOI 10.1093/nar/gkab608; Jurenas D, 2021, MOL MICROBIOL, V115, P383, DOI 10.1111/mmi.14648; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HS, 2015, J BIOL CHEM, V290, P25103, DOI 10.1074/jbc.M115.658781; Kim HS, 2013, ACTA CRYSTALLOGR D, V69, P420, DOI 10.1107/S0907444912048998; Kudryashev M, 2015, CELL, V160, P952, DOI 10.1016/j.cell.2015.01.037; Kuru E, 2019, ACS CHEM BIOL, V14, P2745, DOI 10.1021/acschembio.9b00664; Kuru E, 2017, NAT MICROBIOL, V2, P1648, DOI 10.1038/s41564-017-0029-y; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Feria JM, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.584751; Mulder DT, 2012, INFECT IMMUN, V80, P1996, DOI 10.1128/IAI.06205-11; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park YJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07796-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Pissaridou P, 2018, P NATL ACAD SCI USA, V115, P12519, DOI 10.1073/pnas.1814181115; Quentin D, 2018, NAT MICROBIOL, V3, P1142, DOI 10.1038/s41564-018-0238-z; Renault MG, 2018, J MOL BIOL, V430, P3143, DOI 10.1016/j.jmb.2018.07.018; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2014, NAT REV MICROBIOL, V12, P137, DOI 10.1038/nrmicro3185; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Santin YG, 2018, NAT MICROBIOL, V3, P1304, DOI 10.1038/s41564-018-0234-3; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Si MR, 2017, P NATL ACAD SCI USA, V114, pE2233, DOI 10.1073/pnas.1614902114; Sibinelli-Sousa S, 2022, FEBS J, V289, P4192, DOI 10.1111/febs.16211; Sibinelli-Sousa S, 2021, J BACTERIOL, V203, DOI 10.1128/JB.00478-20; Sibinelli-Sousa S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107813; Souza DP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7453; Sycuro LK, 2013, MOL MICROBIOL, V90, P869, DOI 10.1111/mmi.12405; Tipping MJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007885; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Nguyen VS, 2018, CURR OPIN STRUC BIOL, V49, P77, DOI 10.1016/j.sbi.2018.01.007; Verster AJ, 2017, CELL HOST MICROBE, V22, P411, DOI 10.1016/j.chom.2017.08.010; Vollmer W, 2008, BBA-BIOMEMBRANES, V1778, P1714, DOI 10.1016/j.bbamem.2007.06.007; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wang TT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005020; Wenren LM, 2013, MBIO, V4, DOI 10.1128/mBio.00374-13; Whitney JC, 2015, CELL, V163, P607, DOI 10.1016/j.cell.2015.09.027; Whitney JC, 2013, J BIOL CHEM, V288, P26616, DOI 10.1074/jbc.M113.488320; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wood TE, 2019, CELL REP, V29, P187, DOI 10.1016/j.celrep.2019.08.094	77	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102556	10.1016/j.jbc.2022.102556	http://dx.doi.org/10.1016/j.jbc.2022.102556			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36183829	Green Published, gold, Green Submitted			2022-12-26	WOS:000886086000011
J	Ki, N; Kim, J; Jo, I; Hyun, Y; Ryu, S; Ha, NC				Ki, Nayeon; Kim, Jinshil; Jo, Inseong; Hyun, Yongseong; Ryu, Sangryeol; Ha, Nam-Chul			Isocitrate binds to the itaconic acid-responsive LysR-type transcriptional regulator RipR in Salmonella pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PATHWAY; GENE; CATABOLISM	Macrophages produce itaconic acid in phagosomes in response to bacterial cell wall component lipopolysaccharide to eliminate invading pathogenic bacteria. Itaconic acid compet-itively inhibits the first enzyme of the bacterial glyoxylate cycle. To overcome itaconic acid stress, bacteria employ the bacterial LysR-type transcriptional regulator RipR. However, it remains unknown which molecule activates RipR in bacterial patho-genesis. In this study, we determined the crystal structure of the regulatory domain of RipR from the intracellular pathogen Salmonella. The RipR regulatory domain structure exhibited the typical dimeric arrangement with the putative ligand-binding site between the two subdomains. Our isothermal titration calorimetry experiments identified isocitrate as the physiological ligand of RipR, whose intracellular level is increased in response to itaconic acid stress. We further found that 3-phenylpropionic acid significantly decreased the resis-tance of the bacteria to an itaconic acid challenge. Consistently, the complex structure revealed that the compound is antago-nistically bound to the RipR ligand-binding site. This study provides the molecular basis of bacterial survival in itaconic acid stress from our immune systems. Further studies are required to reveal biochemical activity, which would elucidate how Salmonella survives in macrophage phagosomes by defending against itaconic acid inhibition of bacterial metabolism.	[Ki, Nayeon; Kim, Jinshil; Jo, Inseong; Hyun, Yongseong; Ryu, Sangryeol; Ha, Nam-Chul] Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Seoul, South Korea; [Ki, Nayeon; Kim, Jinshil; Jo, Inseong; Hyun, Yongseong; Ryu, Sangryeol; Ha, Nam-Chul] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Ki, Nayeon; Kim, Jinshil; Jo, Inseong; Hyun, Yongseong; Ryu, Sangryeol; Ha, Nam-Chul] Sejong Univ, Ctr Food & Bioconvergence, Seoul 05006, South Korea; [Kim, Jinshil] Sejong Univ, Dept Food Sci & Biotechnol, Seoul 05006, South Korea; [Kim, Jinshil] Sejong Univ, Carbohydrate Bioprod Res Ctr, Seoul 05006, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sejong University; Sejong University; Sejong University	Ryu, S; Ha, NC (corresponding author), Seoul Natl Univ, Dept Food & Anim Biotechnol, Dept Agr Biotechnol, Seoul, South Korea.; Ryu, S; Ha, NC (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.; Ryu, S; Ha, NC (corresponding author), Sejong Univ, Ctr Food & Bioconvergence, Seoul 05006, South Korea.	sangryu@snu.ac.kr; hanc210@snu.ac.kr		Hyun, Yongseong/0000-0002-4731-8492	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through the High Value-added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA) [321036052HD020]; Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [2019M3E5D6063871]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2022R1A6A1A03055869]; Ministry of Food and Drug Safety [20162MFDS142]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through the High Value-added Food Technology Development Program - Ministry of Agriculture, Food and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of KoreaInstitute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	These works were supported by the Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry (IPET) through the High Value-added Food Technology Development Program funded by the Ministry of Agriculture, Food and Rural Affairs (MAFRA) (No. 321036052HD020 to N.-C. H.) . This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) , which is funded by the Ministry of Science & ICT (2019M3E5D6063871 to N.-C. H.) . This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2022R1A6A1A03055869 to J. K.) . This research was supported by a grant (20162MFDS142 to S. R.) from Ministry of Food and Drug Safety in 2022.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Api A. M., 2019, FOOD CHEM TOXICOL, V134; Barnes MR, 1997, J BACTERIOL, V179, P6145, DOI 10.1128/jb.179.19.6145-6153.1997; Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Bintsis T, 2017, AIMS MICROBIOL, V3, P529, DOI 10.3934/microbiol.2017.3.529; BURLINGAME R, 1983, J BACTERIOL, V155, P113, DOI 10.1128/JB.155.1.113-121.1983; C. L. M. Gilchrist, 2022, bioRxiv, DOI 10.1101/2022.02.07.479398; Chew S. Y., 2021, ENCY MYCOLOGY, P220; Chew SY, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0546-5; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Coelho C, 2022, PLOS PATHOG, V18, DOI 10.1371/journal.ppat.1010361; Cordes T, 2015, ANNU REV NUTR, V35, P451, DOI 10.1146/annurev-nutr-071714-034243; Craven SH, 2009, MOL MICROBIOL, V72, P881, DOI 10.1111/j.1365-2958.2009.06686.x; Cronan John E Jr, 2005, EcoSal Plus, V1, DOI 10.1128/ecosalplus.3.5.2; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; Diaz E, 1998, J BACTERIOL, V180, P2915; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gautam A, 2011, INFECT IMMUN, V79, P4876, DOI 10.1128/IAI.05451-11; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hersch SJ, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00303-20; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Jo I, 2019, P NATL ACAD SCI USA, V116, P3740, DOI 10.1073/pnas.1811509116; Jo I, 2017, J BIOL CHEM, V292, P7223, DOI 10.1074/jbc.M116.743765; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Lahiri A, 2009, INT J BIOCHEM CELL B, V41, P2129, DOI 10.1016/j.biocel.2009.05.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; M. Mirdita, 2021, bioRxiv, DOI 10.1101/2021.08.15.456425; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mahounga DM, 2018, ACTA CRYSTALLOGR F, V74, P506, DOI 10.1107/S2053230X18008841; Manso I, 2009, J BIOL CHEM, V284, P21218, DOI 10.1074/jbc.M109.008243; MCFADDEN BA, 1977, J BACTERIOL, V131, P136, DOI 10.1128/JB.131.1.136-144.1977; Menage S, 2014, NAT CHEM BIOL, V10, P326, DOI 10.1038/nchembio.1505; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ren J, 2015, APPL ENVIRON MICROB, V81, P5675, DOI 10.1128/AEM.01009-15; Sasikaran J, 2014, NAT CHEM BIOL, V10, P371, DOI 10.1038/nchembio.1482; Tangsudjai S, 2010, MICROBIOL IMMUNOL, V54, P282, DOI 10.1111/j.1348-0421.2010.00205.x; Taylor JL, 2012, MOL MICROBIOL, V83, P457, DOI 10.1111/j.1365-2958.2011.07919.x; Thomas DM, 2005, FASEB J, V19, P515, DOI 10.1096/fj.05-4873fje; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	49	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102562	10.1016/j.jbc.2022.102562	http://dx.doi.org/10.1016/j.jbc.2022.102562			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36198361	Green Published, gold			2022-12-26	WOS:000882199400006
J	Srivastava, S; Jiang, J; Misra, J; Seim, G; Staschke, KA; Zhong, MH; Zhou, L; Liu, Y; Chen, C; Dave, U; Kapur, R; Batra, S; Zhang, C; Zhou, JH; Fan, J; Wek, RC; Zhang, J				Srivastava, Sankalpip; Jiang, Jie; Misra, Jagannath; Seim, Gretchen; Staschke, Kirk A.; Zhong, Minghua; Zhou, Leonardo; Liu, Yu; Chen, Chong; Dave, Utpal; Kapur, Reuben; Batra, Sandeep; Zhang, Chi; Zhou, Jiehao; Fan, Jing; Wek, Ronald C.; Zhang, Ji			Asparagine bioavailability regulates the translation of MYC oncogene	ONCOGENE			English	Article							C-MYC; GLUTAMINE; METABOLISM; DEPRIVATION; SUPPRESSION; ADAPTATION	Amino acid restriction has recently emerged as a compelling strategy to inhibit tumor growth. Recent work suggests that amino acids can regulate cellular signaling in addition to their role as biosynthetic substrates. Using lymphoid cancer cells as a model, we found that asparagine depletion acutely reduces the expression of c-MYC protein without changing its mRNA expression. Furthermore, asparagine depletion inhibits the translation of MYC mRNA without altering the rate of MYC protein degradation. Of interest, the inhibitory effect on MYC mRNA translation during asparagine depletion is not due to the activation of the general controlled nonderepressible 2 (GCN2) pathway and is not a consequence of the inhibition of global protein synthesis. In addition, both the 5' and 3' untranslated regions (UTRs) of MYC mRNA are not required for this inhibitory effect. Finally, using a MYC-driven mouse B cell lymphoma model, we found that shRNA inhibition of asparagine synthetase (ASNS) or pharmacological inhibition of asparagine production can significantly reduce the MYC protein expression and tumor growth when environmental asparagine becomes limiting. Since MYC is a critical oncogene, our results uncover a molecular connection between MYC mRNA translation and asparagine bioavailability and shed light on a potential to target MYC oncogene post-transcriptionally through asparagine restriction.	[Srivastava, Sankalpip; Jiang, Jie; Zhong, Minghua; Zhou, Leonardo; Kapur, Reuben; Zhang, Ji] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Srivastava, Sankalpip; Misra, Jagannath; Staschke, Kirk A.; Wek, Ronald C.; Zhang, Ji] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Seim, Gretchen] Univ Wisconsin Madison, Morgridge Inst Res, Madison, WI 53715 USA; [Seim, Gretchen] Univ Wisconsin Madison, Dept Nutr Sci, Madison, WI 53715 USA; [Chen, Chong] Sichuan Univ, West China Hosp, Dept Hematol, State Key Lab Biotherapy, Chengdu 610000, Sichuan, Peoples R China; [Chen, Chong] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610000, Sichuan, Peoples R China; [Dave, Utpal] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Batra, Sandeep] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN 46202 USA; [Zhang, Chi] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Zhou, Jiehao] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; Sichuan University; Sichuan University; Indiana University System; Indiana University Bloomington; Indiana University System; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, J (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.; Zhang, J (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	jzh1@iu.edu	Misra, Jagannath/AAW-8774-2021; Staschke, Kirk/HGC-5664-2022	Staschke, Kirk/0000-0001-8722-9585; Chen, Chong/0000-0002-6787-0495; Dave, Utpal/0000-0002-9416-1686	NIH/NCI [CA244625]; American Society of Hematologyand the Riley Children Foundation; NIH/NIGMS [GM136331]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Hematologyand the Riley Children Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NCI CA244625, the American Society of Hematologyand the Riley Children Foundation. RCW is supported by NIH/NIGMS GM136331 and isa member of the advisory board of HiberCell, Inc.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Averous J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27698; Avramis VI, 2012, ANTICANCER RES, V32, P2423; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; BROOME JD, 1961, NATURE, V191, P1114, DOI 10.1038/1911114a0; Clasquin Michelle F, 2012, Curr Protoc Bioinformatics, VChapter 14, DOI 10.1002/0471250953.bi1411s37; Concordet JP, 2018, NUCLEIC ACIDS RES, V46, pW242, DOI 10.1093/nar/gky354; Csibi A, 2014, CURR BIOL, V24, P2274, DOI 10.1016/j.cub.2014.08.007; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang Chi V, 2010, Genes Cancer, V1, P526; Dejure FR, 2017, EMBO J, V36, P1854, DOI 10.15252/embj.201796662; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deng LF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15573-6; Farrell AS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014365; Fine BM, 2005, CANCER RES, V65, P291; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Halbrook CJ, 2020, BIORXIV, DOI [10.1101/2020.05.15.098368v1.full, DOI 10.1101/2020.05.15.098368V1.FULL]; Hoffman B, 2002, ONCOGENE, V21, P3414, DOI 10.1038/sj.onc.1205400; Jiang J, 2021, METABOLITES, V11, DOI 10.3390/metabo11060402; Jiang J, 2019, J BIOL CHEM, V294, P18674, DOI 10.1074/jbc.RA119.010447; Krall AS, 2021, CELL METAB, V33, P1013, DOI 10.1016/j.cmet.2021.02.001; Krall AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11457; Layer JH, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00652-19; Luengo A, 2017, CELL CHEM BIOL, V24, P1161, DOI 10.1016/j.chembiol.2017.08.028; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; Meng DL, 2020, J BIOL CHEM, V295, P2890, DOI 10.1074/jbc.AC119.011578; Misra J, 2021, NUCLEIC ACIDS RES, V49, P5726, DOI 10.1093/nar/gkab362; Nakamura A, 2018, P NATL ACAD SCI USA, V115, pE7776, DOI 10.1073/pnas.1805523115; Pathria G, 2019, NAT CELL BIOL, V21, P1590, DOI 10.1038/s41556-019-0415-1; Pavlova NN, 2018, CELL METAB, V27, P428, DOI 10.1016/j.cmet.2017.12.006; Pelossof R, 2017, NAT BIOTECHNOL, V35, P350, DOI 10.1038/nbt.3807; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Stine ZE, 2022, NAT REV DRUG DISCOV, V21, P141, DOI 10.1038/s41573-021-00339-6; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wilson GJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1124, DOI 10.1152/ajpendo.00080.2013; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Wu J, 2021, NAT CELL BIOL, V23, DOI 10.1038/s41556-020-00615-4; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Yue M, 2017, CELL REP, V21, P3819, DOI 10.1016/j.celrep.2017.12.002; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099	54	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2022	41	44					4855	4865		10.1038/s41388-022-02474-9	http://dx.doi.org/10.1038/s41388-022-02474-9		OCT 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5U1RX	36182969	Green Accepted			2022-12-26	WOS:000862526800003
J	Jo, S; Centeio, R; Park, J; Ousingsawat, J; Jeon, DK; Talbi, K; Schreiber, R; Ryu, K; Kahlenberg, K; Somoza, V; Delpiano, L; Gray, MA; Amaral, MD; Railean, V; Beekman, JM; Rodenburg, LW; Namkung, W; Kunzelmann, K				Jo, Sungwoo; Centeio, Raquel; Park, Jinhong; Ousingsawat, Jiraporn; Jeon, Dong-Kyu; Talbi, Khaoula; Schreiber, Rainer; Ryu, Kunhi; Kahlenberg, Kristin; Somoza, Veronika; Delpiano, Livia; Gray, Michael A.; Amaral, Margarida D.; Railean, Violeta; Beekman, Jeffrey M.; Rodenburg, Lisa W.; Namkung, Wan; Kunzelmann, Karl			The SLC26A9 inhibitor S9-A13 provides no evidence for a role of SLC26A9 in airway chloride secretion but suggests a contribution to regulation of ASL pH and gastric proton secretion	FASEB JOURNAL			English	Article						airways; asthma; Cl- secretion; cystic fibrosis; pH regulation; S9-A13	TRANSMEMBRANE CONDUCTANCE REGULATOR; FUNCTIONAL-CHARACTERIZATION; CL-/HCO3-EXCHANGE; EPITHELIAL-CELLS; CL-TRANSPORT; CFTR; CHANNEL; EXPRESSION; DAMAGE; HCO3	The solute carrier 26 family member A9 (SLC26A9) is an epithelial anion transporter that is assumed to contribute to airway chloride secretion and surface hydration. Whether SLC26A9 or CFTR is responsible for airway Cl- transport under basal conditions is still unclear, due to the lack of a specific inhibitor for SLC26A9. In the present study, we report a novel potent and specific inhibitor for SLC26A9, identified by screening of a drug-like molecule library and subsequent chemical modifications. The most potent compound S9-A13 inhibited SLC26A9 with an IC50 of 90.9 +/- 13.4 nM. S9-A13 did not inhibit other members of the SLC26 family and had no effects on Cl- channels such as CFTR, TMEM16A, or VRAC. S9-A13 inhibited SLC26A9 Cl- currents in cells that lack expression of CFTR. It also inhibited proton secretion by HGT-1 human gastric cells. In contrast, S9-A13 had minimal effects on ion transport in human airway epithelia and mouse trachea, despite clear expression of SLC26A9 in the apical membrane of ciliated cells. In both tissues, basal and stimulated Cl- secretion was due to CFTR, while acidification of airway surface liquid by S9-A13 suggests a role of SLC26A9 for airway bicarbonate secretion.	[Jo, Sungwoo; Park, Jinhong; Jeon, Dong-Kyu; Ryu, Kunhi; Namkung, Wan] Yonsei Univ, Coll Pharm, Yonsei Inst Pharmaceut Sci, Incheon, South Korea; [Centeio, Raquel; Ousingsawat, Jiraporn; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Physiol Inst, Univ St 31, D-93053 Regensburg, Germany; [Talbi, Khaoula; Kahlenberg, Kristin; Somoza, Veronika] Tech Univ Munich, Leibniz Inst Food Syst Biol, Freising Weihenstephan, Germany; [Delpiano, Livia; Gray, Michael A.] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Amaral, Margarida D.; Railean, Violeta] Univ Lisbon, Fac Sci, BioISI Biosyst & Integrat Sci Inst, Lisbon, Portugal; [Beekman, Jeffrey M.; Rodenburg, Lisa W.] Univ Utrecht, Univ Med Ctr, Regenerat Med Utrecht, Utrecht, Netherlands	Yonsei University; University of Regensburg; Leibniz-Institute for Food Systems Biology at the Technical University of Munich; Technical University of Munich; Newcastle University - UK; BIOISI; Universidade de Lisboa; Utrecht University; Utrecht University Medical Center	Kunzelmann, K (corresponding author), Univ Regensburg, Physiol Inst, Univ St 31, D-93053 Regensburg, Germany.; Namkung, W (corresponding author), Yonsei Univ, Coll Pharm, 85 Songdogwahak Ro, Incheon 21983, South Korea.; Namkung, W (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, 85 Songdogwahak Ro, Incheon 21983, South Korea.	wnamkung@yonsei.ac.kr; karl.kunzelmann@ur.de	Amaral, Margarida/E-5748-2012; Somoza, Veronika/D-4141-2013	Amaral, Margarida/0000-0002-0828-8630; Somoza, Veronika/0000-0003-2456-9245; Delpiano, Livia/0000-0002-2319-4456	Deutsche Forschungsgemeinschaft (DFG) [DFG KU756/14-1]; Gilead Sciences (Gilead); UK CF-Trust [SRC013]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gilead Sciences (Gilead)(Gilead Sciences); UK CF-Trust	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: DFG KU756/14-1; Gilead Sciences (Gilead), Grant/Award Number: Mucus in CF; UK CF-Trust, Grant/Award Number: SRC013	ALBAZZAZ FJ, 1994, AM J PHYSIOL, V267, pL193, DOI 10.1152/ajplung.1994.267.2.L193; Avella M, 2011, J CELL PHYSIOL, V226, P212, DOI 10.1002/jcp.22328; BALLARD ST, 1994, AM J PHYSIOL, V267, pL79, DOI 10.1152/ajplung.1994.267.1.L79; Benedetto R, 2020, PFLUG ARCH EUR J PHY, V472, P1507, DOI 10.1007/s00424-020-02440-y; Bertrand CA, 2017, AM J PHYSIOL-LUNG C, V312, pL912, DOI 10.1152/ajplung.00178.2016; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Besteman SB, 2022, J INFECT DIS, V226, P258, DOI 10.1093/infdis/jiac114; Cabrita I, 2021, AM J RESP CELL MOL, V64, P50, DOI 10.1165/rcmb.2019-0442OC; Centeio R, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22105133; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Chang MH, 2009, J MEMBRANE BIOL, V228, P125, DOI 10.1007/s00232-009-9165-5; Chen AP, 2012, HUM MUTAT, V33, P1275, DOI 10.1002/humu.22107; Demitrack ES, 2010, AM J PHYSIOL-GASTR L, V299, pG255, DOI 10.1152/ajpgi.00037.2010; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; El Khouri E, 2014, INT J BIOCHEM CELL B, V52, P58, DOI 10.1016/j.biocel.2014.02.001; Holik AK, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22115881; Ishibashi K, 2008, AM J PHYSIOL-REG I, V294, pR1729, DOI 10.1152/ajpregu.00758.2007; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Lam ATN, 2020, J CLIN INVEST, V130, P272, DOI 10.1172/JCI129833; Larsen MB, 2021, AM J PHYSIOL-LUNG C, V321, pL1147, DOI 10.1152/ajplung.00563.2020; Liu XM, 2015, PFLUG ARCH EUR J PHY, V467, P1261, DOI 10.1007/s00424-014-1543-x; Lohi H, 2002, J BIOL CHEM, V277, P14246, DOI 10.1074/jbc.M111802200; Loriol C, 2008, CELL PHYSIOL BIOCHEM, V22, P15, DOI 10.1159/000149780; Miller MR, 2015, J PEDIATR-US, V166, P1152, DOI 10.1016/j.jpeds.2015.01.044; Needham PG, 2021, BIOCHEM J, V478, P4203, DOI 10.1042/BCJ20210644; Ousingsawat J, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23062998; Ousingsawat J, 2012, J CELL PHYSIOL, V227, P2323, DOI 10.1002/jcp.22967; Park J, 2019, J ALLERGY CLIN IMMUN, V144, P1425, DOI 10.1016/j.jaci.2019.07.016; Pinto MC, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222313064; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Rakonczay Z, 2008, J CELL PHYSIOL, V214, P442, DOI 10.1002/jcp.21220; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Rode B, 2012, HUM MOL GENET, V21, P1287, DOI 10.1093/hmg/ddr558; Saint-Criq V, 2019, JOVE-J VIS EXP, DOI 10.3791/59815; Salomon JJ, 2016, AM J PHYSIOL-LUNG C, V310, pL593, DOI 10.1152/ajplung.00321.2015; Sato Y, 2019, J BIOL CHEM, V294, P18269, DOI 10.1074/jbc.RA119.010192; Schreiber R, 2008, PFLUG ARCH EUR J PHY, V457, P431, DOI 10.1007/s00424-008-0543-0; Simao S, 2013, LIFE SCI, V93, P435, DOI 10.1016/j.lfs.2013.07.026; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; Strug LJ, 2016, HUM MOL GENET, V25, P4590, DOI 10.1093/hmg/ddw290; Sun L, 2012, NAT GENET, V44, P562, DOI 10.1038/ng.2221; Walter JD, 2019, ELIFE, V8, DOI 10.7554/eLife.46986; Wang XF, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-7; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105	47	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22534	10.1096/fj.202200313RR	http://dx.doi.org/10.1096/fj.202200313RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A5VB	36183361	Green Published			2022-12-26	WOS:000862954000001
J	Nie, Y; Fan, HL; Li, JH; Lei, XJ; Zhang, TC; Wang, YF; Mao, ZZ; Tao, KS; Song, WJ				Nie, Ye; Fan, Hanlu; Li, Jianhui; Lei, Xinjun; Zhang, Tianchen; Wang, Yanfang; Mao, Zhenzhen; Tao, Kaishan; Song, Wenjie			Tertiary lymphoid structures: Associated multiple immune cells and analysis their formation in hepatocellular carcinoma	FASEB JOURNAL			English	Article						hepatocellular carcinoma; immune cell; prognosis; tertiary lymphoid structure; tertiary lymphoid structure formation	T-CELLS; IMMUNOTHERAPY; INFILTRATION; PROGNOSIS; SURVIVAL; CANCERS; CLUSTER; STAGE	The prognostic value of immune cells in tertiary lymphoid structures (TLSs) remains unclear in hepatocellular carcinoma (HCC). Here, 59 of 145 patients had TLSs in training set, 48 of 120 patients had TLSs in testing set. Immunohistochemistry (IHC) were used to label CD3+ T cells, CD20+ B cells, CD8+ T cells, CD208+ dendritic cells, and CD21+ follicular dendritic cells in TLSs. High CD20+, CD208+, and CD8+ cell densities were favorable prognostic factors for overall survival (OS). High CD3+, CD20+, CD208+, and CD8+ cell densities were significantly associated with reduced early recurrence. TLSs were divided into three grades (A, B, and C) based on immune cell density. Patients with grade C or B had significantly improved OS. Patients with grade C had the lowest recurrence rate, followed by those with grade B, while patients with grade A had the highest recurrence rate. The stromal, immune, and ESTIMATE scores derived from the ESTIMATE package were significantly higher and tumor purity was significantly lower in patients with TLSs. Patients with TLSs had significantly higher relative numbers of memory B cells, plasma cells, CD8+ T cells, NK cells, and dendritic cells and lower relative numbers of Treg cells, macrophages, and M2 macrophages according to the CIBERSORT assessment. Bioinformatics analysis and experiments confirmed that KLRK1 and GZMA expression are associated TLSs formation and can predict TLSs existence. Grade B and grade C were favorable prognostic factors for OS and recurrence and could represent immune-active tumors.	[Nie, Ye; Fan, Hanlu; Wang, Yanfang; Mao, Zhenzhen; Tao, Kaishan; Song, Wenjie] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [Li, Jianhui] Anhui Med Univ, Dept Gen Surg, Affiliated Hosp 1, Hefei, Peoples R China; [Lei, Xinjun] Ctr Hosp Weinan Shaanxi, Dept Gen Surg, Weinan, Peoples R China; [Zhang, Tianchen] Xian Med Univ, Dept Gen Surg, Affiliated Hosp 1, Xian, Peoples R China; [Wang, Yanfang; Mao, Zhenzhen] Xian Med Univ, Xian, Peoples R China	Air Force Military Medical University; Anhui Medical University; Xi'an Medical University; Xi'an Medical University	Tao, KS; Song, WJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China.	taokaishan0686@163.com; songvvenjie1230123@163.com		Li, Jianhui/0000-0002-7946-0768	National Natural Science Foundation of China [81672716]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81672716).	Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Arulraj T, 2021, J IMMUNOL, V206, P1436, DOI 10.4049/jimmunol.2001355; Bin Seow DY, 2020, BREAST CANCER RES TR, V180, P369, DOI 10.1007/s10549-020-05548-y; Blanchard L, 2021, ANGIOGENESIS, V24, P719, DOI 10.1007/s10456-021-09792-8; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Calderaro J, 2017, J HEPATOL, V67, P727, DOI 10.1016/j.jhep.2017.05.014; Colbeck EJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01830; Cui YF, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01591-1; Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216; Engelhard VH, 2018, J IMMUNOL, V200, P432, DOI 10.4049/jimmunol.1701269; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Fujita M, 2020, EBIOMEDICINE, V53, DOI 10.1016/j.ebiom.2020.102659; He WT, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00980; Heinemann J, 2019, METHODS MOL BIOL, V1859, P275, DOI 10.1007/978-1-4939-8757-3_16; Gunderson AJ, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1900635; Kaseb AO, 2019, CANCER IMMUNOL RES, V7, P1390, DOI 10.1158/2326-6066.CIR-18-0605; Li H, 2020, AGING-US, V12, P3451, DOI 10.18632/aging.102821; Li W, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2019.1672495; Lin ZY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78560-3; Liu ZQ, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-020-02697-y; Longo V, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100698; Marinkovic T, 2006, J CLIN INVEST, V116, P2622, DOI 10.1172/JCI28993; Moreno-Cubero E, 2016, WORLD J GASTROENTERO, V22, P6469, DOI 10.3748/wjg.v22.i28.6469; Mori T, 2021, CANCER SCI, V112, P1746, DOI 10.1111/cas.14888; Munguia-Fuentes R, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.587809; Nie Y, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.706915; Oh SA, 2020, NAT CANCER, V1, P681, DOI 10.1038/s43018-020-0075-x; Poggi A, 2007, ANN NY ACAD SCI, V1109, P47, DOI 10.1196/annals.1398.007; Qin M, 2021, ONCOL LETT, V22, DOI 10.3892/ol.2021.13097; Raskov H, 2021, BRIT J CANCER, V124, P359, DOI 10.1038/s41416-020-01048-4; Reading JL, 2018, IMMUNOL REV, V283, P194, DOI 10.1111/imr.12657; Sakimura C, 2017, J SURG RES, V215, P74, DOI 10.1016/j.jss.2017.03.033; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Shimizu K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01450; Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007; Singh L, 2021, CANCER IMMUNOL IMMUN, V70, P1291, DOI 10.1007/s00262-020-02773-8; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Wang J, 2018, J CLIN GASTROENTEROL, V52, P437, DOI 10.1097/MCG.0000000000000859; Yoon HH, 2019, CLIN CANCER RES, V25, P125, DOI 10.1158/1078-0432.CCR-18-1984; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang Y, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110562; Zhong C, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.589680; Zhu J, 2020, J GASTROINTEST ONCOL, V11, P1364, DOI 10.21037/jgo-20-556; Ziogas IA, 2021, ONCOLOGIST, V26, pE1036, DOI 10.1002/onco.13638	44	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22586	10.1096/fj.202200269RR	http://dx.doi.org/10.1096/fj.202200269RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B0CF	36190431	hybrid			2022-12-26	WOS:000863244100001
J	Seth, A; Rivera, A; Chahdi, A; Choi, IS; Medina-Martinez, O; Lewis, S; O'Neill, M; Ridgeway, A; Moore, J; Jorgez, C; Lamb, DJ				Seth, Abhishek; Rivera, Armando; Chahdi, Ahmed; Choi, In-Seon; Medina-Martinez, Olga; Lewis, Shaye; O'Neill, Marisol; Ridgeway, Alex; Moore, Joshua; Jorgez, Carolina; Lamb, Dolores J.			Gene dosage changes in KCTD13 result in penile and testicular anomalies via diminished androgen receptor function	FASEB JOURNAL			English	Article						copy number variant; cryptorchidism; KCTD13; penile anomalies	AUTOSOMAL SEX REVERSAL; CAMPOMELIC DYSPLASIA; COPY NUMBER; 16P11.2; PROTEIN; MICE; DEGRADATION; CHROMOSOME; DISORDERS; MUTATIONS	Despite the high prevalence of hypospadias and cryptorchidism, the genetic basis for these conditions is only beginning to be understood. Using array-comparative-genomic-hybridization (aCGH), potassium-channel-tetramerization-domain-containing-13 (KCTD13) encoded at 16p11.2 was identified as a candidate gene involved in hypospadias, cryptorchidism and other genitourinary (GU) tract anomalies. Copy number variants (CNVs) at 16p11.2 are among the most common syndromic genomic variants identified to date. Many patients with CNVs at this locus exhibit GU and/or neurodevelopmental phenotypes. KCTD13 encodes a substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3-ubiquitin-protein-ligase complex (BCR (BTB-CUL3-RBX1) E3-ubiquitin-protein-ligase complex (B-cell receptor (BCR) [BTB (the BTB domain is a conserved motif involved in protein-protein interactions) Cullin3 complex RING protein Rbx1] E3-ubiqutin-protein-ligase complex), which has essential roles in the regulation of cellular cytoskeleton, migration, proliferation, and neurodevelopment; yet its role in GU development is unknown. The prevalence of KCTD13 CNVs in patients with GU anomalies (2.58%) is significantly elevated when compared with patients without GU anomalies or in the general population (0.10%). KCTD13 is robustly expressed in the developing GU tract. Loss of KCTD13 in cell lines results in significantly decreased levels of nuclear androgen receptor (AR), suggesting that loss of KCTD13 affects AR sub-cellular localization. Kctd13 haploinsufficiency and homozygous deletion in mice cause a significant increase in the incidence of cryptorchidism and micropenis. KCTD13-deficient mice exhibit testicular and penile abnormalities together with significantly reduced levels of nuclear AR and SOX9. In conclusion, gene-dosage changes of murine Kctd13 diminish nuclear AR sub-cellular localization, as well as decrease SOX9 expression levels which likely contribute in part to the abnormal GU tract development in Kctd13 mouse models and in patients with CNVs in KCTD13.	[Seth, Abhishek; Rivera, Armando; Choi, In-Seon; Medina-Martinez, Olga; Lewis, Shaye; Jorgez, Carolina; Lamb, Dolores J.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Seth, Abhishek; Rivera, Armando; Choi, In-Seon; Medina-Martinez, Olga; Lewis, Shaye; O'Neill, Marisol; Ridgeway, Alex; Moore, Joshua; Jorgez, Carolina; Lamb, Dolores J.] Baylor Coll Med, Ctr Reprod Med, Houston, TX 77030 USA; [Seth, Abhishek; Chahdi, Ahmed] Nemours Childrens Hosp, Dept Surg, 6535 Nemours Pkwy, Orlando, FL 32827 USA; [O'Neill, Marisol; Ridgeway, Alex; Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Lamb, Dolores J.] Weill Cornell Med Coll, James Buchanan Brady Fdn, Ctr Reprod Genom, Dept Urol, New York, NY 10065 USA; [Lamb, Dolores J.] Weill Cornell Med Coll, Englander Inst Personalized Med, 525 East 68th St,Box 94, New York, NY 10065 USA; [Lamb, Dolores J.] Weill Cornell Med Coll, James Buchanan Urol, Ctr Reprod Genom, 525 East 68th St,Box 94, New York, NY 10065 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Cornell University; Cornell University; Cornell University	Seth, A (corresponding author), Nemours Childrens Hosp, Dept Surg, 6535 Nemours Pkwy, Orlando, FL 32827 USA.; Lamb, DJ (corresponding author), Weill Cornell Med Coll, Englander Inst Personalized Med, 525 East 68th St,Box 94, New York, NY 10065 USA.; Lamb, DJ (corresponding author), Weill Cornell Med Coll, James Buchanan Urol, Ctr Reprod Genom, 525 East 68th St,Box 94, New York, NY 10065 USA.	abhishek.seth@nemours.org; dlamb@med.cornell.edu		Choi, In-Seon/0000-0001-5237-0255; Lewis, Shaye Kamal/0000-0001-8937-0857; Rivera, Armando/0000-0001-7076-8566; Ridgeway, Alex/0000-0001-6055-6375; Moore, Joshua A/0000-0001-7879-0135	National Institutes of Health Multidisciplinary K12 Urologic Research (KURe) Career Development Program from the National Institute of Digestive Diseases and Kidney [K12DK0083014]; National Institutes of Health, National Institute of Digestive Diseases and Kidney [R01DK078121]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [1R01HD100985]; Society for Pediatric Urology annual research award (2017); Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust; Robert S. Dow Professorship; Integrated Microscopy Core at Baylor College of Medicine; NIH [DK56338, CA125123]; CPRIT [RP150578]; Dan L. Duncan Comprehensive Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics;  [T32DK007763]	National Institutes of Health Multidisciplinary K12 Urologic Research (KURe) Career Development Program from the National Institute of Digestive Diseases and Kidney; National Institutes of Health, National Institute of Digestive Diseases and Kidney; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Society for Pediatric Urology annual research award (2017); Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust; Robert S. Dow Professorship; Integrated Microscopy Core at Baylor College of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Dan L. Duncan Comprehensive Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; 	This study was supported in part by The National Institutes of Health Multidisciplinary K12 Urologic Research (KURe) Career Development Program K12DK0083014 from the National Institute of Digestive Diseases and Kidney to D.J.L (AS, SL and CJJ were K12 scholars), R01DK078121 from the National Institutes of Health, National Institute of Digestive Diseases and Kidney to DJL, and 1R01HD100985 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to AS and CJJ and the Society for Pediatric Urology annual research award (2017) to AS. MO was a pre-doctoral trainee supported on T32DK007763 (to DJL). DJL is also supported in part by the Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust and the Robert S. Dow Professorship. We thank Drs. Francesco DeMayo and Jason Heaney at the Baylor College of Medicine's GEM core for their assistance in generating the Kctd13 deleted mice and Dr. Victor Ruthig, Ms. Adlai Nelson, and Carolyn Schum for helpful editing of the manuscript. The Optical Imaging and Vital Microscopy core used in this project was supported by the Integrated Microscopy Core at Baylor College of Medicine with funding from the NIH (DK56338, and CA125123), CPRIT (RP150578), the Dan L. Duncan Comprehensive Cancer Center, and the John S. Dunn Gulf Coast Consortium for Chemical Genomics. The authors thank Dr. Ahmed Chahdi for his contributions towards this study.	Arbogast T, 2019, HUM MOL GENET, V28, P1474, DOI 10.1093/hmg/ddy436; Argentaro A, 2003, J BIOL CHEM, V278, P33839, DOI 10.1074/jbc.M302078200; Bennett NC, 2010, INT J BIOCHEM CELL B, V42, P813, DOI 10.1016/j.biocel.2009.11.013; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Bouty A, 2015, SEX DEV, V9, P239, DOI 10.1159/000441988; Burska UL, 2013, J BIOL CHEM, V288, P32641, DOI 10.1074/jbc.M113.485912; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Davies Jamie A, 2012, Methods Mol Biol, V886, P185, DOI 10.1007/978-1-61779-851-1_17; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Escamilla CO, 2017, NATURE, V551, P227, DOI 10.1038/nature24470; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Feng S, 2009, ANN NY ACAD SCI, V1160, P197, DOI 10.1111/j.1749-6632.2009.03841.x; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fu XH, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15018232; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Haller M, 2018, P NATL ACAD SCI USA, V115, pE1849, DOI 10.1073/pnas.1716092115; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Hernando C, 2002, J Med Genet, V39, pE24, DOI 10.1136/jmg.39.5.e24; Hornig NC, 2016, J CLIN ENDOCR METAB, V101, P4468, DOI 10.1210/jc.2016-1990; Hughes IA, 2007, ENDOCRIN DEV, V11, P47, DOI 10.1159/000111057; Ishikawa N, 2006, CANCER SCI, V97, P737, DOI 10.1111/j.1349-7006.2006.00258.x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Jorgez CJ, 2011, J CLIN ENDOCR METAB, V96, pE674, DOI 10.1210/jc.2010-2018; Kaur J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-168; Kino T, 2012, J CLIN ENDOCR METAB, V97, pE1557, DOI 10.1210/jc.2011-3493; Kolon TF, 2014, J UROLOGY, V192, P337, DOI 10.1016/j.juro.2014.05.005; Konyukh M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017289; Kumar A, 2014, DEV DYNAM, V243, P937, DOI [10.1002/DVDY.24125, 10.1002/dvdy.24125]; Kusenda M, 2015, J CHILD NEUROL, V30, P1947, DOI 10.1177/0883073815602066; Lin DH, 2005, P NATL ACAD SCI USA, V102, P4306, DOI 10.1073/pnas.0409767102; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Loke J, 2014, HUM MOL GENET, V23, P1073, DOI 10.1093/hmg/ddt502; Morandell J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23123-x; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nik-Zainal S, 2011, J MED GENET, V48, P197, DOI 10.1136/jmg.2010.082412; O'Neill M, 2017, J SEX MED, V14, P1533, DOI 10.1016/j.jsxm.2017.10.065; Ostrer H, 2014, J CLIN ENDOCR METAB, V99, P1503, DOI 10.1210/jc.2013-3690; Pearlman A, 2010, AM J HUM GENET, V87, P898, DOI 10.1016/j.ajhg.2010.11.003; Phillips TR, 2015, SEX DEV, V9, P162, DOI 10.1159/000431010; Pluciennik A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI134565; Pohl HG, 2007, J UROLOGY, V177, P1646, DOI 10.1016/j.juro.2007.01.058; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Robaire B, 2011, J ANDROL, V32, P592, DOI 10.2164/jandrol.111.014266; Rosenfeld JA, 2010, J NEURODEV DISORD, V2, P26, DOI 10.1007/s11689-009-9037-4; Sampson MG, 2010, AM J MED GENET A, V152A, P2618, DOI 10.1002/ajmg.a.33628; Sasaki G, 2019, ENDOCR J, V66, P837, DOI 10.1507/endocrj.EJ19-0111; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shinawi M, 2010, AM J MED GENET A, V152A, P1832, DOI 10.1002/ajmg.a.33475; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Sreenivasan R, 2017, J STEROID BIOCHEM, V170, P28, DOI 10.1016/j.jsbmb.2016.10.009; Srivastava D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.1; Stockley P, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-66; Szafran AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003605; Tannour-Louet M, 2014, NAT MED, V20, P715, DOI 10.1038/nm.3580; Tannour-Louet M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015392; Tomiyama H, 2003, J PEDIATR SURG, V38, P1793, DOI 10.1016/j.jpedsurg.2003.08.047; Tucker T, 2013, MOL GENET GENOM MED, V1, P87, DOI 10.1002/mgg3.12; Vlaskamp DRM, 2019, EUR J MED GENET, V62, P265, DOI 10.1016/j.ejmg.2018.08.002; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wen SM, 2020, ASIAN J UROL, V7, P203, DOI 10.1016/j.ajur.2019.11.001; Wirth J, 1996, HUM GENET, V97, P186, DOI 10.1007/BF02265263; Xu KX, 2009, CANCER CELL, V15, P270, DOI 10.1016/j.ccr.2009.02.021; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Zheng ZG, 2015, P NATL ACAD SCI USA, V112, pE7194, DOI 10.1073/pnas.1515981112; Zhou L, 2015, J NEUROL SCI, V358, P362, DOI 10.1016/j.jns.2015.09.363	69	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22567	10.1096/fj.202200558R	http://dx.doi.org/10.1096/fj.202200558R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B9ID	36196997				2022-12-26	WOS:000863879600001
J	Wang, CX; Long, QL; Fu, Q; Xu, QX; Fu, D; Li, Y; Gao, LB; Guo, JM; Zhang, XL; Lam, EWF; Campisi, J; Sun, Y				Wang, Changxu; Long, Qilai; Fu, Qiang; Xu, Qixia; Fu, Da; Li, Yan; Gao, Libin; Guo, Jianming; Zhang, Xiaoling; Lam, Eric W-F; Campisi, Judith; Sun, Yu			Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance	ONCOGENE			English	Article							SENESCENCE; CANCER; PATHWAY; EGFR; AMPHIREGULIN; PANITUMUMAB; TRIAL	The tumor microenvironment (TME) represents a milieu enabling cancer cells to develop malignant properties, while concerted interactions between cancer and stromal cells frequently shape an "activated/reprogramed" niche to accelerate pathological progression. Here we report that a soluble factor epiregulin (EREG) is produced by senescent stromal cells, which non-cell-autonomously develop the senescence-associated secretory phenotype (SASP) upon DNA damage. Genotoxicity triggers EREG expression by engaging NF-kappa B and C/EBP, a process supported by elevated chromatin accessibility and increased histone acetylation. Stromal EREG reprograms the expression profile of recipient neoplastic cells in a paracrine manner, causing upregulation of MARCHF4, a membrane-bound E3 ubiquitin ligase involved in malignant progression, specifically drug resistance. A combinational strategy that empowers EREG-specific targeting in treatment-damaged TME significantly promotes cancer therapeutic efficacy in preclinical trials, achieving response indices superior to those of solely targeting cancer cells. In clinical oncology, EREG is expressed in tumor stroma and handily measurable in circulating blood of cancer patients post-chemotherapy. This study establishes EREG as both a targetable SASP factor and a new noninvasive biomarker of treatment-damaged TME, thus disclosing its substantial value in translational medicine. [GRAPHICS] .	[Wang, Changxu; Xu, Qixia; Li, Yan; Gao, Libin; Sun, Yu] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China; [Long, Qilai; Guo, Jianming] Fudan Univ, Zhongshan Hosp, Dept Urol, Shanghai 200032, Peoples R China; [Fu, Qiang; Sun, Yu] Binzhou Med Univ, Inst Aging Med, Dept Pharmacol, Yantai 264003, Shandong, Peoples R China; [Fu, Da] Tongji Univ, Shanghai Peoples Hosp 10, Cent Lab Med Res, Sch Med, Shanghai 200072, Peoples R China; [Zhang, Xiaoling] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Orthoped Surg, Sch Med, Shanghai 200092, Peoples R China; [Lam, Eric W-F] Imperial Coll London, Dept Surg & Canc, London W12 0NN, England; [Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA; [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Sun, Yu] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Sun, Yu] Univ Washington, VAPSHCS, Seattle, WA 98195 USA	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; Fudan University; Binzhou Medical University; Tongji University; Shanghai Jiao Tong University; Imperial College London; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sun, Y (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China.; Sun, Y (corresponding author), Binzhou Med Univ, Inst Aging Med, Dept Pharmacol, Yantai 264003, Shandong, Peoples R China.; Sun, Y (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.; Sun, Y (corresponding author), Univ Washington, VAPSHCS, Seattle, WA 98195 USA.	sunyu@sibs.ac.cn	fu, qiang/O-7262-2014	fu, qiang/0000-0002-6932-7103; Lam, Eric/0000-0003-1274-3576	National Key Research and Development Program of China [2020YFC2002800, 2016YFC1302400]; National Natural Science Foundation of China (NSFC) [81472709, 31671425, 31871380, 82130045]; Strategic Priority Research Program of Chinese Academy of Sciences [XDB39010500]; Anti-Aging Collaborative Program of SINH and BY-HEALTH [C01201911260006, C01202112160005]; Joint Fund Program of Natural Science Foundation of Shandong Province [ZR202108130049, ZR2021LSW021]; University and Locality Collaborative Development Program of Yantai [2019XDRHXMRC08, 2020XDRHXMXK02, 2021XDHZ082]; U.S. DoD PCRP [PC111703]; National Natural Science Foundation of China [81370730, 81571512]; Yantai Double Hundred Program	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Anti-Aging Collaborative Program of SINH and BY-HEALTH; Joint Fund Program of Natural Science Foundation of Shandong Province; University and Locality Collaborative Development Program of Yantai; U.S. DoD PCRP; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yantai Double Hundred Program	We are grateful to members of Sun laboratory for reagents, comments and other contributions to this project. We appreciate Ge Zhang for technical assistance of bioinformatics profiling of epigenetic datasets. The work was supported by grants from National Key Research and Development Program of China (2020YFC2002800, 2016YFC1302400), National Natural Science Foundation of China (NSFC) (81472709, 31671425, 31871380, 82130045) to YS, the Strategic Priority Research Program of Chinese Academy of Sciences (XDB39010500) to YS, Anti-Aging Collaborative Program of SINH and BY-HEALTH (C01201911260006 and C01202112160005) to YS, Joint Fund Program of Natural Science Foundation of Shandong Province (ZR202108130049 and ZR2021LSW021), the University and Locality Collaborative Development Program of Yantai (2019XDRHXMRC08 and 2020XDRHXMXK02) to YS, and the U.S. DoD PCRP (Idea Development Award PC111703) to YS; National Natural Science Foundation of China (81370730, 81571512), the University and Locality Collaborative Development Program of Yantai (2021XDHZ082) and Yantai Double Hundred Program to QF.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Babon JJ, 2019, BIOCHEM J, V476, P2869, DOI 10.1042/BCJ20190577; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Birch J, 2020, GENE DEV, V34, P1565, DOI 10.1101/gad.343129.120; Bruyere C, 2014, J INORG BIOCHEM, V141, P144, DOI 10.1016/j.jinorgbio.2014.08.015; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chen F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06860-4; Cho MC, 2008, BIOCHEM BIOPH RES CO, V377, P832, DOI 10.1016/j.bbrc.2008.10.053; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Costa VM, 2020, ARCH TOXICOL, V94, P4067, DOI 10.1007/s00204-020-02874-4; D'Alterio C, 2020, SEMIN CANCER BIOL, V60, P351, DOI 10.1016/j.semcancer.2019.08.019; Das T, 2021, DRUG RESIST UPDATE, V55, DOI 10.1016/j.drup.2021.100754; Demaria M, 2017, CANCER DISCOV, V7, P165, DOI 10.1158/2159-8290.CD-16-0241; Di Nicolantonio F, 2021, NAT REV CLIN ONCOL, V18, P506, DOI 10.1038/s41571-021-00495-z; Dueck AC, 2020, JAMA ONCOL, V6, DOI 10.1001/jamaoncol.2019.3332; El-Hashim AZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09349-0; Fedchenko N, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0221-9; Fitsiou E, 2022, SEMIN CANCER BIOL, V81, P5, DOI 10.1016/j.semcancer.2021.03.021; Flanagan KC, 2018, ONCOTARGET, V9, P21, DOI 10.18632/oncotarget.22940; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gao L, 2018, PATHOL RES PRACT, V214, P732, DOI 10.1016/j.prp.2018.03.002; Gorgoulis V, 2019, CELL, V179, P813, DOI 10.1016/j.cell.2019.10.005; He MJ, 2019, ONCOGENE, V38, P5551, DOI 10.1038/s41388-019-0817-3; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033; Hollis A, 2012, CHEMBIOCHEM, V13, P302, DOI 10.1002/cbic.201100652; Job S, 2019, CANCERS, V11, DOI 10.3390/cancers11060795; Kamide D, 2016, CANCER SCI, V107, P666, DOI 10.1111/cas.12914; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kohsaka S, 2014, NEURO-ONCOLOGY, V16, P960, DOI 10.1093/neuonc/not315; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Laberge RM, 2015, NAT CELL BIOL, V17, P1049, DOI 10.1038/ncb3195; Li SQ, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.634097; Lim JJ, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9141343; Liu PY, 2021, NAT CELL BIOL, V23, P355, DOI 10.1038/s41556-021-00656-3; Liu SL, 2020, THERANOSTICS, V10, P10589, DOI 10.7150/thno.47176; Ma SQ, 2021, ONCOGENE, V40, P2596, DOI 10.1038/s41388-021-01734-4; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mancini M, 2018, EMBO MOL MED, V10, P294, DOI 10.15252/emmm.201708076; Neufert C, 2013, J CLIN INVEST, V123, P1428, DOI 10.1172/JCI63748; Parry AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04283-9; Pilie PG, 2019, NAT REV CLIN ONCOL, V16, P81, DOI 10.1038/s41571-018-0114-z; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qu X, 2016, ONCOGENE, V35, P6403, DOI 10.1038/onc.2016.170; Qu YD, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0992-4; Riese DJ, 2014, SEMIN CELL DEV BIOL, V28, P49, DOI 10.1016/j.semcdb.2014.03.005; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ruscetti M, 2020, CELL, V181, P424, DOI 10.1016/j.cell.2020.03.008; Seligmann JF, 2020, ANN ONCOL, V31, P1021, DOI 10.1016/j.annonc.2020.04.476; Sen P, 2019, MOL CELL, V73, P684, DOI 10.1016/j.molcel.2019.01.021; Song SL, 2020, TRENDS BIOCHEM SCI, V45, P578, DOI 10.1016/j.tibs.2020.03.008; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Strimpakos A, 2013, CLIN COLORECTAL CANC, V12, P267, DOI 10.1016/j.clcc.2013.07.001; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Sun Y, 2016, CANCER LETT, V380, P205, DOI 10.1016/j.canlet.2015.07.044; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Torring N, 2005, PROSTATE, V64, P1, DOI 10.1002/pros.20214; Wang YJ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1277-x; Watanabe T, 2010, EUR J CANCER, V46, P2119, DOI 10.1016/j.ejca.2010.04.019; Westendorp F, 2021, ONCOGENE, V40, P1628, DOI 10.1038/s41388-020-01633-0; Wiley CD, 2017, AGING CELL, V16, P1043, DOI 10.1111/acel.12632; Williams CJM, 2021, CLIN CANCER RES, V27, P3422, DOI 10.1158/1078-0432.CCR-21-0120; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xia QY, 2019, PATHOL RES PRACT, V215, P873, DOI 10.1016/j.prp.2019.01.030; Yang JL, 2014, CANCER CHEMOTH PHARM, V74, P637, DOI 10.1007/s00280-014-2523-8; Zhang BY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04010-4	72	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2022	41	45					4941	4959		10.1038/s41388-022-02476-7	http://dx.doi.org/10.1038/s41388-022-02476-7		OCT 2022	19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5W8QC	36202915	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000864553300001
J	Yu, YQ; Lin, C				Yu, Yongquan; Lin, Chao			Screw analysis and experimental study of spatial noncircular gear compound transmission	PLOS ONE			English	Article							DESIGN; MOTION; RATIO; TRAIN	Curve face gear pair and noncircular bevel gear pair are collectively referred to as spatial noncircular gear pair (SNCGP). Different from the traditional gear transmission with fixed shafts, spatial noncircular gear (SNCG) compound transmission can realize compound motion with variable transmission ratio between intersecting axes, and has a broad engineering application prospect. It includes two categories named speed reduction and speed increase. Based on the gear meshing theory, screw theory and calculus, a screw analysis method of SNCG compound transmission was proposed, which directly and comprehensively reflected the compound motion characteristics of rotation and axial movement. Firstly, a unified coordinate system was established. The screw geometric characteristics of compound motion were discussed, including instant screw axis, axode, pitch surface and its normal equidistant surface. The screw principle of compound motion was revealed. Then, according to this method, combined with the motion process of generator with different tooth profiles, the tooth surface of each SNCG was obtained. Finally, gear machining, tooth surface measurement, transmission ratio measurement and axial displacement measurement were carried out, which verified the correctness of this screw analysis method for SNCG compound transmission, and laid a foundation for further study and application.	[Yu, Yongquan; Lin, Chao] Chongqing Univ, State Key Lab Mech Transmiss, Chongqing, Peoples R China	Chongqing University	Lin, C (corresponding author), Chongqing Univ, State Key Lab Mech Transmiss, Chongqing, Peoples R China.	linchao@cqu.edu.cn			National Natural Science Foundation of China [51675060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: National Natural Science Foundation of China (No.51675060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addomine M, 2018, MECH MACH THEORY, V122, P219, DOI 10.1016/j.mechmachtheory.2017.12.027; Alexandru P, 2012, MECH MACH THEORY, V52, P267, DOI 10.1016/j.mechmachtheory.2012.02.005; Aziz Shujahadeen B., ENVIRON TOXICOL PHAR, V3, P1, DOI [10.1371/journal.pone.0155431, DOI 10.1142/9881, 10.1016/j.jsamd.2018.01.002, DOI 10.1016/J.ETAP.2013.05.008]; Ball R., 1900, TREATISE THEORY SCRE; Chen CH, 2008, THEORY CONJUGATE SUR; Dai JS, 2014, SCREW ALGEBRA KINEMA; Ding XL, 2021, IEEE T TRANSP ELECTR, V7, P1976, DOI 10.1109/TTE.2020.3048405; Ding XL, 2022, IEEE T IND INFORM, V18, P4466, DOI 10.1109/TII.2021.3118683; Ding XL, 2020, IEEE T VEH TECHNOL, V69, P12797, DOI 10.1109/TVT.2020.3026106; Dooner DB, 2002, J MECH DESIGN, V124, P733, DOI 10.1115/1.1518501; Dooner DB, 2012, KINEMATIC GEOMETRY G; He CJ, 2017, MECH MACH THEORY, V115, P267, DOI 10.1016/j.mechmachtheory.2017.05.014; Hou YJ, 2019, J BRAZ SOC MECH SCI, V42, DOI 10.1007/s40430-019-2147-3; Hu YA, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11188706; Hunt KH, 1978, KINEMATIC GEOMETRY M; Lin C, 2019, DESIGN APPL TIME VAR; Lin C, 2017, J ADV MECH DES SYST, V11, DOI [10.1299/jamdsm.2017jamdsm0011, DOI 10.1299/JAMDSM.2017JAMDSM0011]; Lin C, 2022, P I MECH ENG C-J MEC, V236, P4026, DOI 10.1177/09544062211047075; Lin C, 2021, J MECH SCI TECHNOL, V35, P5571, DOI 10.1007/s12206-021-1128-5; Lin C, 2018, MECH MACH THEORY, V128, P298, DOI 10.1016/j.mechmachtheory.2018.06.004; Lin C, 2016, J BRAZ SOC MECH SCI, V38, P1797, DOI 10.1007/s40430-015-0432-3; Lin C, 2013, P I MECH ENG C-J MEC, V227, P779, DOI 10.1177/0954406212453382; Litvin FL, 2009, NONCIRCULAR GEARS DE; Litvin FL., 2004, GEAR GEOMETRY APPL T; Liu JY, 2006, P I MECH ENG C-J MEC, V220, P1229, DOI 10.1243/09544062JMES268; Mundo D, 2006, MECH MACH THEORY, V41, P456, DOI 10.1016/j.mechmachtheory.2005.06.003; Mundo D, 2009, MECH MACH THEORY, V44, P751, DOI 10.1016/j.mechmachtheory.2008.04.011; Ottaviano E, 2008, MECH MACH THEORY, V43, P996, DOI 10.1016/j.mechmachtheory.2007.07.004; Phillips J, 2003, GEN SPATIAL INVOLUTE; PHILLIPS JR, 1964, AUST J APPL SCI, V15, P267; Radzevich SP, 2012, THEORY GEARING KINEM; Wu D, 1992, GEOMETRIC THEORY CON; Xia JQ, 2008, J MECH DESIGN, V130, DOI 10.1115/1.2885510; Yu YQ, 2021, INT J ADV MANUF TECH, V114, P1913, DOI 10.1007/s00170-021-06986-8; Zheng FY, 2018, MECH MACH THEORY, V122, P326, DOI 10.1016/j.mechmachtheory.2018.01.007; Zheng FY, 2016, J MECH DESIGN, V138, DOI 10.1115/1.4033396; Zheng FY, 2016, J MANUF SCI E-T ASME, V138, DOI 10.1115/1.4033045; Zhuang WH, 2017, INT J MECH SCI, V133, P129, DOI 10.1016/j.ijmecsci.2017.08.025	38	0	0	10	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2022	17	9							e0274575	10.1371/journal.pone.0274575	http://dx.doi.org/10.1371/journal.pone.0274575			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R7LS	36178958	Green Published, gold			2022-12-26	WOS:000892480900001
J	Suphakhong, K; Terashima, M; Wanna-udom, S; Takatsuka, R; Ishimura, A; Takino, T; Suzuki, T				Suphakhong, Kusuma; Terashima, Minoru; Wanna-udom, Sasithorn; Takatsuka, Risa; Ishimura, Akihiko; Takino, Takahisa; Suzuki, Takeshi			m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-beta-induced epithelial-mesenchymal transition of lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M(6)A MODIFICATION; EXPRESSION; TRANSLATION; CONTRIBUTES; DECREASES; MIGRATION; EMT	N6-methyladenosine (m6A) is the most common internal chemical modification of mRNAs involved in many patholog-ical processes including various cancers. In this study, we investigated the m6A-dependent regulation of JUN and JUNB transcription factors (TFs) during transforming growth factor-beta-induced epithelial-mesenchymal transition (EMT) of A549 and LC2/ad lung cancer cell lines, as the function and regulation of these TFs within this process remains to be clarified. We found that JUN and JUNB played an important and nonredundant role in the EMT-inducing gene expression program by regulating different mesenchymal genes and that their expressions were controlled by methyltransferase-like 3 (METTL3) m6A methyltransferase. METTL3-mediated regu-lation of JUN expression is associated with the translation process of JUN protein but not with the stability of JUN protein or mRNA, which is in contrast with the result of m6A-mediated regulation of JUNB mRNA stability. We identified the specific m6A motifs responsible for the regulation of JUN and JUNB in EMT within 30UTR of JUN and JUNB. Furthermore, we discovered that different m6A reader proteins interacted with JUN and JUNB mRNA and controlled m6A-dependent expression of JUN protein and JUNB mRNA. These results demonstrate that the different modes of m6A-mediated regu-lation of JUN and JUNB TFs provide critical input in the gene regulatory network during transforming growth factor-beta- induced EMT of lung cancer cells.	[Suphakhong, Kusuma; Terashima, Minoru; Wanna-udom, Sasithorn; Takatsuka, Risa; Ishimura, Akihiko; Suzuki, Takeshi] Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa, Japan; [Takino, Takahisa] Kanazawa Univ, Inst Liberal Arts & Sci, Div Educ Global Stand, Kanazawa, Ishikawa, Japan; [Suzuki, Takeshi] Naresuan Univ, Fac Med Sci, Dept Anat, Phitsanulok, Thailand	Kanazawa University; Kanazawa University; Naresuan University	Suzuki, T (corresponding author), Naresuan Univ, Fac Med Sci, Dept Anat, Phitsanulok, Thailand.	suzuki-t@staff.kanazawa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan;  [22K06880];  [22K07147];  [22K07146]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; 	Funding and additional information-This work was supported in part by Grants-in-Aid for Scientific Research C (grant numbers: 22K06880 to T. S., 22K07147 to M. T., and 22K07146 to A. I.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Chang GQ, 2020, CANCER CELL, V38, P857, DOI 10.1016/j.ccell.2020.10.004; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Cheng C, 2021, MOL THER-NUCL ACIDS, V23, P487, DOI 10.1016/j.omtn.2020.12.001; Cheng MS, 2019, ONCOGENE, V38, P3667, DOI 10.1038/s41388-019-0683-z; Dai XY, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.635329; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Gervasi M, 2012, J CELL BIOL, V196, P589, DOI 10.1083/jcb.201109045; Ghosh Subarna, 2021, Oncotarget, V12, P1520, DOI 10.18632/oncotarget.28026; He PC, 2021, EMBO J, V40, DOI 10.15252/embj.2020105977; Hua WF, 2018, GYNECOL ONCOL, V151, P356, DOI 10.1016/j.ygyno.2018.09.015; Huang HL, 2020, CANCER CELL, V37, P270, DOI 10.1016/j.ccell.2020.02.004; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Huang XW, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0628-y; Huo FC, 2021, ONCOGENE, V40, P2968, DOI 10.1038/s41388-021-01753-1; Ishimura A, 2016, CELL TISSUE RES, V363, P723, DOI 10.1007/s00441-015-2276-7; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lan Q, 2019, CANCER RES, V79, P1285, DOI 10.1158/0008-5472.CAN-18-2965; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li T, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1038-7; Lin GX, 2018, ONCOTARGETS THER, V11, P3805, DOI 10.2147/OTT.S162700; Lin XY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09865-9; Lin YX, 2022, ANN TRANSL MED, V10, DOI 10.21037/atm-21-6857; Liu T, 2020, J CELL PHYSIOL, V235, P548, DOI 10.1002/jcp.28994; Miao WJ, 2019, BIOCHEM BIOPH RES CO, V516, P719, DOI 10.1016/j.bbrc.2019.06.128; Muller S, 2019, NUCLEIC ACIDS RES, V47, P375, DOI 10.1093/nar/gky1012; Oktyabri D, 2014, BIOCHEM BIOPH RES CO, V453, P124, DOI 10.1016/j.bbrc.2014.09.082; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Song BW, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab088; Stemmler MP, 2019, NAT CELL BIOL, V21, P102, DOI 10.1038/s41556-018-0196-y; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tange S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115684; Terashima M, 2018, J BIOL CHEM, V293, P18016, DOI 10.1074/jbc.RA118.004006; Terashima M, 2017, J BIOL CHEM, V292, P82, DOI 10.1074/jbc.M116.750950; Visvanathan A, 2018, ONCOGENE, V37, P522, DOI 10.1038/onc.2017.351; Wanna-Udom S, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015502; Wanna-udom S, 2020, BIOCHEM BIOPH RES CO, V524, P150, DOI 10.1016/j.bbrc.2020.01.042; Xu YF, 2022, ONCOGENE, V41, P1281, DOI 10.1038/s41388-021-02146-0; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343; Yue B, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1065-4; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zirkel A, 2013, NUCLEIC ACIDS RES, V41, P6618, DOI 10.1093/nar/gkt410	46	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102554	10.1016/j.jbc.2022.102554	http://dx.doi.org/10.1016/j.jbc.2022.102554			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36183833	gold, Green Published			2022-12-26	WOS:000882627400006
J	Zhang, XF; Zuo, LG; Geng, ZJ; Song, X; Li, J; Ge, ST; Jiang, YF; Yang, Z; Liu, GY; Zhao, YJ; Zhao, H; Yu, L; Hu, JG				Zhang, Xiaofeng; Zuo, Lugen; Geng, Zhijun; Song, Xue; Li, Jing; Ge, Sitang; Jiang, Yifan; Yang, Zi; Liu, Guangyong; Zhao, Yajing; Zhao, Hao; Yu, Liang; Hu, Jianguo			Vindoline ameliorates intestinal barrier damage in Crohn's disease mice through MAPK signaling pathway	FASEB JOURNAL			English	Article						colitis; Crohn's disease; intestinal barrier damage; macrophage-mediated inflammation; vindoline	POLARIZATION; MACROPHAGES; CELLS	Intestinal inflammation and intestinal barrier damage are important pathological changes in Crohn's disease (CD). Vindoline is a natural monomer with anti-inflammatory effects. We employed CD model mice to explore the effect of Vindoline on CD-like colitis and the possible mechanism. Il-10-deficient (Il-10(-/-)) mice and wild-type (WT) mice (both aged 15 weeks, male) were used to explore the effect of Vindoline on colitis and intestinal barrier damage, as well as macrophage-mediated inflammation. Bone-marrow-derived macrophages (BMDMs) and colonic organoids from mice were used to explore the inhibitory effect of Vindoline on macrophage-mediated inflammation and the protective effect on inflammation-induced intestinal barrier damage as well as the possible mechanism. We found that Vindoline significantly ameliorated colitis in CD mice, as evidenced by increased weight change and colon length and decreased the colon macroscopic injury score, histological inflammatory score, and the expression of pro-inflammatory mediators. Vindoline also protected against intestinal barrier damage in CD mice. Furthermore, Vindoline inhibited macrophage-mediated inflammation and protected against inflammation-induced intestinal barrier damage in the coculture system. In addition, Vindoline ameliorated colitis in CD mice by protecting against inflammation-induced intestinal barrier damage, which may be caused by inhibition of MAPK signaling pathway. This protective effect suggests that Vindoline has potential value for clinical application in the treatment of CD.	[Zhang, Xiaofeng; Zuo, Lugen; Geng, Zhijun; Song, Xue; Li, Jing; Ge, Sitang; Yang, Zi; Zhao, Hao; Yu, Liang] Bengbu Med Coll, Dept Cent Lab, Affiliated Hosp 1, Bengbu, Peoples R China; [Zhang, Xiaofeng; Geng, Zhijun; Song, Xue; Jiang, Yifan; Liu, Guangyong; Zhao, Yajing; Hu, Jianguo] Bengbu Med Coll, Anhui Key Lab Tissue Transplantat, Bengbu, Peoples R China; [Zuo, Lugen; Ge, Sitang] Bengbu Med Coll, Dept Gastrointestinal Surg, Affiliated Hosp 1, Bengbu, Peoples R China; [Li, Jing; Hu, Jianguo] Bengbu Med Coll, Dept Clin Lab, Affiliated Hosp 1, 287 Changhuai Rd, Bengbu 233004, Anhui, Peoples R China	Bengbu Medical College; Bengbu Medical College; Bengbu Medical College; Bengbu Medical College	Hu, JG (corresponding author), Bengbu Med Coll, Dept Clin Lab, Affiliated Hosp 1, 287 Changhuai Rd, Bengbu 233004, Anhui, Peoples R China.	jghu9200@bbmc.edu.cn			Major science and technology project incubation program of Bengbu Medical College [2020byfy003]; National Natural Science Foundation of China (NSFC) [82070561]; First Affiliated Hospital of Bengbu Medical College Science Fund for Distinguished Young Scholars [2019byyfyjq01]; First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars [2019byyfyyq02, 2019byyfyyq08]	Major science and technology project incubation program of Bengbu Medical College; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); First Affiliated Hospital of Bengbu Medical College Science Fund for Distinguished Young Scholars; First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars	Major science and technology project incubation program of Bengbu Medical College, Grant/Award Number: 2020byfy003; National Natural Science Foundation of China (NSFC), Grant/Award Number: 82070561; The First Affiliated Hospital of Bengbu Medical College Science Fund for Distinguished Young Scholars, Grant/Award Number: 2019byyfyjq01; The First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars, Grant/Award Number: 2019byyfyyq02 and 2019byyfyyq08	APPLEYARD CB, 1995, AM J PHYSIOL-GASTR L, V269, pG119, DOI 10.1152/ajpgi.1995.269.1.G119; Ferre MPB, 2018, MED CLIN-BARCELONA, V151, P26, DOI 10.1016/j.medcli.2017.10.036; Cao ST, 2020, FREE RADICAL BIO MED, V147, P8, DOI 10.1016/j.freeradbiomed.2019.12.004; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Di Tommaso N, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182312836; Feuerstein JD, 2017, MAYO CLIN PROC, V92, P1088, DOI 10.1016/j.mayocp.2017.04.010; Funes SC, 2018, IMMUNOLOGY, V154, P186, DOI 10.1111/imm.12910; Garcia LS, 2010, CLIN LAB MED, V30, P93, DOI 10.1016/j.cll.2009.10.001; Goboza M, 2019, BIOMED PHARMACOTHER, V112, DOI 10.1016/j.biopha.2019.108638; Han X, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9230; Jia YF, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101534; Kidd M, 2009, NEUROGASTROENT MOTIL, V21, P439, DOI 10.1111/j.1365-2982.2008.01210.x; Kim Y, 2018, MATRIX BIOL, V66, P93, DOI 10.1016/j.matbio.2017.09.003; Lauro A, 2017, EXPERT REV GASTROENT, V11, P1105, DOI 10.1080/17474124.2017.1367665; Li J, 2019, J CELL MOL MED, V23, P5632, DOI 10.1111/jcmm.14471; Lissner D, 2015, INFLAMM BOWEL DIS, V21, P1297, DOI 10.1097/MIB.0000000000000384; Liu LL, 2020, BMC IMMUNOL, V21, DOI 10.1186/s12865-020-00355-y; Liu R, 2018, INT J MOL MED, V42, P2903, DOI 10.3892/ijmm.2018.3829; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Motta JP, 2021, J CROHNS COLITIS, V15, P787, DOI 10.1093/ecco-jcc/jjaa229; Oguntibeju OO, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7030059; Patterson L, 2020, FASEB J, V34, P15922, DOI 10.1096/fj.202001669R; Russo L, 2018, IMMUNOLOGY, V155, P407, DOI 10.1111/imm.13002; Schoultz I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020193; Schultz M, 1999, AM J PHYSIOL-GASTR L, V276, pG1461, DOI 10.1152/ajpgi.1999.276.6.G1461; Sertel S, 2011, BIOCHEM PHARMACOL, V81, P723, DOI 10.1016/j.bcp.2010.12.026; SHARIF H, 1992, INT SURG, V77, P15; Song X, 2022, J CELL MOL MED, V26, P216, DOI 10.1111/jcmm.17077; Spalinger MR, 2020, GASTROENTEROLOGY, V159, P1763, DOI 10.1053/j.gastro.2020.07.004; Talamonti E, 2017, CELL MOL LIFE SCI, V74, P2815, DOI 10.1007/s00018-017-2498-9; Tang Y, 2020, DIGEST DIS, V38, P211, DOI 10.1159/000501122; Turpin W, 2020, GASTROENTEROLOGY, V159, DOI 10.1053/j.gastro.2020.08.005; Vrakas S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170034; Wang HG, 2013, BRIT J NUTR, V109, P1990, DOI 10.1017/S0007114512004308; Wang ZX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.563784; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Yang BL, 2018, WORLD J GASTROENTERO, V24, P3414, DOI 10.3748/wjg.v24.i30.3414; Yin Z, 2018, J CELL BIOCHEM, V119, P9419, DOI 10.1002/jcb.27259; Zhan YF, 2020, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01587; Zhou X, 2019, CELL REP, V27, P1176, DOI 10.1016/j.celrep.2019.03.028; Zhu B, 2018, J ETHNOPHARMACOL, V226, P143, DOI 10.1016/j.jep.2018.08.023; Zhu YS, 2016, INT IMMUNOPHARMACOL, V30, P74, DOI 10.1016/j.intimp.2015.11.031; Zuo LG, 2019, J CELL MOL MED, V23, P5588, DOI 10.1111/jcmm.14457; Zuo LG, 2019, J CROHNS COLITIS, V13, P931, DOI 10.1093/ecco-jcc/jjz001; Zuo LG, 2014, J CROHNS COLITIS, V8, P1710, DOI 10.1016/j.crohns.2014.08.008	45	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22589	10.1096/fj.202200234RR	http://dx.doi.org/10.1096/fj.202200234RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B9QR	36197455				2022-12-26	WOS:000863903200001
J	Harrod, A; Lai, CF; Goldsbrough, I; Simmons, GM; Oppermans, N; Santos, DB; Gyorffy, B; Allsopp, RC; Toghill, BJ; Balachandran, K; Lawson, M; Morrow, CJ; Surakala, M; Carnevalli, LS; Zhang, P; Guttery, DS; Shaw, JA; Coombes, RC; Buluwela, L; Ali, S				Harrod, Alison; Lai, Chun-Fui; Goldsbrough, Isabella; Simmons, Georgia M.; Oppermans, Natasha; Santos, Daniela B.; Gyorffy, Balazs; Allsopp, Rebecca C.; Toghill, Bradley J.; Balachandran, Kirsty; Lawson, Mandy; Morrow, Christopher J.; Surakala, Manasa; Carnevalli, Larissa S.; Zhang, Pei; Guttery, David S.; Shaw, Jacqueline A.; Coombes, R. Charles; Buluwela, Lakjaya; Ali, Simak			Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer	ONCOGENE			English	Article							LIGAND-BINDING DOMAIN; ACQUIRED ENDOCRINE RESISTANCE; ACTIVATING ESR1 MUTATIONS; ALPHA MUTATIONS; THERAPEUTIC VULNERABILITIES; AROMATASE INHIBITORS; CELLS; ANTAGONISM; LANDSCAPE; STABILITY	Mutations in the estrogen receptor (ESR1) gene are common in ER-positive breast cancer patients who progress on endocrine therapies. Most mutations localise to just three residues at, or near, the C-terminal helix 12 of the hormone binding domain, at leucine-536, tyrosine-537 and aspartate-538. To investigate these mutations, we have used CRISPR-Cas9 mediated genome engineering to generate a comprehensive set of isogenic mutant breast cancer cell lines. Our results confirm that L536R, Y537C, Y537N, Y537S and D538G mutations confer estrogen-independent growth in breast cancer cells. Growth assays show mutation-specific reductions in sensitivities to drugs representing three classes of clinical anti-estrogens. These differential mutation- and drug-selectivity profiles have implications for treatment choices following clinical emergence of ER mutations. Our results further suggest that mutant expression levels may be determinants of the degree of resistance to some anti-estrogens. Differential gene expression analysis demonstrates up-regulation of estrogen-responsive genes, as expected, but also reveals that enrichment for interferon-regulated gene expression is a common feature of all mutations. Finally, a new gene signature developed from the gene expression profiles in ER mutant cells predicts clinical response in breast cancer patients with ER mutations.	[Harrod, Alison; Lai, Chun-Fui; Goldsbrough, Isabella; Simmons, Georgia M.; Oppermans, Natasha; Santos, Daniela B.; Balachandran, Kirsty; Coombes, R. Charles; Buluwela, Lakjaya; Ali, Simak] Imperial Coll London, Dept Surg & Canc, London W12 0NN, England; [Gyorffy, Balazs] Semmelweis Univ, Dept Bioinformat, H-1094 Budapest, Hungary; [Gyorffy, Balazs] TTK Canc Biomarker Res Grp, H-1117 Budapest, Hungary; [Allsopp, Rebecca C.; Toghill, Bradley J.; Guttery, David S.; Shaw, Jacqueline A.] Univ Leicester, Leicester Canc Res Ctr, Dept Genet & Genome Biol, Leicester Royal Infirm, Robert Kilpatrick Clin Sci Bldg, Leicester LE2 7LX, Leics, England; [Lawson, Mandy; Morrow, Christopher J.; Surakala, Manasa; Carnevalli, Larissa S.; Zhang, Pei] AstraZeneca, Early Oncol R&D, Biomed Campus,1 Francis Crick Ave, Cambridge CB2 0AA, England; [Harrod, Alison] Inst Canc Res, Fulham Rd, London SW3 6JB, England	Imperial College London; Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Leicester; AstraZeneca; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Buluwela, L; Ali, S (corresponding author), Imperial Coll London, Dept Surg & Canc, London W12 0NN, England.	l.buluwela@imperial.ac.uk; simak.ali@imperial.ac.uk	; Ali, Simak/M-6912-2018	Coombes, Raoul Charles/0000-0002-4811-1100; Carnevalli, Larissa/0000-0001-7432-0195; Ali, Simak/0000-0002-1320-0816; Harrod, Alison/0000-0002-3977-2791	Cancer Research UK Imperial Centre; Medical Research Council [MR/P016413/1, MR/P018521/1]; Breast Cancer Now [2014MayPR234]; Cancer Research UK [C37/A18784]; Ministry for Innovation and Technology in Hungary [2020-1.1.6-JoVO-2021-00013, 2020-4.1.1.-TKP2020]; Imperial Experimental Cancer Medicine Centre; Imperial NIHR Biomedical Research Centre	Cancer Research UK Imperial Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Breast Cancer Now; Cancer Research UK(Cancer Research UK); Ministry for Innovation and Technology in Hungary; Imperial Experimental Cancer Medicine Centre; Imperial NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	We thank Dr Jun Liang (Genentech) for GDC-0810. AH was supported by a Ph.D. studentship from the Cancer Research UK Imperial Centre. IG and KB were supported by a Medical Research Council Industrial CASE studentship (MR/P016413/1) and clinical research training fellowship (MR/P018521/1), respectively. CFL was supported by Breast Cancer Now (2014MayPR234) and Cancer Research UK (C37/A18784). BG was supported by the 2020-1.1.6-JoVO-2021-00013 and 2020-4.1.1.-TKP2020 grants of the Ministry for Innovation and Technology in Hungary. Additional support was provided by the Imperial Experimental Cancer Medicine Centre and the Imperial NIHR Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Abe O, 2005, LANCET, V366, P2087; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andreano KJ, 2020, MOL CANCER THER, V19, P1395, DOI 10.1158/1535-7163.MCT-19-1148; Arnesen S, 2021, CANCER RES, V81, P539, DOI 10.1158/0008-5472.CAN-20-1171; Bahreini A, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0851-4; Baird R, 2021, CANCER RES, V81; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Barrangou R, 2016, NAT BIOTECHNOL, V34, P933, DOI 10.1038/nbt.3659; Bidard FC, 2022, J CLIN ONCOL, V40, P3246, DOI 10.1200/JCO.22.00338; Bottcher R, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku289; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carlson KE, 1997, BIOCHEMISTRY-US, V36, P14897, DOI 10.1021/bi971746l; Chumsri S, 2011, J STEROID BIOCHEM, V125, P13, DOI 10.1016/j.jsbmb.2011.02.001; Coombes RC, 2019, CLIN CANCER RES, V25, P4255, DOI 10.1158/1078-0432.CCR-18-3663; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dahlgren M, 2021, JNCI CANCER SPECT, V5, DOI 10.1093/jncics/pkab028; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Eng FCS, 1997, MOL CELL BIOL, V17, P4644, DOI 10.1128/MCB.17.8.4644; Fanning Sean W, 2016, Elife, V5, DOI 10.7554/eLife.12792; Fribbens C, 2016, J CLIN ONCOL, V34, P2961, DOI 10.1200/JCO.2016.67.3061; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Gates LA, 2018, ONCOGENE, V37, P4581, DOI 10.1038/s41388-018-0284-2; Gelsomino L, 2018, CANCER LETT, V428, P12, DOI 10.1016/j.canlet.2018.04.023; Gu GW, 2021, ONCOGENE, V40, P997, DOI 10.1038/s41388-020-01563-x; HACKENBERG R, 1992, J STEROID BIOCHEM, V43, P599, DOI 10.1016/0960-0760(92)90284-P; Harrod A, 2017, ONCOGENE, V36, P2286, DOI 10.1038/onc.2016.382; Herynk MH, 2004, ENDOCR REV, V25, P869, DOI 10.1210/er.2003-0010; Herzog SK, 2022, BRIT J CANCER, V126, P174, DOI 10.1038/s41416-021-01564-x; Hickey TE, 2021, NAT MED, V27, P310, DOI 10.1038/s41591-020-01168-7; Jeselsohn R, 2018, CANCER CELL, V33, P173, DOI 10.1016/j.ccell.2018.01.004; Jeselsohn R, 2015, NAT REV CLIN ONCOL, V12, P573, DOI 10.1038/nrclinonc.2015.117; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Jia SH, 2018, ONCOLOGY-BASEL, V94, P176, DOI 10.1159/000485510; Kalinsky K, 2021, J CLIN ONCOL, V39, P100, DOI 10.1200/JCO.20.03040; Katzenellenbogen JA, 2018, NAT REV CANCER, V18, P377, DOI 10.1038/s41568-018-0001-z; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lanczky A, 2021, J MED INTERNET RES, V23, DOI 10.2196/27633; Li SQ, 2013, CELL REP, V4, P1116, DOI 10.1016/j.celrep.2013.08.022; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Ma CX, 2015, NAT REV CANCER, V15, P261, DOI 10.1038/nrc3920; Mao CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34753; Merenbakh-Lamin K, 2013, CANCER RES, V73, P6856, DOI 10.1158/0008-5472.CAN-13-1197; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; O'Leary B, 2018, CANCER DISCOV, V8, P1390, DOI 10.1158/2159-8290.CD-18-0264; O'Leary B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03215-x; Oesterreich S, 2013, NAT GENET, V45, P1415, DOI 10.1038/ng.2831; Pan HC, 2017, NEW ENGL J MED, V377, P1836, DOI 10.1056/NEJMoa1701830; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pearce ST, 2003, J BIOL CHEM, V278, P7630, DOI 10.1074/jbc.M211129200; Pleasance E, 2020, NAT CANCER, V1, P452, DOI 10.1038/s43018-020-0050-6; Puyang XL, 2018, CANCER DISCOV, V8, P1176, DOI 10.1158/2159-8290.CD-17-1229; Razavi P, 2018, CANCER CELL, V34, P427, DOI 10.1016/j.ccell.2018.08.008; Rinaldi J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231999; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Sava GP, 2020, ONCOGENE, V39, P651, DOI 10.1038/s41388-019-1008-y; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Shaw JA, 2017, CLIN CANCER RES, V23, P88, DOI 10.1158/1078-0432.CCR-16-0825; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Spoerke JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11579; STOVER EP, 1987, ENDOCRINOLOGY, V120, P2597, DOI 10.1210/endo-120-6-2597; Toy W, 2017, CANCER DISCOV, V7, P277, DOI 10.1158/2159-8290.CD-15-1523; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Weis KE, 1996, MOL ENDOCRINOL, V10, P1388, DOI 10.1210/me.10.11.1388; White R, 1997, EMBO J, V16, P1427, DOI 10.1093/emboj/16.6.1427; Williams MM, 2021, CANCER RES, V81, P732, DOI 10.1158/0008-5472.CAN-20-1200; Yu LQ, 2019, CANCER LETT, V442, P373, DOI 10.1016/j.canlet.2018.10.041; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhao CQ, 2003, J BIOL CHEM, V278, P27278, DOI 10.1074/jbc.M303840200	73	0	0	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2022	41	44					4905	4915		10.1038/s41388-022-02483-8	http://dx.doi.org/10.1038/s41388-022-02483-8		OCT 2022	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5U1RX	36198774	Green Published, hybrid			2022-12-26	WOS:000864316200001
J	Wisniewski, E; Czaran, D; Kovacs, F; Bahurek, E; Nemeth, A; Sasvari, P; Szanda, G; Pettko-Szandtner, A; Klement, E; Ligeti, E; Csepanyi-Komi, R				Wisniewski, Eva; Czaran, Domonkos; Kovacs, Fanni; Bahurek, Eniko; Nemeth, Afrodite; Sasvari, Peter; Szanda, Gergo; Pettko-Szandtner, Aladar; Klement, Eva; Ligeti, Erzsebet; Csepanyi-Komi, Roland			A novel BRET-Based GAP assay reveals phosphorylation-dependent regulation of the RAC-specific GTPase activating protein ARHGAP25	FASEB JOURNAL			English	Article						ARHGAP25; bioluminescence resonance energy transfer (BRET); GTPase activating protein (GAP); phosphorylation; RAC (RAC GTPase)	NADPH OXIDASE; CELL-ADHESION; RHO GTPASES; PATHWAY; GROWTH; GEFS	ARHGAP25, a RAC-specific GTPase activating protein (GAP), is an essential regulator of phagocyte effector functions such as phagocytosis, superoxide production, and transendothelial migration. Furthermore, its complex role in tumor behavior has recently been recognized. We previously demonstrated that phosphorylation of serine 363 in ARHGAP25 regulates hematopoietic stem cells and progenitor cells in mouse bone marrow. However, the significance of other potential phosphorylation sites of ARHGAP25 remained unknown. Now, we developed a novel, real-time bioluminescence resonance energy transfer (BRET) assay to monitor the GAP activity of ARHGAP25 in vitro. Using this approach, we revealed that phosphorylation of S363 and S488, but not that of S379-380, controls ARHGAP25's RACGAP activity. On the other hand, we found in granulocyte-differentiated human PLB-985 cells that superoxide production and actin depolymerization are regulated by residues S363 and S379-380. The present data demonstrate the value of our BRET-GAP assay and show that different phosphorylation patterns regulate ARHGAP25's GAP activity and its effect on superoxide production and phagocytosis.	[Wisniewski, Eva; Czaran, Domonkos; Kovacs, Fanni; Bahurek, Eniko; Nemeth, Afrodite; Sasvari, Peter; Szanda, Gergo; Ligeti, Erzsebet; Csepanyi-Komi, Roland] Semmelweis Univ, Dept Physiol, Tuzolto U 37-47, H-1094 Budapest, Hungary; [Pettko-Szandtner, Aladar; Klement, Eva] Biol Res Ctr, Lab Prote Res, Szeged, Hungary; [Klement, Eva] Hungarian Ctr Excellence Mol Med, Single Cell Omics ACF, Szeged, Hungary	Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Csepanyi-Komi, R (corresponding author), Semmelweis Univ, Dept Physiol, Tuzolto U 37-47, H-1094 Budapest, Hungary.	csepanyi-komi.roland@med.semmelweis-univ.hu	; Wisniewski, Eva/O-9233-2015	Sasvari, Peter/0000-0002-6026-9226; Wisniewski, Eva/0000-0001-8698-6867	Development and Innovation Office of Hungary [GINOP-2.3.2-15-2016-00032]; Higher Education Institutional Excellence Program of the Ministry of Human Capacities; Horizon 2020 research and innovation program [739593]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development, and Innovation [UNKP-20-5-SE-2]; NKFI \ National Research, Development and Innovation Office [FK_18 128376, FK_124038, 119236]; VEKOP [2.3.2-16-2016-00002]	Development and Innovation Office of Hungary; Higher Education Institutional Excellence Program of the Ministry of Human Capacities; Horizon 2020 research and innovation program; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development, and Innovation; NKFI \ National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); VEKOP	Development and Innovation Office of Hungary, Grant/Award Number: GINOP-2.3.2-15-2016-00032; Higher Education Institutional Excellence Program of the Ministry of Human Capacities; Horizon 2020 research and innovation program, Grant/Award Number: 739593; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development, and Innovation, Grant/Award Number: UNKP-20-5-SE-2; NKFI vertical bar National Research, Development and Innovation Office, Grant/Award Number: FK_18 128376, FK_124038 and 119236; VEKOP, Grant/Award Number: 2.3.2-16-2016-00002	BECKER EL, 1979, AM J PATHOL, V95, P81; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; COHEN HJ, 1981, BLOOD, V58, P975; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Csepanyi-Komi R, 2016, J IMMUNOL, V197, P2807, DOI 10.4049/jimmunol.1502342; Csepanyi-Komi R, 2012, BLOOD, V119, P573, DOI 10.1182/blood-2010-12-324053; Csepanyi-Komi R, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12993; Csepanyi-Komi Roland, 2013, Small GTPases, V4, P90, DOI 10.4161/sgtp.23708; Ding FP, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-02308-w; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Huang WK, 2021, INT J BIOL SCI, V17, P1808, DOI 10.7150/ijbs.55919; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Katoh M, 2004, INT J MOL MED, V14, P333; Kaya AI, 2020, P NATL ACAD SCI USA, V117, P14139, DOI 10.1073/pnas.1918736117; Klement E, 2019, METHODS MOL BIOL, V2026, P41, DOI 10.1007/978-1-4939-9612-4_4; Kobayashi K, 2015, EMBO J, V34, P1992, DOI 10.15252/embj.201490899; Levay M, 2009, BIOCHEMISTRY-US, V48, P8615, DOI 10.1021/bi900667y; Lorincz AM, 2014, FREE RADICAL BIO MED, V68, P65, DOI 10.1016/j.freeradbiomed.2013.12.001; McCormack J, 2013, J CELL SCI, V126, P379, DOI 10.1242/jcs.097923; Nomura M, 2003, MOL CARCINOGEN, V38, P25, DOI 10.1002/mc.10140; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sadok Amine, 2014, Small GTPases, V5, pe29710, DOI 10.4161/sgtp.29710; Schlam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9623; Tao L, 2019, EUR J PHARMACOL, V858, DOI 10.1016/j.ejphar.2019.172476; Tao L, 2019, BIOTECHNOL APPL BIOC, V66, P787, DOI 10.1002/bab.1784; Thuault S, 2016, MOL BIOL CELL, V27, P2653, DOI 10.1091/mbc.E16-01-0041; van Buul JD, 2014, CELL ADHES MIGR, V8, P108, DOI 10.4161/cam.27599; Wang LD, 2016, BLOOD, V128, P1465, DOI 10.1182/blood-2016-05-711424; Xu K, 2019, ONCOTARGETS THER, V12, P6699, DOI 10.2147/OTT.S207540	37	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22584	10.1096/fj.202200689R	http://dx.doi.org/10.1096/fj.202200689R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A9UZ	36190314	Green Accepted, hybrid			2022-12-26	WOS:000863225300001
J	Mohanty, S; Mohapatra, P; Shriwas, O; Ansari, SA; Priyadarshini, M; Priyadarsini, S; Rath, R; Sultania, M; Das Majumdar, SK; Swain, RK; Dash, R				Mohanty, Sibasish; Mohapatra, Pallavi; Shriwas, Omprakash; Ansari, Shamima Azma; Priyadarshini, Manashi; Priyadarsini, Swatismita; Rath, Rachna; Sultania, Mahesh; Das Majumdar, Saroj Kumar; Swain, Rajeeb K.; Dash, Rupesh			CRISPR-based kinome-screening revealed MINK1 as a druggable player to rewire 5FU-resistance in OSCC through AKT/MDM2/p53 axis	ONCOGENE			English	Article							LESTAURTINIB CEP701; P53; PHOSPHORYLATION; INHIBITOR; CANCER; MDM2	Cisplatin, 5FU and docetaxel (TPF) are the most common chemotherapy regimen used for advanced OSCC. However, many cancer patients experience relapse, continued tumor growth, and spread due to drug resistance, which leads to treatment failure and metastatic disease. Here, using a CRISPR/Cas9 based kinome knockout screening, Misshapen-like kinase 1 (MINK1) is identified as an important mediator of 5FU resistance in OSCC. Analysis of clinical samples demonstrated significantly higher MINK1 expression in the tumor tissues of chemotherapy non-responders as compared to chemotherapy responders. The nude mice and zebrafish xenograft experiments indicate that knocking out MINK1 restores 5FU mediated cell death in chemoresistant OSCC. An antibody based phosphorylation array screen revealed MINK1 as a negative regulator of p53. Mechanistically, MINK1 modulates AKT phosphorylation at Ser473, which enables p-MDM2 (Ser 166) mediated degradation of p53. We also identified lestaurtinib as a potent inhibitor of MINK1 kinase activity. The patient derived TPF resistant cell based xenograft data suggest that lestaurtinib restores 5FU sensitivity and facilitates a significant reduction of tumor burden. Overall, our study suggests that MINK1 is a major driver of 5FU resistance in OSCC. The novel combination of MINK1 inhibitor lestaurtinib and 5FU needs further clinical investigation in advanced OSCC.	[Mohanty, Sibasish; Mohapatra, Pallavi; Shriwas, Omprakash; Ansari, Shamima Azma; Priyadarshini, Manashi; Priyadarsini, Swatismita; Swain, Rajeeb K.; Dash, Rupesh] Inst Life Sci, Bhubaneswar 751023, Odisha, India; [Mohanty, Sibasish; Mohapatra, Pallavi; Ansari, Shamima Azma] Reg Ctr Biotechnol, Faridabad, India; [Priyadarshini, Manashi] KIIT Univ, KIIT Sch Biotechnol, Bhubaneswar, India; [Rath, Rachna] SCB Dent Coll Hosp, Dept Oral & Maxillofacial Pathol, Cuttack 753007, Odisha, India; [Sultania, Mahesh] All India Inst Med Sci, Dept Surg Oncol, Bhubaneswar 751019, Odisha, India; [Das Majumdar, Saroj Kumar] All India Inst Med Sci, Dept Radiotherapy, Bhubaneswar 751019, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Kalinga Institute of Industrial Technology (KIIT); Srirama Chandra Bhanja Medical College & Hospital; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; All India Institute of Medical Sciences (AIIMS) Bhubaneswar	Dash, R (corresponding author), Inst Life Sci, Bhubaneswar 751023, Odisha, India.	rupeshdash@ils.res.in			ICMR [5/13/9/2019-NCD-III]; Institute of Life Sciences, Bhubaneswar intramural; DBT [BT/INF/22/SP28293/2018]	ICMR(Indian Council of Medical Research (ICMR)); Institute of Life Sciences, Bhubaneswar intramural; DBT(Department of Biotechnology (DBT) India)	This work is supported by ICMR (5/13/9/2019-NCD-III), Institute of Life Sciences, Bhubaneswar intramural support and DBT BT/INF/22/SP28293/2018 (for imaging facility).	[Anonymous], 2020, Nat Rev Dis Primers, V6, P93, DOI 10.1038/s41572-020-00233-2; Chaturvedi A, 2020, HEAD NECK PATHOL, V14, P616, DOI 10.1007/s12105-019-01082-6; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; Daulat AM, 2016, DEV CELL, V37, P311, DOI 10.1016/j.devcel.2016.04.011; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gross S, 2015, J CLIN INVEST, V125, P1780, DOI 10.1172/JCI76094; Hexner EO, 2008, BLOOD, V111, P5663, DOI 10.1182/blood-2007-04-083402; Jin LT, 2018, CANCER CELL, V34, P315, DOI 10.1016/j.ccell.2018.06.012; John LSS, 2000, CANCER GENE THER, V7, P749, DOI 10.1038/sj.cgt.7700166; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Lakin ND, 1999, ONCOGENE, V18, P3989, DOI 10.1038/sj.onc.1202973; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Maji S, 2019, CARCINOGENESIS, V40, P173, DOI 10.1093/carcin/bgy135; Maji S, 2018, ADV CANCER RES, V137, P37, DOI 10.1016/bs.acr.2017.11.001; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Moll UM, 2003, MOL CANCER RES, V1, P1001; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Shabbir M, 2010, EXPERT OPIN INV DRUG, V19, P427, DOI 10.1517/13543781003598862; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Vishak S, 2015, INDIAN J MED PAEDIAT, V36, P148, DOI 10.4103/0971-5851.166716; YEUDALL WA, 1995, ORAL ONCOL, V31B, P136, DOI 10.1016/0964-1955(94)00030-8; Yogosawa S, 2018, CANCER SCI, V109, P3376, DOI 10.1111/cas.13792	25	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 3	2022	41	45					4929	4940		10.1038/s41388-022-02475-8	http://dx.doi.org/10.1038/s41388-022-02475-8		OCT 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5W8QC	36182968	Green Published, hybrid			2022-12-26	WOS:000862526800002
J	Carlson, CR; Adly, AN; Bi, M; Howard, CJ; Frost, A; Cheng, YF; Morgan, DO				Carlson, Christopher R.; Adly, Armin N.; Bi, Maxine; Howard, Conor J.; Frost, Adam; Cheng, Yifan; Morgan, David O.			Reconstitution of the SARS-CoV-2 ribonucleosome provides insights into genomic RNA packaging and regulation by phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONAVIRUS NUCLEOCAPSID PROTEIN; N-TERMINAL DOMAIN; SARS CORONAVIRUS; DIMERIZATION DOMAIN; RICH MOTIF; MEMBRANE; VIRUS; RIBONUCLEOPROTEIN; MULTIMERIZATION; REPLICATION	The nucleocapsid (N) protein of severe acute respiratory syndrome coronavirus 2 is responsible for compaction of the X30-kb RNA genome in the X90-nm virion. Previous studies suggest that each virion contains 35 to 40 viral ribonucleoprotein (vRNP) complexes, or ribonucleosomes, arrayed along the genome. There is, however, little mechanistic understanding of the vRNP complex. Here, we show that N protein, when combined in vitro with short fragments of the viral genome, forms 15-nm particles similar to the vRNP structures observed within virions. These vRNPs depend on regions of N protein that promote protein-RNA and protein-protein interactions. Phosphorylation of N protein in its disordered serine/arginine region weakens these interactions to generate less compact vRNPs. We propose that unmodified N protein binds structurally diverse regions in genomic RNA to form compact vRNPs within the nucleocapsid, while phosphorylation alters vRNP structure to support other N protein functions in viral transcription.	[Carlson, Christopher R.; Adly, Armin N.; Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94118 USA; [Bi, Maxine; Howard, Conor J.; Frost, Adam; Cheng, Yifan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94118 USA.	David.Morgan@ucsf.edu		Carlson, Christopher/0000-0003-3599-4044; Morgan, David/0000-0001-8753-4416	ARCS; National Institute of General Medical Sciences [R35-GM118053]; UCSF Program for Breakthrough Biomedical Research; QBI Coronavirus Research Group at UCSF; Sandler Foundation; Chan Zuckerberg Biohub	ARCS; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCSF Program for Breakthrough Biomedical Research; QBI Coronavirus Research Group at UCSF; Sandler Foundation; Chan Zuckerberg Biohub	This work was supported a graduate research fellowship from ARCS (C. R. C.), and grants (to D. O. M.) from the National Institute of General Medical Sciences (R35-GM118053) and the UCSF Program for Breakthrough Biomedical Research, which is funded in part by the Sandler Foundation. A. F. is supported by the Chan Zuckerberg Biohub and the QBI Coronavirus Research Group at UCSF. Y. C. is an investigator of the Howard Hughes Medical Institute.	A. T.Harding, 2020, bioRxiv, DOI 10.1101/2020.08.14.251207; Almazan F, 2004, J VIROL, V78, P12683, DOI 10.1128/JVI.78.22.12683-12688.2004; Barcena M, 2009, P NATL ACAD SCI USA, V106, P582, DOI 10.1073/pnas.0805270106; Bessa LM, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abm4034; Bost AG, 2000, J VIROL, V74, P3379, DOI 10.1128/JVI.74.7.3379-3387.2000; Bouhaddou M, 2020, CELL, V182, P685, DOI 10.1016/j.cell.2020.06.034; Cao CC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22785-x; Carlson CR, 2020, MOL CELL, V80, P1092, DOI 10.1016/j.molcel.2020.11.025; Chang CK, 2014, ANTIVIR RES, V103, P39, DOI 10.1016/j.antiviral.2013.12.009; Chang CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065045; Chang CK, 2009, J VIROL, V83, P2255, DOI 10.1128/JVI.02001-08; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Cong YY, 2020, J VIROL, V94, DOI 10.1128/JVI.01925-19; Cong YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06062-w; DAVIES HA, 1981, J GEN VIROL, V53, P67, DOI 10.1099/0022-1317-53-1-67; Dolan K. A., 2022, BIORXIV, DOI [10.1101/2022.06.12.495841, DOI 10.1101/2022.06.12.495841]; Fan H, 2005, STRUCTURE, V13, P1859, DOI 10.1016/j.str.2005.08.021; Franklin R., 2021, BIORXIV, DOI [10.1101/2021.10.22.465468, DOI 10.1101/2021.10.22.465468]; Fung TS, 2019, ANNU REV MICROBIOL, V73, P529, DOI 10.1146/annurev-micro-020518-115759; Grossoehme NE, 2009, J MOL BIOL, V394, P544, DOI 10.1016/j.jmb.2009.09.040; He RT, 2004, BIOCHEM BIOPH RES CO, V316, P476, DOI 10.1016/j.bbrc.2004.02.074; Hurst KR, 2009, J VIROL, V83, P7221, DOI 10.1128/JVI.00440-09; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; Huston NC, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.041; Iserman C, 2020, MOL CELL, V80, P1078, DOI 10.1016/j.molcel.2020.11.041; Jayaram H, 2006, J VIROL, V80, P6612, DOI 10.1128/JVI.00157-06; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Klein S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19619-7; Koetzner CA, 2022, VIROLOGY, V567, DOI 10.1016/j.virol.2021.12.004; Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002; Kuo LL, 2016, VIROLOGY, V494, P100, DOI 10.1016/j.virol.2016.04.009; Kuo L, 2014, J VIROL, V88, P4451, DOI 10.1128/JVI.03866-13; Kuo LL, 2013, J VIROL, V87, P5182, DOI 10.1128/JVI.00100-13; Liu XL, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2113401118, 10.1101/2021.02.17.21251933]; Lu S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20768-y; Luo HB, 2006, BIOCHEMISTRY-US, V45, P11827, DOI 10.1021/bi0609319; Luo HB, 2005, FEBS LETT, V579, P2623, DOI 10.1016/j.febslet.2005.03.080; Luo HB, 2005, BIOCHEMISTRY-US, V44, P15351, DOI 10.1021/bi051122c; Luo HB, 2004, BIOPHYS CHEM, V112, P15, DOI 10.1016/j.bpc.2004.06.008; MACNAUGHTON MR, 1978, J GEN VIROL, V39, P545, DOI 10.1099/0022-1317-39-3-545; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Masters PS, 2019, VIROLOGY, V537, P198, DOI 10.1016/j.virol.2019.08.031; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Neuman BW, 2011, J STRUCT BIOL, V174, P11, DOI 10.1016/j.jsb.2010.11.021; Nikolakaki E, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00219; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Perdikari TM, 2020, EMBO J, V39, DOI 10.15252/embj.2020106478; Sawicki SG, 2007, J VIROL, V81, P20, DOI 10.1128/JVI.01358-06; Scherer KM, 2022, SCI ADV, V8, DOI 10.1126/sciadv.abl4895; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Snijder EJ, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000715; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Takeda M, 2008, J MOL BIOL, V380, P608, DOI 10.1016/j.jmb.2007.11.093; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; V'kovski P, 2019, ELIFE, V8, DOI 10.7554/eLife.42037; Verheije MH, 2010, J VIROL, V84, P11575, DOI 10.1128/JVI.00569-10; Verma S, 2006, J VIROL, V80, P4344, DOI 10.1128/JVI.80.9.4344-4355.2006; Wolff G, 2020, SCIENCE, V369, P1395, DOI 10.1126/science.abd3629; Wu CH, 2014, CELL HOST MICROBE, V16, P462, DOI 10.1016/j.chom.2014.09.009; Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200; X. Wang, 2022, bioRxiv, DOI 10.1101/2022.06.28.497981; Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Ye QZ, 2020, PROTEIN SCI, V29, P1890, DOI [10.1002/pro.3909, 10.1101/2020.05.17.100685]; Zhang ZK, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-32019-3; Zhou CY, 2016, METHOD ENZYMOL, V573, P119, DOI 10.1016/bs.mie.2016.01.015; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zuniga S, 2010, J VIROL, V84, P2169, DOI 10.1128/JVI.02011-09	72	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102560	10.1016/j.jbc.2022.102560	http://dx.doi.org/10.1016/j.jbc.2022.102560			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36202211	Green Submitted, Green Published, gold			2022-12-26	WOS:000882199400004
J	Martinez, CA; Jiramongkol, Y; Bal, N; Alwis, I; Nedoboy, PE; Farnham, MMJ; White, MD; Cistulli, PA; Cook, KM				Martinez, Chloe -Anne; Jiramongkol, Yannasittha; Bal, Neha; Alwis, Imala; Nedoboy, Polina E.; Farnham, Melissa M. J.; White, Mark D.; Cistulli, Peter A.; Cook, Kristina M.			Intermittent hypoxia enhances the expression of hypoxia inducible factor HIF1A through histone demethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYOCARDIAL-INFARCTION; OBSTRUCTIVE SLEEP-APNEA; OXYGEN; CHROMATIN; METHYLATION; SURVIVAL; ANIMALS; TARGETS	The cellular response to hypoxia is regulated through enzymatic oxygen sensors, including the prolyl hydroxylases, which control degradation of the well-known hypoxia induc-ible factors (HIFs). Other enzymatic oxygen sensors have been recently identified, including members of the KDM histone demethylase family. Little is known about how different oxygen-sensing pathways interact and if this varies depending on the form of hypoxia, such as chronic or intermittent. In this study, we investigated how two proposed cellular oxygen -sensing systems, HIF-1 and KDM4A, KDM4B, and KDM4C, respond in cells exposed to rapid forms of intermittent hypoxia (minutes) and compared to chronic hypoxia (hours). We found that intermittent hypoxia increases HIF-1 alpha protein through a pathway distinct from chronic hypoxia, involving the KDM4A, KDM4B, and KDM4C histone lysine demethylases. Intermit-tent hypoxia increases the quantity and activity of KDM4A, KDM4B, and KDM4C, resulting in a decrease in histone 3 lysine 9 (H3K9) trimethylation near the HIF1A locus. We demonstrate that this contrasts with chronic hypoxia, which decreases KDM4A, KDM4B, and KDM4C activity, leading to hypertrimethylation of H3K9 globally and at the HIF1A locus. Altogether, we found that demethylation of histones bound to the HIF1A gene in intermittent hypoxia increases HIF1A mRNA expression, which has the downstream effect of increasing overall HIF-1 activity and expression of HIF target genes. This study highlights how multiple oxygen-sensing pathways can interact to regulate and fine tune the cellular hypoxic response depending on the period and length of hypoxia.	[Martinez, Chloe -Anne; Bal, Neha; Farnham, Melissa M. J.; Cistulli, Peter A.; Cook, Kristina M.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Jiramongkol, Yannasittha] Univ Sydney, Fac Sci, Charles Perkins Ctr, Sydney, NSW, Australia; [Jiramongkol, Yannasittha] Univ Sydney, Sch Chem, Sydney, NSW, Australia; [Alwis, Imala; Nedoboy, Polina E.; Farnham, Melissa M. J.] Univ Sydney, Heart Res Inst, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; Heart Research Institute	Cook, KM (corresponding author), Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia.	kristina.cook@sydney.edu.au		Jiramongkol, Yannasittha/0000-0003-1824-4313; Farnham, Melissa/0000-0002-7612-1015; White, Mark/0000-0002-1431-0339	Cancer Institute NSW Early Career; University of Sydney; NSW Health grant - A. E. and F. A. Q. Stephens PhD Scholarship from the University of Sydney; RTP (International) Scholarship - Australian Government	Cancer Institute NSW Early Career; University of Sydney(University of Sydney); NSW Health grant - A. E. and F. A. Q. Stephens PhD Scholarship from the University of Sydney; RTP (International) Scholarship - Australian Government	Funding and additional information - This study was funded by a Cancer Institute NSW Early Career Fellowship, a University of Sydney Fellowship and an NSW Health grant to K. M. C. C. A. M. is funded by an A. E. and F. A. Q. Stephens PhD Scholarship from the University of Sydney. Y. J. is funded by an RTP (International) Scholarship provided by the Australian Government.	Almendros I, 2013, RESP PHYSIOL NEUROBI, V186, P303, DOI 10.1016/j.resp.2013.03.001; Ardaseva A, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00754-7; Batie M, 2019, SCIENCE, V363, P1222, DOI 10.1126/science.aau5870; Beyer S, 2008, J BIOL CHEM, V283, P36542, DOI 10.1074/jbc.M804578200; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Cascella B, 2012, BIOCHEMISTRY-US, V51, P8699, DOI 10.1021/bi3012466; Cavadas MAS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17851; Chakraborty AA, 2019, SCIENCE, V363, P1217, DOI 10.1126/science.aaw1026; Chopra S, 2016, AM J RESP CELL MOL, V54, P299, DOI 10.1165/rcmb.2015-0218TR; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Dobrynin G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11658-3; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gillies RJ, 2018, NAT REV CANCER, V18, P576, DOI 10.1038/s41568-018-0030-7; Gupta V., 2017, CIRCULATION, V136; Haase VH, 2013, BLOOD REV, V27, P41, DOI 10.1016/j.blre.2012.12.003; Hancock RL, 2017, ACS CHEM BIOL, V12, P1011, DOI 10.1021/acschembio.6b00958; Hancock RL, 2015, EPIGENOMICS-UK, V7, P791, DOI 10.2217/epi.15.24; Hu K, 2020, BMC CARDIOVASC DISOR, V20, DOI 10.1186/s12872-020-01702-y; Hunyor I, 2018, AM J PHYSIOL-REG I, V315, pR669, DOI 10.1152/ajpregu.00036.2018; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kukwa W, 2013, SLEEP BREATH, V17, P1063, DOI 10.1007/s11325-013-0801-z; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Martinez CA, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3371; Martinez CA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020445; Masson N, 2019, SCIENCE, V365, P65, DOI 10.1126/science.aaw0112; Mohananey D, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006133; Philipp S, 2006, EUR J HEART FAIL, V8, P347, DOI 10.1016/j.ejheart.2005.10.009; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Prabhakar NR, 2016, PFLUG ARCH EUR J PHY, V468, P71, DOI 10.1007/s00424-015-1719-z; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Saxena K, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9080339; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shah N. A., 2011, HYPOXIA, VA109, pA2485; Shah N, 2013, SLEEP BREATH, V17, P819, DOI 10.1007/s11325-012-0770-7; Shmakova A, 2014, BIOCHEM J, V462, P385, DOI 10.1042/BJ20140754; Vordermark D, 2001, NEOPLASIA, V3, P527, DOI 10.1038/sj.neo.7900192; Weiswald LB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-106; Wenger RH, 1996, BIOCHEM BIOPH RES CO, V223, P54, DOI 10.1006/bbrc.1996.0845; Wilson JW, 2020, FEBS J, V287, P3888, DOI 10.1111/febs.15374; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Zong P, 2004, EXP BIOL MED, V229, P806, DOI 10.1177/153537020422900813	42	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102536	10.1016/j.jbc.2022.102536	http://dx.doi.org/10.1016/j.jbc.2022.102536			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36174675	Green Published, gold			2022-12-26	WOS:000882199400002
J	Randolph, CE; Dwyer, MB; Aumiller, JL; Dixon, AJ; Inoue, A; Osei-Owusu, P; Wedegaertner, PB				Randolph, Clinita E.; Dwyer, Morgan B.; Aumiller, Jenna L.; Dixon, Alethia J.; Inoue, Asuka; Osei-Owusu, Patrick; Wedegaertner, Philip B.			Enhanced membrane binding of oncogenic G protein?qQ209L confers resistance to inhibitor YM-254890	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED SUBCELLULAR REDISTRIBUTION; HETEROTRIMERIC G-PROTEINS; COUPLED RECEPTOR KINASE; ACTIVATED G-PROTEIN; G-BETA-GAMMA; PLASMA-MEMBRANE; PHOSPHOLIPASE-C; UVEAL MELANOMA; RGS DOMAIN; G-ALPHA(S)	Heterotrimeric G proteins couple activated G protein- coupled receptors (GPCRs) to intracellular signaling path-ways. They can also function independently of GPCR activation upon acquiring mutations that prevent GTPase activity and result in constitutive signaling, as occurs with the alpha qQ209L mutation in uveal melanoma. YM-254890 (YM) can inhibit signaling by both GPCR-activated WT alpha q and GPCR-independent alpha qQ209L. Although YM inhibits WT alpha q by binding to alpha q-GDP and preventing GDP/GTP exchange, the mechanism of YM inhibition of cellular alpha qQ209L remains to be fully understood. Here, we show that YM promotes a sub -cellular redistribution of alpha qQ209L from the plasma membrane (PM) to the cytoplasm. To test if this loss of PM localization could contribute to the mechanism of inhibition of alpha qQ209L by YM, we developed and examined N-terminal mutants of alpha qQ209L, termed PM-restricted alpha qQ209L, in which the addi-tion of membrane-binding motifs enhanced PM localization and prevented YM-promoted redistribution. Treatment of cells with YM failed to inhibit signaling by these PM-restricted alpha qQ209L. Additionally, pull-down experiments demonstrated that YM promotes similar conformational changes in both alpha qQ209L and PM-restricted alpha qQ209L, resulting in increased binding to beta gamma and decreased binding to regulator RGS2, and effectors p63RhoGEF-DH/PH and phospholipase C-beta. GPCR-dependent signaling by PM-restricted WT alpha q is strongly inhibited by YM, demonstrating that resistance to YM inhibi-tion by membrane-binding mutants is specific to constitutively active alpha qQ209L. Together, these results indicate that changes in membrane binding impact the ability of YM to inhibit alpha qQ209L and suggest that YM contributes to inhibition of alpha qQ209L by promoting its relocalization.	[Randolph, Clinita E.; Dwyer, Morgan B.; Aumiller, Jenna L.; Wedegaertner, Philip B.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19144 USA; [Dixon, Alethia J.; Osei-Owusu, Patrick] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH USA; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Japan	Jefferson University; Case Western Reserve University; Tohoku University	Wedegaertner, PB (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Biochem & Mol Biol, Philadelphia, PA 19144 USA.	philip.wedegaertner@jefferson.edu			National Institutes of Health (NIH) [R01 HL139754, R01 GM138943]; NIH [R01 HL139754]; American Heart Association Scientist Development Grant [16SDG27260276]; LEAP [20gm0010004]; Japan Agency for Medical Research and Development (AMED) [JP20am0101095]; Japan Society for the Promotion of Science (JSPS) [21H04791, 21H051130]; Japan Science and Technology Agency (JST) [JPMJFR215T]; Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation; Tokyo Biochemical Research Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Scientist Development Grant(American Heart Association); LEAP; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Daiichi Sankyo Foundation of Life Science; Uehara Memorial Foundation(Uehara Memorial Foundation); Tokyo Biochemical Research Foundation	Funding and additional information-This work was supported by National Institutes of Health (NIH) Grants R01 GM138943 R01 GM56444 and the Dr. Ralph and Marian Falk Medical Research Trust (P. B. W.) ; NIH Grant R01 HL139754 and American Heart Association Scientist Development Grant 16SDG27260276 (P. O.-O.) ; and NIH Grants F31 CA224803 and T32 GM100836 (C. E. R.) . A. I. was funded by the LEAP 20gm0010004 and the BINDS JP20am0101095 from the Japan Agency for Medical Research and Development (AMED) ; KAKENHI 21H04791 and 21H051130 from by the Japan Society for the Promotion of Science (JSPS) ; FOREST Program JPMJFR215T from Japan Science and Technology Agency (JST) ; Daiichi Sankyo Foundation of Life Science; The Uehara Memorial Foundation; The Tokyo Biochemical Research Founda-tion. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JA, 2005, MOL PHARMACOL, V67, P1493, DOI 10.1124/mol.104.008342; Annala S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau5948; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Charpentier TH, 2016, J BIOL CHEM, V291, P25608, DOI 10.1074/jbc.M116.740407; Chen X, 2017, CANCER CELL, V31, P685, DOI 10.1016/j.ccell.2017.04.002; Crouthamel M, 2008, CELL SIGNAL, V20, P1900, DOI 10.1016/j.cellsig.2008.06.019; Cervantes-Villagrana RD, 2019, J BIOL CHEM, V294, P531, DOI 10.1074/jbc.RA118.006254; Day PW, 2004, J BIOL CHEM, V279, P53643, DOI 10.1074/jbc.M401438200; Day PW, 2004, METHOD ENZYMOL, V390, P295; Evanko DS, 2000, J BIOL CHEM, V275, P1327, DOI 10.1074/jbc.275.2.1327; Evanko DS, 2005, CELL SIGNAL, V17, P1218, DOI 10.1016/j.cellsig.2004.12.008; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Helms MC, 2016, CELL SIGNAL, V28, P43, DOI 10.1016/j.cellsig.2015.10.004; Hitchman TD, 2021, CLIN CANCER RES, V27, P1476, DOI 10.1158/1078-0432.CCR-20-2860; Hu Q, 2018, CELL, V173, P1254, DOI 10.1016/j.cell.2018.03.018; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Kostenis E, 2020, J BIOL CHEM, V295, P5206, DOI 10.1074/jbc.REV119.007061; Lapadula D, 2019, MOL CANCER RES, V17, P963, DOI 10.1158/1541-7786.MCR-18-0574; LEE CH, 1992, J BIOL CHEM, V267, P16044; Martin BR, 2016, J BIOL CHEM, V291, P20295, DOI 10.1074/jbc.M116.729731; Maziarz M, 2018, J BIOL CHEM, V293, P19586, DOI 10.1074/jbc.RA118.005291; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Moore AR, 2018, CELL REP, V22, P2455, DOI 10.1016/j.celrep.2018.01.081; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Onken MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao6852; Robertson AG, 2018, CANCER CELL, V33, P151, DOI 10.1016/j.ccell.2017.12.013; Schlegel JG, 2021, ACS PHARMACOL TRANSL, V4, P888, DOI 10.1021/acsptsci.1c00021; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sprang SR, 2016, BIOPOLYMERS, V105, P449, DOI 10.1002/bip.22836; STERNWEIS PC, 1992, PHILOS T ROY SOC B, V336, P35, DOI 10.1098/rstb.1992.0041; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Thiyagarajan MM, 2002, BIOCHEMISTRY-US, V41, P9470, DOI 10.1021/bi025533u; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; Wedegaertner PB, 1996, MOL BIOL CELL, V7, P1225, DOI 10.1091/mbc.7.8.1225; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; WU DQ, 1992, J BIOL CHEM, V267, P25798; Xu H, 2014, MOL BIOL CELL, V25, P2105, DOI 10.1091/mbc.E13-09-0547; Yu JZ, 2002, MOL PHARMACOL, V61, P352, DOI 10.1124/mol.61.2.352	46	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102538	10.1016/j.jbc.2022.102538	http://dx.doi.org/10.1016/j.jbc.2022.102538			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36174676	Green Published, gold			2022-12-26	WOS:000886086000006
J	Young, LV; Wakelin, G; Cameron, AWR; Springer, SA; Ross, JP; Wolters, G; Murphy, JP; Arsenault, MG; Ng, S; Collao, N; De Lisio, M; Ljubicic, V; Johnston, APW				Young, Laura, V; Wakelin, Griffen; Cameron, Alasdair W. R.; Springer, Stevan A.; Ross, Joel P.; Wolters, Grant; Murphy, J. Patrick; Arsenault, Michel G.; Ng, Sean; Collao, Nicolas; De Lisio, Michael; Ljubicic, Vladimir; Johnston, Adam P. W.			Muscle injury induces a transient senescence-like state that is required for myofiber growth during muscle regeneration	FASEB JOURNAL			English	Article						muscle; regeneration; senescence; single-cell RNA sequencing	CELLULAR SENESCENCE; SKELETAL-MUSCLE; STEM-CELLS; DIFFERENTIATION; MECHANISMS	Cellular senescence is the irreversible arrest of normally dividing cells and is driven by the cell cycle inhibitors Cdkn2a, Cdkn1a, and Trp53. Senescent cells are implicated in chronic diseases and tissue repair through their increased secretion of pro-inflammatory factors known as the senescence-associated secretory phenotype (SASP). Here, we use spatial transcriptomics and single-cell RNA sequencing (scRNAseq) to demonstrate that cells displaying senescent characteristics are "transiently" present within regenerating skeletal muscle and within the muscles of D2-mdx mice, a model of Muscular Dystrophy. Following injury, multiple cell types including macrophages and fibrog-adipogenic progenitors (FAPs) upregulate senescent features such as senescence pathway genes, SASP factors, and senescence-associated beta-gal (SA-beta-gal) activity. Importantly, when these cells were removed with ABT-263, a senolytic compound, satellite cells are reduced, and muscle fibers were impaired in growth and myonuclear accretion. These results highlight that an "acute" senescent phenotype facilitates regeneration similar to skin and neonatal myocardium.	[Young, Laura, V; Wakelin, Griffen; Cameron, Alasdair W. R.; Springer, Stevan A.; Ross, Joel P.; Wolters, Grant; Murphy, J. Patrick; Arsenault, Michel G.; Johnston, Adam P. W.] Univ Prince Edward Isl, Dept Appl Human Sci, Charlottetown, PE, Canada; [Ng, Sean; Ljubicic, Vladimir] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Collao, Nicolas; De Lisio, Michael] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada; [Johnston, Adam P. W.] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE, Canada; [Johnston, Adam P. W.] Dalhousie Univ, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada	University of Prince Edward Island; McMaster University; University of Ottawa; University of Prince Edward Island; Dalhousie University	Johnston, APW (corresponding author), Dalhousie Univ, Dept Med Neurosci, Halifax, NS B3H 4R2, Canada.	adamjohnston@dal.ca		Wakelin, Griffen/0000-0001-9339-5387	Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-05747]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: RGPIN-2016-05747	Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Behmoaras J, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202010162; Biran A, 2017, AGING CELL, V16, P661, DOI 10.1111/acel.12592; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chiche A, 2017, CELL STEM CELL, V20, P407, DOI 10.1016/j.stem.2016.11.020; De Micheli AJ, 2020, CELL REP, V30, P3583, DOI 10.1016/j.celrep.2020.02.067; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Feng T, 2019, CIRCULATION, V139, P2495, DOI 10.1161/CIRCULATIONAHA.119.039530; Flamini V, 2018, STEM CELL REP, V10, P970, DOI 10.1016/j.stemcr.2018.01.007; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Giordani L, 2019, MOL CELL, V74, P609, DOI 10.1016/j.molcel.2019.02.026; Hall BM, 2017, AGING-US, V9, P1867, DOI 10.18632/aging.101268; Hernandez-Segura A, 2017, CURR BIOL, V27, P2652, DOI 10.1016/j.cub.2017.07.033; Herranz N, 2018, J CLIN INVEST, V128, P1238, DOI 10.1172/JCI95148; Hickson LJ, 2019, EBIOMEDICINE, V47, P446, DOI 10.1016/j.ebiom.2019.08.069; Hindi L, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2248; Itahana K, 2004, BIOGERONTOLOGY, V5, P1, DOI 10.1023/B:BGEN.0000017682.96395.10; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kats I., 2021, BIORXIV; Lee S, 2019, NAT CELL BIOL, V21, P94, DOI 10.1038/s41556-018-0249-2; Mademtzoglou D, 2018, ELIFE, V7, DOI 10.7554/eLife.33337; Magimaidas A, 2016, ONCOTARGET, V7, P26935, DOI 10.18632/oncotarget.8854; McKellar DW., 2020, BIORXIV; Moses L, 2022, NAT METHODS, V19, P534, DOI 10.1038/s41592-022-01409-2; Motohashi N, 2014, JOVE-J VIS EXP, DOI 10.3791/50846; Noel T, 2022, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.809346; Noren Hooten N, 2017, JOVE-J VIS EXP, DOI 10.3791/55533; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; Porrello A, 2000, J CELL BIOL, V151, P1295, DOI 10.1083/jcb.151.6.1295; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Saito Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14734-x; Shimizu I, 2019, J CARDIOL, V74, P313, DOI 10.1016/j.jjcc.2019.05.002; Sousa-Victor P, 2014, NATURE, V506, P316, DOI 10.1038/nature13013; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xu Q, 2016, ONCOTARGET, V7, P60290, DOI 10.18632/oncotarget.11200; Young LV, 2021, AM J PHYSIOL-CELL PH, V321, pC94, DOI 10.1152/ajpcell.00397.2020; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9	39	1	2	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22587	10.1096/fj.202200289RR	http://dx.doi.org/10.1096/fj.202200289RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B0AB	36190443				2022-12-26	WOS:000863238500001
J	Liu, ZX; Chen, MM; Sun, YN; Li, X; Cao, L; Ma, XC				Liu, Zixuan; Chen, Mingming; Sun, Yini; Li, Xu; Cao, Liu; Ma, Xiaochun			Transforming growth factor-beta receptor type 2 is required for heparin-binding protein-induced acute lung injury and vascular leakage for transforming growth factor-beta/Smad/Rho signaling pathway activation	FASEB JOURNAL			English	Article						acute lung injury; heparin-binding protein (HBP); infection; transforming growth factor-beta receptor type 2 (TGF-beta-R2); vascular permeability	ORGAN DYSFUNCTION; SEPSIS; FIBROBLASTS; HBP/CAP37; CELLS; CAP37; LINK	Heparin-binding protein (HBP), as a granule protein secreted by polymorphonuclear neutrophils, participates in the pathophysiological process of sepsis. It has been reported that HBP is a biomarker of sepsis related to the severity of septic shock and organ dysfunction. HBP binds to vascular endothelial cells as a primary target site. However, it is still unclear whether HBP-binding protein receptors exist on the surface of endothelial cells. The effect of HBP on vascular permeability in sepsis and its mechanism needs to be explored. We conducted in vivo and in vitro studies and demonstrated that HBP binds to transforming growth factor-beta receptor type 2 (TGF-beta-R2) as a ligand. Glutathione S-transferase pulldown analysis revealed that HBP mainly interacts with the extracellular domain of TGF-beta-R2. HBP induces acute lung injury and vascular leakage via activation of the TGF-beta/SMAD2/3 signaling pathway. A permeability assay suggested that TGF-beta-R2 is necessary for HBP-induced increased permeability. We also defined the role of HBP and its potential membrane receptor TGF-beta-R2 in the blood-gas barrier in the pathogenesis of HBP-related acute lung injury.	[Liu, Zixuan; Chen, Mingming; Sun, Yini; Li, Xu; Ma, Xiaochun] China Med Univ, Dept Crit Care Med, Hosp 1, 155 Nanjing North St, Shenyang 11000, Liaoning, Peoples R China; [Liu, Zixuan] Chinese Acad Med Sci, Inst Hematol, Dept Crit Care Med, Tianjin, Peoples R China; [Liu, Zixuan] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Cao, Liu] China Med Univ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, Inst Translat Med, Key Lab Cell Biol,Minist Publ Hlth, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Cao, Liu] China Med Univ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, Key Lab Med Cell Biol, Minist Educ, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; China Medical University; China Medical University	Ma, XC (corresponding author), China Med Univ, Dept Crit Care Med, Hosp 1, 155 Nanjing North St, Shenyang 11000, Liaoning, Peoples R China.; Cao, L (corresponding author), China Med Univ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, Inst Translat Med, Key Lab Cell Biol,Minist Publ Hlth, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.; Cao, L (corresponding author), China Med Univ, Liaoning Prov Collaborat Innovat Ctr Aging Relate, Key Lab Med Cell Biol, Minist Educ, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	lcao@cmu.edu.cn; maxc_cmu@sina.com			Clinical Research Center of Critical Care Medicine, Shenyang [20-204-4-41]; National 14th Five-Year Key Research and Development Plan [2021YFC2500805]; National Natural Science Foundation of China [82102266]; Clinical Research Center of Critical Care Medicine, Liaoning province [1586657730871]	Clinical Research Center of Critical Care Medicine, Shenyang; National 14th Five-Year Key Research and Development Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Clinical Research Center of Critical Care Medicine, Liaoning province	Clinical Research Center of Critical Care Medicine, Shenyang, Grant/ Award Number: 20-204-4-41; The National 14th Five-Year Key Research and Development Plan, Grant/Award Number: 2021YFC2500805; The National Natural Science Foundation of China, Grant/Award Number: 82102266; Clinical Research Center of Critical Care Medicine, Liaoning province, Grant/Award Number: 1586657730871	Al-Ani B, 2013, SAUDI MED J, V34, P477; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bentzer Peter, 2016, Intensive Care Med Exp, V4, P33; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Fisher J, 2017, J INTERN MED, V281, P562, DOI 10.1111/joim.12604; Friedrich M, 2019, MUCOSAL IMMUNOL, V12, P656, DOI 10.1038/s41385-019-0135-7; Gautam N, 2001, NAT MED, V7, P1123, DOI 10.1038/nm1001-1123; Gonzalez ML, 2004, MICROVASC RES, V67, P168, DOI 10.1016/j.mvr.2003.12.007; Griffith GL, 2013, INVEST OPHTH VIS SCI, V54, P6712, DOI 10.1167/iovs.13-12054; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Karnad DR, 2014, INTENS CARE MED, V40, P830, DOI 10.1007/s00134-014-3278-8; Lin QH, 2013, CRIT CARE, V17, DOI 10.1186/cc12834; Linder A, 2015, CRIT CARE MED, V43, P2378, DOI 10.1097/CCM.0000000000001265; Liu Y, 2018, LIFE SCI, V203, P92, DOI 10.1016/j.lfs.2018.04.029; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; McAuley DF, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-47; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; Olofsson AM, 1999, J CLIN INVEST, V104, P885, DOI 10.1172/JCI6671; Opal SM, 2015, J INTERN MED, V277, P277, DOI 10.1111/joim.12331; OSTERGAARD E, 1992, J LEUKOCYTE BIOL, V51, P316, DOI 10.1002/jlb.51.4.316; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; Pereira HA, 1996, J LEUKOCYTE BIOL, V60, P415, DOI 10.1002/jlb.60.3.415; Persson BP, 2014, ACTA ANAESTH SCAND, V58, P549, DOI 10.1111/aas.12301; SHAFER WM, 1984, INFECT IMMUN, V45, P29, DOI 10.1128/IAI.45.1.29-35.1984; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Suzuki K, 2020, BRIT J PHARMACOL, V177, P4021, DOI 10.1111/bph.15153; Tapper H, 2002, BLOOD, V99, P1785, DOI 10.1182/blood.V99.5.1785; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; Vardouli L, 2008, FEBS J, V275, P4074, DOI 10.1111/j.1742-4658.2008.06549.x; Varon C, 2006, EXP CELL RES, V312, P3604, DOI 10.1016/j.yexcr.2006.08.006; Wu QG, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay9819; Wu YL, 2021, CRIT CARE MED, V49, pE80, DOI 10.1097/CCM.0000000000004738; Xavier S, 2004, J BIOL CHEM, V279, P15167, DOI 10.1074/jbc.M309798200; Zhou M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01612	35	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22580	10.1096/fj.202200228RRRRR	http://dx.doi.org/10.1096/fj.202200228RRRRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A7PL	36189652	hybrid			2022-12-26	WOS:000863075200001
J	Sekiguchi, T; Yoshida, K; Wakabayashi, KI; Hisabori, T				Sekiguchi, Takatoshi; Yoshida, Keisuke; Wakabayashi, Ken-Ichi; Hisabori, Toru			Dissipation of the proton electrochemical gradient in chloroplasts promotes the oxidation of ATP synthase by thioredoxin-like proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNIT; THIOL MODULATION; REGULATORY REGION; PLASTIDIAL THIOREDOXINS; INTACT CHLOROPLASTS; INVERSE REGULATION; ARABIDOPSIS; ACTIVATION; MUTATION; LIGHT	Chloroplast FoF1-ATP synthase (CFoCF1) uses an electro-chemical gradient of protons across the thylakoid membrane (Delta mu H+) as an energy source in the ATP synthesis reaction. CFoCF1 activity is regulated by the redox state of a Cys pair on its central axis, that is, the gamma subunit (CF1-gamma). When the Delta mu H+ is formed by the photosynthetic electron transfer chain under light conditions, CF1-gamma is reduced by thioredoxin (Trx), and the entire CFoCF1 enzyme is activated. The redox regulation of CFoCF1 is a key mechanism underlying the control of ATP synthesis under light conditions. In contrast, the oxidative deactivation process involving CFoCF1 has not been clarified. In the present study, we analyzed the oxidation of CF1-gamma by two physiological oxidants in the chloroplast, namely the proteins Trx-like 2 and atypical Cys-His-rich Trx. Using the thylakoid membrane containing the reduced form of CFoCF1, we were able to assess the CF1-gamma oxidation ability of these Trx-like proteins. Our kinetic analysis indicated that these proteins oxidized CF1-gamma with a higher efficiency than that achieved by a chemical oxidant and typical chloroplast Trxs. Additionally, the CF1-gamma oxidation rate due to Trx-like proteins and the af-finity between them were changed markedly when Delta mu H+ for-mation across the thylakoid membrane was manipulated artificially. Collectively, these results indicate that the forma-tion status of the Delta mu H+ controls the redox regulation of CFoCF1 to prevent energetic disadvantages in plants.	[Sekiguchi, Takatoshi; Yoshida, Keisuke; Wakabayashi, Ken-Ichi; Hisabori, Toru] Tokyo Inst Technol, Inst Innovat Res, Lab Chem & Life Sci, Midori Ku, Yokohama, Japan; [Sekiguchi, Takatoshi; Yoshida, Keisuke; Wakabayashi, Ken-Ichi; Hisabori, Toru] Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Yokohama, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Lab Chem & Life Sci, Midori Ku, Yokohama, Japan.; Hisabori, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Midori Ku, Yokohama, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014; Yoshida, Keisuke/E-5231-2014; Wakabayashi, Ken-ichi/D-2440-2015	Hisabori, Toru/0000-0003-2046-0277; Yoshida, Keisuke/0000-0001-6542-6254; Wakabayashi, Ken-ichi/0000-0002-1025-9249; Sekiguchi, Takatoshi/0000-0003-4193-2683	Japan Society for the Promotion of Science [21H02502]; Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials [21H02502];  [22J13334]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials; 	This study was supported by Grants-in-Aid for Scientific Research (Grant 21H02502 to T. H.) from the Japan Society for the Promotion of Science and partly by a Grant-in-Aid for JSPS Research Fellows (Grant 22J13334 to T. S.) as well as the Dynamic Alliance for Open Innovation Bridging Human, Environment, and Materials.	Akanuma G, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.815; Arsova B, 2010, PLANT CELL, V22, P1498, DOI 10.1105/tpc.109.071001; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Cain P, 2009, PLANT MOL BIOL, V70, P273, DOI 10.1007/s11103-009-9471-4; Chibani K, 2009, MOL PLANT, V2, P308, DOI 10.1093/mp/ssn076; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; Dal Bosco C, 2004, J BIOL CHEM, V279, P1060, DOI 10.1074/jbc.M308435200; Dangoor I, 2009, PLANT PHYSIOL, V149, P1240, DOI 10.1104/pp.108.128314; Hahn A, 2018, SCIENCE, V360, P620, DOI 10.1126/science.aat4318; Hightower KE, 1996, BIOCHEMISTRY-US, V35, P4846, DOI 10.1021/bi952913p; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HUANG CS, 1983, BIOCHIM BIOPHYS ACTA, V722, P107, DOI 10.1016/0005-2728(83)90163-9; Jacquot JP, 1997, NEW PHYTOL, V136, P543, DOI 10.1046/j.1469-8137.1997.00784.x; JAGENDORF AT, 1966, P NATL ACAD SCI USA, V55, P170, DOI 10.1073/pnas.55.1.170; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; Kanazawa A, 2002, P NATL ACAD SCI USA, V99, P12789, DOI 10.1073/pnas.182427499; KETCHAM SR, 1984, J BIOL CHEM, V259, P7286; Kohzuma K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01248; Kohzuma K, 2013, J BIOL CHEM, V288, P13156, DOI 10.1074/jbc.M113.453225; KomatsuTakaki M, 1996, EUR J BIOCHEM, V236, P470, DOI 10.1111/j.1432-1033.1996.00470.x; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Konno H, 2012, PLANT CELL PHYSIOL, V53, P626, DOI 10.1093/pcp/pcs018; KRAMER DM, 1989, BIOCHIM BIOPHYS ACTA, V976, P28, DOI 10.1016/S0005-2728(89)80186-0; Lemaire SD, 2007, CURR GENET, V51, P343, DOI 10.1007/s00294-007-0128-z; McCarty RE, 2005, J BIOENERG BIOMEMBR, V37, P289, DOI 10.1007/s10863-005-8640-7; MCKINNEY DW, 1979, BIOCHEM BIOPH RES CO, V86, P1178, DOI 10.1016/0006-291X(79)90241-9; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Meyer Y, 2006, PHOTOSYNTH RES, V89, P179, DOI 10.1007/s11120-006-9095-3; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MILLS JD, 1980, FEBS LETT, V112, P173, DOI 10.1016/0014-5793(80)80173-6; MILLS JD, 1982, BIOCHIM BIOPHYS ACTA, V679, P75, DOI 10.1016/0005-2728(82)90257-2; MITCHELL P, 1966, BIOL REV, V41, P445, DOI 10.1111/j.1469-185X.1966.tb01501.x; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Okegawa Y, 2015, PLANT J, V84, P900, DOI 10.1111/tpj.13049; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; QUICK WP, 1986, BIOCHIM BIOPHYS ACTA, V851, P166, DOI 10.1016/0005-2728(86)90122-2; SCHMID GH, 1978, Z NATURFORSCH C, V33, P723; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Sekiguchi T, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148261; Sugiyama K, 2003, BIOCHEM BIOPH RES CO, V301, P311, DOI 10.1016/S0006-291X(02)03022-X; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; Vaseghi MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.38194; Wu G, 2007, J BIOL CHEM, V282, P36782, DOI 10.1074/jbc.M707007200; Yang JH, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01221-8; Yokochi Y, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2114952118; Yokochi Y, 2019, J BIOL CHEM, V294, P17437, DOI 10.1074/jbc.RA119.010401; Yoshida K, 2021, PLANT CELL PHYSIOL, V62, P401, DOI 10.1093/pcp/pcaa174; Yoshida K, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01534; Yoshida K, 2019, BIOCHEM J, V476, P1781, DOI 10.1042/BCJ20190336; Yoshida K, 2018, P NATL ACAD SCI USA, V115, pEB296, DOI 10.1073/pnas.1808284115; Yoshida K, 2017, BIOCHEM J, V474, P1347, DOI 10.1042/BCJ20161089; Yoshida K, 2015, J BIOL CHEM, V290, P14278, DOI 10.1074/jbc.M115.647545; Yoshida K, 2014, PLANT CELL PHYSIOL, V55, P1415, DOI 10.1093/pcp/pcu066; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	55	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102541	10.1016/j.jbc.2022.102541	http://dx.doi.org/10.1016/j.jbc.2022.102541			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36174673	Green Published, gold			2022-12-26	WOS:000882199400009
J	Ramarao, KDR; Somasundram, C; Razali, Z; Kunasekaran, W; Jin, TL; Musa, S; Achari, VM				Ramarao, Kivaandra Dayaa Rao; Somasundram, Chandran; Razali, Zuliana; Kunasekaran, Wijenthiran; Jin, Tan Li; Musa, Sabri; Achari, Vijayan Manickam			Antiproliferative effects of dried Moringa oleifera leaf extract on human Wharton's Jelly mesenchymal stem cells	PLOS ONE			English	Article							CANCER; APIGENIN; IDENTIFICATION; OPTIMIZATION; EXPRESSION; FLAVONOIDS	Mesenchymal stem cells (MSCs) have seen an elevated use in clinical works like regenerative medicine. Its potential therapeutic properties increases when used in tandem with complementary agents like bio-based materials. Therefore, the present study is the first to investigate the cytotoxicity of a highly valued medicinal plant, Moringa oleifera, on human Wharton's Jelly mesenchymal stem cells (hWJMSCs) and its effects on the cells' gene expression when used as a pre-treatment agent in vitro. M. oleifera leaves (MOL) were dried and subjected to UHPLC-QTOF/MS analysis, revealing several major compounds like apigenin, kaempferol, and quercetin in the MOL, with various biological activities like antioxidant and anti-cancer properties. We then treated the hWJMSCs with MOL and noticed a dose-dependant inhibition on the cells' proliferation. RNA-sequencing was performed to explain the possible mechanism of action and revealed genes like PPP1R1C, SULT2B1, CDKN1A, mir-154 and CCNB1, whose expression patterns were closely associated with the negative cell cycle regulation and cell cycle arrest process. This is also evident from gene set enrichment analysis where the GO and KEGG terms for down-regulated pathways were closely related to the cell cycle regulation. The Ingenuity pathway analysis (IPA) software further predicted the significant activation of (p < 0.05, z-score > 2) of the G2/M DNA damage checkpoint regulation pathway. The present study suggests that MOL exhibits an antiproliferative effect on hWJMSCs via cell cycle arrest and apoptotic pathways. We believe that this study provides an important baseline reference for future works involving MOL's potential to accompany MSCs for clinical works. Future works can take advantage of the cell's strong anti-cancer gene expression found in this study, and evaluate our MOL treatment on various cancer cell lines.	[Ramarao, Kivaandra Dayaa Rao; Somasundram, Chandran; Razali, Zuliana] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia; [Ramarao, Kivaandra Dayaa Rao; Somasundram, Chandran; Razali, Zuliana] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia; [Kunasekaran, Wijenthiran; Jin, Tan Li] Menara UOA Bangsar, Cytonex Sdn Bhd, Kuala Lumpur, Malaysia; [Musa, Sabri] Univ Malaya, Fac Dent, Dept Paediat Dent & Orthodont, Kuala Lumpur, Malaysia; [Achari, Vijayan Manickam] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Somasundram, C (corresponding author), Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur, Malaysia.; Somasundram, C (corresponding author), Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Malaysia.	chandran@um.edu.my			Cytonex Sdn. Bhd.	Cytonex Sdn. Bhd.	The authors would like to thank Cytonex Sdn. Bhd. for supporting this research and The Centre for Research in Biotechnology for Agriculture (CEBAR) for providing the infrastructure and facilities to carry out this research. We would also like to extend our gratitude to Dr. Mogana Darshini, Nusrat Rehana Bano Binti Naushad Ahmad and Fahmida Binti Irfaan Hamid for their guidance during the course of this work.	Adebayo Ismail Abiola, 2017, Afr J Tradit Complement Altern Med, V14, P282, DOI 10.21010/ajtcam.v14i2.30; Ali MY, 2021, COMPUT TOXICOL, V17; Anuchapreeda S, 2020, MOLECULES, V25, DOI 10.3390/molecules25061300; Aykac A, 2020, CLIN PSYCHOPHARM NEU, V18, P174, DOI 10.9758/cpn.2020.18.2.174; Bharti D, 2018, CELL TISSUE RES, V372, P51, DOI 10.1007/s00441-017-2699-4; Boik J, 2001, NATURAL COMPOUNDS CA; Bonta RK, 2017, J PHARM ANAL, V7, P349, DOI 10.1016/j.jpha.2017.06.005; Oldoni TLC, 2019, FOOD RES INT, V125, DOI 10.1016/j.foodres.2019.108647; Chiricosta L, 2019, MOLECULES, V24, DOI 10.3390/molecules24183217; Choi YJ, 2016, J KOREAN SOC FOOD SC, V45, P819, DOI DOI 10.3746/JKFN.2016.45.6.819; Cirmi S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081930; Djande CYH, 2018, S AFR J BOT, V115, P81, DOI 10.1016/j.sajb.2018.01.009; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; du Toit ES, 2020, S AFR J BOT, V129, P336, DOI 10.1016/j.sajb.2019.08.035; Fernandez-Barral A, 2020, FEBS J, V287, P53, DOI 10.1111/febs.14998; Govender K, 2021, THESIS; Guan YT, 2019, MOL MED REP, V20, P633, DOI 10.3892/mmr.2019.10286; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hapsari BW, 2021, HORTICULTURAE, V7, DOI 10.3390/horticulturae7020035; Hashemzaei M, 2017, ONCOL REP, V38, P819, DOI 10.3892/or.2017.5766; Hashim FJ, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10050889; Hong WT, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1149-6; Hou Y, 2021, AM J TRANSL RES, V13, P2006; Imran M, 2019, MOLECULES, V24, DOI 10.3390/molecules24122277; Jiang SH, 2020, ONCOGENE, V39, P503, DOI 10.1038/s41388-019-1006-0; Jung IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095492; Kabir MF, 2018, PEERJ, V6, DOI 10.7717/peerj.5203; Kachlicki P, 2016, MOLECULES, V21, DOI 10.3390/molecules21111494; Kamal AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193104; Kashyap D, 2021, SEMIN CANCER BIOL, V69, P5, DOI 10.1016/j.semcancer.2019.08.014; Khalafalla MM, 2010, AFR J BIOTECHNOL, V9, P8467; Khor KZ, 2020, INT J NANOMED, V15, P5661, DOI 10.2147/IJN.S244834; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kreis NN, 2014, ONCOGENE, V33, P5716, DOI 10.1038/onc.2013.518; Kreis NN, 2019, CANCERS, V11, DOI 10.3390/cancers11091220; Kreis NN, 2016, ONCOTARGET, V7, P50215, DOI 10.18632/oncotarget.10330; Li SF, 2019, TOXICOL APPL PHARM, V369, P17, DOI 10.1016/j.taap.2019.02.015; Li SW, 2018, ARCH TOXICOL, V92, P1991, DOI 10.1007/s00204-018-2195-y; Li YX, 2021, NUTR CANCER, V73, P1489, DOI 10.1080/01635581.2020.1802494; Liang YJ, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6105608; Lin HQ, 2019, MOLECULES, V24, DOI 10.3390/molecules24050942; Lin XY, 2016, ONCOL LETT, V12, P301, DOI 10.3892/ol.2016.4577; Lin X, 2021, J APPL RES MED AROMA, V20, DOI 10.1016/j.jarmap.2020.100284; Liu LQ, 2017, ONCOTARGET, V8, P114677, DOI 10.18632/oncotarget.21309; Liu YY, 2019, INT J ONCOL, V54, P1907, DOI 10.3892/ijo.2019.4786; Ma YP, 2019, INT J ANTIMICROB AG, V53, P128, DOI 10.1016/j.ijantimicag.2018.07.014; Magiera S, 2015, FOOD ANAL METHOD, V8, P2665, DOI 10.1007/s12161-015-0166-y; Makita C, 2016, S AFR J BOT, V105, P116, DOI 10.1016/j.sajb.2015.12.007; Mammana S, 2019, J TISSUE ENG REGEN M, V13, P1109, DOI 10.1002/term.2857; Market Research Future, 2021, MOR PROD MARK INF TY; Fisall UFM, 2021, MOL BIOL REP, V48, P4465, DOI 10.1007/s11033-021-06466-y; Montalbano J, 2009, J BIOL CHEM, V284, P18129, DOI 10.1074/jbc.M109.009597; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Nekanti U, 2010, STEM CELL RES, V5, P244, DOI 10.1016/j.scr.2010.08.005; Orlando N, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.585519; Pamunuwa G, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8243215; Pappas IS, 2021, FOOD BIOSCI, V43, DOI 10.1016/j.fbio.2021.101221; Patel P, 2014, INT J PHARM PHARM SC, V6, P144; Ramarao KDR, 2021, CZECH J FOOD SCI, V39, P444, DOI 10.17221/257/2020-CJFS; Razali N, 2015, PEERJ, V3, DOI 10.7717/peerj.1292; Rodriguez-Perez C, 2015, IND CROP PROD, V66, P246, DOI 10.1016/j.indcrop.2015.01.002; Serreli G, 2019, FOOD FUNCT, V10, P6999, DOI [10.1039/C9FO01733J, 10.1039/c9fo01733j]; Shao ZM, 2020, INT J MOL MED, V46, P1225, DOI 10.3892/ijmm.2020.4661; Shu XS, 2018, J FUNCT FOODS, V50, P93, DOI 10.1016/j.jff.2018.09.030; Subramanian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127992; Swetha MP, 2018, J FOOD MEAS CHARACT, V12, P1917, DOI 10.1007/s11694-018-9806-4; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Tamayo ADA, 2015, THESIS OHIO STATE U; Tamura RE, 2012, CURR MOL MED, V12, P634; Tiloke C, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-226; Uribe E, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/347532; Vijayalakshmi A, 2017, IRAN J SCI TECHNOL A, V41, P307, DOI 10.1007/s40995-017-0219-8; Vijayaraghavalu S, 2013, MOL PHARMACEUT, V10, P337, DOI 10.1021/mp3004622; Vongsak B, 2015, PLANTA MED, V81, P1084, DOI 10.1055/s-0035-1546168; Wang LX, 2015, PHARMACOL THERAPEUT, V151, P141, DOI 10.1016/j.pharmthera.2015.04.002; Wang QX, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0447-3; Wang SM, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.657665; Welch RH, 2017, J S C ACAD SCI, V15, P4; Wen LR, 2017, FREE RADICAL BIO MED, V110, P92, DOI 10.1016/j.freeradbiomed.2017.05.027; Weng LJ, 2016, EUR J PHARMACOL, V774, P50, DOI 10.1016/j.ejphar.2016.01.015; Williamson EM, 2020, BRIT J PHARMACOL, V177, P1227, DOI 10.1111/bph.14943; Wu YP, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00892; Xiang Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00233; Xu YB, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080296; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Yang XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060853; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Yin LJ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.926780; Yu FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234696; Yumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079895; Zhang HT, 2011, CHINESE MED J-PEKING, V124, P3537, DOI 10.3760/cma.j.issn.0366-6999.2011.21.019; Zhang L, 2014, EXP BIOL MED, V239, P773, DOI 10.1177/1535370214531879; Zhang LJ, 2018, TOXICOL APPL PHARM, V350, P1, DOI 10.1016/j.taap.2018.04.025; Zhang S, 2020, J FUNCT FOODS, V66, DOI 10.1016/j.jff.2020.103822; Zhao XY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00877; Zheng J, 2015, ONCOTARGET, V6, P25339, DOI 10.18632/oncotarget.4509; Zhou ZW, 2018, MOL MED REP, V18, P1560, DOI 10.3892/mmr.2018.9115; Zhu C, 2013, MOL CELL BIOCHEM, V379, P69, DOI 10.1007/s11010-013-1628-4; Zhu YQ, 2020, MOLECULES, V25, DOI 10.3390/molecules25030676; Zhuang HK, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01588-y	100	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2022	17	10								10.1371/journal.pone.0274814	http://dx.doi.org/10.1371/journal.pone.0274814			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6W7CJ	36197921	gold, Green Published			2022-12-26	WOS:000895884500001
J	Bae, WJ; Kim, S; Ahn, JM; Han, JH; Lee, D				Bae, Won Jung; Kim, Seokhwi; Ahn, Ji Mi; Han, Jae Ho; Lee, Dakeun			Estrogen-responsive cancer-associated fibroblasts promote invasive property of gastric cancer in a paracrine manner via CD147 production	FASEB JOURNAL			English	Article						cancer-associated fibroblast; CD147; estrogen; gastric cancer; matrix metalloproteinase	RECEPTOR-ALPHA; EMMPRIN; EXPRESSION; PROGNOSIS; INDUCER; TUMOR; BETA; SEX	Estrogen signaling has been extensively studied, especially in cancers that express estrogen receptor alpha (ER alpha). However, little is known regarding the effect of estrogen on cancer-associated fibroblasts (CAFs). Here, we explored the role of estrogen signaling of CAFs in gastric cancer (GC) progression. We investigated the phenotypic changes in CAFs upon 17 beta-estradiol (E2) treatment using ER alpha-negative/positive CAFs, and the conditioned media (CM) collected from these were compared with regard to cancer cell proliferation, migration, and invasion. A paracrine factor was found using a cytokine array and was confirmed using qRT-PCR, western blotting, and enzyme-linked immunosorbent assays. ER alpha-CD147-matrix metalloproteinase (MMP) axis was confirmed by knockdown experiments using specific siRNAs. We found that a subset of CAFs expressed ER alpha. ER alpha-positive CAFs were responsive to E2, inducing ER alpha expression in a dose-dependent manner. Although E2 did not induce the proliferation of ER alpha-positive CAFs, the CM from E2-bound ER alpha-positive CAFs significantly promoted cancer cell migration and invasion. Cytokine array revealed that CD147 was induced in ER alpha-positive CAFs upon E2 treatment; this was mediated via ER alpha. Increased CD147 upregulated MMP2 and MMP9 in CAFs, and also influenced cancer cells in a paracrine manner to increase MMPs and CD147 in cancer cells. High CD147 expression in tumor tissue was associated with a worse prognosis in GC patients. Our data suggest that estrogen signaling activation in CAFs and the byproduct CD147 are among the critical mediators between the interplay of CAFs and cancer cells to facilitate cancer progression.	[Bae, Won Jung; Kim, Seokhwi; Ahn, Ji Mi; Han, Jae Ho; Lee, Dakeun] Ajou Univ, Dept Pathol, Sch Med, Suwon, South Korea; [Bae, Won Jung; Kim, Seokhwi; Ahn, Ji Mi; Lee, Dakeun] Ajou Univ, Dept Biomed Sci, Grad Sch Med, Suwon, South Korea	Ajou University; Ajou University	Han, JH; Lee, D (corresponding author), Ajou Univ, Dept Pathol, Sch Med, 164 Worldcup Ro, Suwon 16499, Gyeonggi Do, South Korea.	hanpathol@ajou.ac.kr; dakeun@gmail.com			National Research Foundation of Korea (NRF) [2021R1A2C2005853, 2018R1A6A3A01013116, 2021R1A4A1031856]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	National Research Foundation of Korea (NRF), Grant/Award Number: 2021R1A2C2005853, 2018R1A6A3A01013116 and 2021R1A4A1031856	Baba M, 2008, BIOCHEM BIOPH RES CO, V374, P111, DOI 10.1016/j.bbrc.2008.06.122; BISWAS C, 1995, CANCER RES, V55, P434; Burnett LA, 2012, J CLIN ENDOCR METAB, V97, P4613, DOI 10.1210/jc.2012-2098; Caudron A, 2016, EXP DERMATOL, V25, P618, DOI 10.1111/exd.13022; Caudroy S, 2002, CLIN EXP METASTAS, V19, P697, DOI 10.1023/A:1021350718226; Cirri P, 2011, AM J CANCER RES, V1, P482; Davidson B, 2003, CLIN EXP METASTAS, V20, P161, DOI 10.1023/A:1022696012668; Hua H, 2018, EXP HEMATOL ONCOL, V7, DOI 10.1186/s40164-018-0116-7; Humar B, 2009, CANCER RES, V69, P2050, DOI 10.1158/0008-5472.CAN-08-2457; Kameda C, 2010, BRIT J CANCER, V102, P738, DOI 10.1038/sj.bjc.6605517; Kim HW, 2016, ANN SURG ONCOL, V23, P4344, DOI 10.1245/s10434-016-5448-0; Kunz PL, 2012, J CLIN ONCOL, V30, P3507, DOI 10.1200/JCO.2011.35.8028; Landras A, 2019, CANCERS, V11, DOI 10.3390/cancers11111803; Langdon SP, 2020, CANCERS, V12, DOI 10.3390/cancers12102744; Lee D, 2017, GASTRIC CANCER, V20, P591, DOI 10.1007/s10120-016-0669-2; Lee KW, 2015, CANCER RES, V75, P73, DOI 10.1158/0008-5472.CAN-14-0350; Marsh T, 2013, BBA-MOL BASIS DIS, V1832, P1070, DOI 10.1016/j.bbadis.2012.10.013; MATSUI M, 1992, SURG TODAY, V22, P421, DOI 10.1007/BF00308791; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; MIYAUCHI T, 1991, J BIOCHEM-TOKYO, V110, P770, DOI 10.1093/oxfordjournals.jbchem.a123657; Oesterreich S, 2003, CANCER RES, V63, P5203; Reimers N, 2004, CLIN CANCER RES, V10, P3422, DOI 10.1158/1078-0432.CCR-03-0610; RIBEIRO MM, 1981, CANCER, V47, P780, DOI 10.1002/1097-0142(19810215)47:4<780::AID-CNCR2820470424>3.0.CO;2-G; Sienel W, 2008, MODERN PATHOL, V21, P1130, DOI 10.1038/modpathol.2008.102; Srinivasan S, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1187; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Takano N, 2002, CANCER LETT, V176, P129, DOI 10.1016/S0304-3835(01)00739-X; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Ulrich H, 2020, STEM CELL REV REP, V16, P434, DOI 10.1007/s12015-020-09976-7; Walter M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1078056; Xiong LJ, 2014, INT J MOL SCI, V15, P17411, DOI 10.3390/ijms151017411; Xu CY, 2010, ANN SURG ONCOL, V17, P2503, DOI 10.1245/s10434-010-1031-2; Xu J, 2013, CANCER LETT, V335, P380, DOI 10.1016/j.canlet.2013.02.054; Yi JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07592; Zhao XH, 2003, WORLD J GASTROENTERO, V9, P665, DOI 10.3748/wjg.v9.i4.665	35	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22597	10.1096/fj.202200164RR	http://dx.doi.org/10.1096/fj.202200164RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B9QN	36197688				2022-12-26	WOS:000863902600001
J	Jiang, Y; Wang, T; Sheng, DD; Han, CQ; Xu, T; Zhang, P; You, WY; Fan, WW; Zhang, ZY; Jin, TC; Duan, XT; Yuan, X; Liu, X; Zhang, KG; Ruan, K; Shi, J; Guo, J; Cheng, AX; Yang, ZY				Jiang, Ya; Wang, Ting; Sheng, Dandan; Han, Chaoqiang; Xu, Tian; Zhang, Peng; You, Weiyi; Fan, Weiwei; Zhang, Zhiyong; Jin, Tengchuan; Duan, Xiaotao; Yuan, Xiao; Liu, Xing; Zhang, Kaiguang; Ruan, Ke; Shi, Jue; Guo, Jing; Cheng, Aoxing; Yang, Zhenye			Aurora A-mediated pyruvate kinase M2 phosphorylation promotes biosynthesis with glycolytic metabolites and tumor cell cycle progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER METABOLISM; PKM2; SERINE; HALLMARKS; GENE	Cancer cells have distinctive demands for intermediates from glucose metabolism for biosynthesis and energy in different cell cycle phases. However, how cell cycle regulators and glycolytic enzymes coordinate to orchestrate the essential metabolic processes are still poorly characterized. Here, we report a novel interaction between the mitotic kinase, Aurora A, and the glycolytic enzyme, pyruvate kinase M2 (PKM2), in the interphase of the cell cycle. We found Aurora A-mediated phosphorylation of PKM2 at threonine 45. This phosphoryla-tion significantly attenuated PKM2 enzymatic activity by reducing its tetramerization and also promoted glycolytic flux and the branching anabolic pathways. Replacing the endoge-nous PKM2 with a nonphosphorylated PKM2 T45A mutant inhibited glycolysis, glycolytic branching pathways, and tumor growth in both in vitro and in vivo models. Together, our study revealed a new protumor function of Aurora A through modulating a rate-limiting glycolytic enzyme, PKM2, mainly during the S phase of the cell cycle. Our findings also showed that although both Aurora A and Aurora B kinase phosphor-ylate PKM2 at the same residue, the spatial and temporal regulations of the specific kinase and PKM2 interaction are context dependent, indicating intricate interconnectivity be-tween cell cycle and glycolytic regulators.	[Jiang, Ya; Han, Chaoqiang; Jin, Tengchuan; Zhang, Kaiguang; Guo, Jing; Cheng, Aoxing; Yang, Zhenye] Univ Sci & Technol China, Anhui Prov Hosp, Dept Digest Dis, Affiliated Hosp 1, Hefei, Peoples R China; [Jiang, Ya; Wang, Ting; Sheng, Dandan; Xu, Tian; Zhang, Peng; You, Weiyi; Fan, Weiwei; Zhang, Zhiyong; Yuan, Xiao; Liu, Xing; Ruan, Ke; Yang, Zhenye] Univ Sci & Technol China, MOE Key Lab Cellular Dynam, Hefei, Peoples R China; [Duan, Xiaotao] Beijing Inst Pharmacol & Toxicol, State Key Lab Toxicol & Med Countermeasures, Beijing, Peoples R China; [Yuan, Xiao; Liu, Xing] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Anhui, Peoples R China; [Yuan, Xiao; Liu, Xing] CAS Ctr Excellence Mol Cell Sci, Hefei, Anhui, Peoples R China; [Shi, Jue] Hong Kong Baptist Univ, Ctr Quantitat Syst Biol, Dept Phys, Hong Kong, Peoples R China; [Shi, Jue] Hong Kong Baptist Univ, Ctr Quantitat Syst Biol, Dept Biol, Hong Kong, Peoples R China; [Yang, Zhenye] Univ Sci & Technol China, Biomed Sci & Hlth Lab Anhui Prov, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Academy of Military Medical Sciences - China; Hong Kong Baptist University; Hong Kong Baptist University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Cheng, AX; Yang, ZY (corresponding author), Univ Sci & Technol China, Anhui Prov Hosp, Dept Digest Dis, Affiliated Hosp 1, Hefei, Peoples R China.; Yang, ZY (corresponding author), Univ Sci & Technol China, MOE Key Lab Cellular Dynam, Hefei, Peoples R China.; Yang, ZY (corresponding author), Univ Sci & Technol China, Biomed Sci & Hlth Lab Anhui Prov, Hefei, Peoples R China.	chengax@mail.ustc.edu.cn; zhenye@ustc.edu.cn		Cheng, Aoxing/0000-0001-9143-2199	National Science Foundation of China [92057104, 31970670, 32170736, 32000528]; Fundamental Research Funds for the Central Universities; Open Project of the CAS Key Laboratory of Innate Immunity and Chronic Disease; "Laboratory for Synthetic Chemistry and Chemical Biology" under the Health@InnoHK Program by the Innovation and Technology Commission of Hong Kong	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Project of the CAS Key Laboratory of Innate Immunity and Chronic Disease; "Laboratory for Synthetic Chemistry and Chemical Biology" under the Health@InnoHK Program by the Innovation and Technology Commission of Hong Kong	This work was National Science Foundation of China (92057104 to Z. Y., 31970670 and 32170736 to J. G., and 32000528 to A. C.); the Fundamental Research Funds for the Central Universities to A. C. and Z. Y. This work was also supported in part by the Open Project of the CAS Key Laboratory of Innate Immunity and Chronic Disease to Z. Y. J. S. is partly supported by the "Laboratory for Synthetic Chemistry and Chemical Biology" under the Health@InnoHK Program by the Innovation and Technology Commission of Hong Kong.	Alam Muhammad S, 2018, Curr Protoc Immunol, V123, pe58, DOI 10.1002/cpim.58; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Bertolin G, 2018, ELIFE, V7, DOI 10.7554/eLife.38111; Briassouli P, 2007, CANCER RES, V67, P1689, DOI 10.1158/0008-5472.CAN-06-2272; Cheng AX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13485-8; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Du RJ, 2021, MOL CANCER, V20, DOI 10.1186/s12943-020-01305-3; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Icard P, 2019, TRENDS BIOCHEM SCI, V44, P490, DOI 10.1016/j.tibs.2018.12.007; Ishrat I, 2022, MOL BIOL REP, V49, P1, DOI 10.1007/s11033-021-06693-3; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Jiang YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6566; Jiang YH, 2014, MOL CELL, V53, P75, DOI 10.1016/j.molcel.2013.11.001; Leal-Esteban LC, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165715; Liang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12431; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; NOGUCHI T, 1986, J BIOL CHEM, V261, P3807; Olson KA, 2016, TRENDS BIOCHEM SCI, V41, P219, DOI 10.1016/j.tibs.2016.01.002; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Salazar-Roa M, 2017, TRENDS CELL BIOL, V27, P69, DOI 10.1016/j.tcb.2016.08.009; Sun LC, 2015, CELL RES, V25, P429, DOI 10.1038/cr.2015.33; Tian SY, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900413; Wang HZ, 2017, NATURE, V546, P426, DOI 10.1038/nature22797; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yan M, 2016, MED RES REV, V36, P1036, DOI 10.1002/med.21399; Yang M, 2016, NAT REV CANCER, V16, P650, DOI 10.1038/nrc.2016.81; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yu FZ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2016.49; Zhang JJ, 2021, NAT METAB, V3, P859, DOI 10.1038/s42255-021-00405-8; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	39	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102561	10.1016/j.jbc.2022.102561	http://dx.doi.org/10.1016/j.jbc.2022.102561			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G4BI	36198360	gold, Green Published			2022-12-26	WOS:000884698500009
J	Chen, K; Xue, R; Geng, YP; Zhang, SS				Chen, Ke; Xue, Ran; Geng, Yaping; Zhang, Shenshen			Galangin inhibited ferroptosis through activation of the PI3K/AKT pathway in vitro and in vivo	FASEB JOURNAL			English	Article						ferroptosis; galangin; glutathione peroxidase 4; signaling pathway	CELL-DEATH; REPERFUSION INJURY; APOPTOSIS; ISCHEMIA; STRESS	Ferroptosis is an iron-dependent form of nonapoptotic cell death characterized by the accumulation of lipid peroxides in cells. In recent years, extensive attention has been dedicated to exploring safe and effective natural ferroptosis regulators which can provide novel treatment strategies for ferroptosis-related diseases. This study identified galangin, a natural flavonoid, as an effective inhibitor of ferroptosis, which could increase cell viability in RSL3-inhibited HT1080 cells, decrease levels of lipid ROS and MDA, improve PTGS2 mRNA expression, and enhance the expression of glutathione peroxidase 4 (GPX4). Ferroptosis is widely present in ischemia-reperfusion (IR) injury. This study found that galangin significantly ameliorated the pathological damage of liver tissue in mice with IR, reduced levels of serum ALT, AST, and MDA, and increased the expression of GPX4. The results of RNA-seq exhibited ferroptosis was significant and the PI3K/AKT pathway deserved to explore the inhibition effects of galangin on ferroptosis. Indeed, galangin treatment significantly rescued RSL3-inhibited phosphorylation levels of PI3K, AKT, and CREB proteins, and the ferroptosis inhibitory effects of galangin were counteracted by PI3K inhibitor LY294002. These findings indicated that galangin may exert its anti-ferroptosis effects via activating the PI3K/AKT/CREB signaling pathway and it will hopefully serve as a promising effective measure to attenuate IR injury by inhibiting ferroptosis.	[Chen, Ke; Geng, Yaping; Zhang, Shenshen] Zhengzhou Univ, Coll Publ & Hlth, Nutr & Hlth Food Res Inst, Dept Nutr & Food Hyg, Zhengzhou, Peoples R China; [Xue, Ran] Jinan Ctr Dis Control & Prevent, Inst TB Control, Jinan, Peoples R China	Zhengzhou University	Zhang, SS (corresponding author), Zhengzhou Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Dept Precis Nutr Innovat Ctr, Zhengzhou, Peoples R China.	zsslb2005@163.com		Zhang, Shenshen/0000-0002-7849-371X	National Natural Science Foundation of China [81903314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81903314) .	Abubakar IB, 2018, J ETHNOPHARMACOL, V224, P45, DOI 10.1016/j.jep.2018.05.027; Bi M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00618-0; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Choi MJ, 2017, BIOCHEM PHARMACOL, V144, P120, DOI 10.1016/j.bcp.2017.07.021; Dare AJ, 2015, REDOX BIOL, V5, P163, DOI 10.1016/j.redox.2015.04.008; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Fang XX, 2019, P NATL ACAD SCI USA, V116, P2672, DOI 10.1073/pnas.1821022116; Fu C, 2022, J ETHNOPHARMACOL, V289, DOI 10.1016/j.jep.2022.115021; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Guan X, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118660; Han C, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00239; He Y, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00828-5; Huang HZ, 2020, MOLECULES, V25, DOI 10.3390/molecules25071579; Jiang Y, 2015, J NEUROCHEM, V134, P173, DOI 10.1111/jnc.13097; Kitagawa H, 2017, J NEUROSCI, V37, P1, DOI [10.1523/JNEUROSCI.0943-16.2017, 10.1523/JNEUROSCI.0943-16.2016]; Koppula P, 2021, PROTEIN CELL, V12, P599, DOI 10.1007/s13238-020-00789-5; Le HN, 2018, INT J MOL MED, V41, P888, DOI 10.3892/ijmm.2017.3296; Li BD, 2022, EUR J PHARMACOL, V917, DOI 10.1016/j.ejphar.2022.174759; Li C, 2021, PHARMACOL RES, V174, DOI 10.1016/j.phrs.2021.105933; Li Q, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90777; Li Y, 2018, CELL PHYSIOL BIOCHEM, V51, P1354, DOI 10.1159/000495553; Liao J, 2021, TOXICOL RES-UK, V10, P551, DOI 10.1093/toxres/tfab009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Qiu YM, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104919; Rampogu S, 2021, BIOMED PHARMACOTHER, V141, DOI 10.1016/j.biopha.2021.111808; Revathidevi S, 2019, SEMIN CANCER BIOL, V59, P80, DOI 10.1016/j.semcancer.2019.06.002; Shen ZY, 2018, ADV MATER, V30, DOI 10.1002/adma.201704007; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Su LJ, 2019, J BIOL CHEM, V294, P19395, DOI 10.1074/jbc.RA119.010949; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Wang HT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00255; Wang HB, 2019, J CELL PHYSIOL, V234, P15654, DOI 10.1002/jcp.28216; Weiland A, 2019, MOL NEUROBIOL, V56, P4880, DOI 10.1007/s12035-018-1403-3; Wu J, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00660-4; Wu X, 2018, NEUROCHEM RES, V43, P886, DOI 10.1007/s11064-018-2494-y; Wu Y, 2022, CELL DEATH DIFFER, V29, P1705, DOI 10.1038/s41418-022-00957-6; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Yan HF, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-020-00428-9; Yan HF, 2020, ZOOL RES, V41, P220, DOI 10.24272/j.issn.2095-8137.2020.042; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yi JM, 2020, P NATL ACAD SCI USA, V117, P31189, DOI 10.1073/pnas.2017152117; Yi ZJ, 2020, HEPATOLOGY, V72, P1394, DOI 10.1002/hep.31147; Zhong XW, 2020, CANCER MED-US, V9, P5546, DOI 10.1002/cam4.3195	47	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22569	10.1096/fj.202200935R	http://dx.doi.org/10.1096/fj.202200935R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A6MA	36183339				2022-12-26	WOS:000862998100001
J	Kendall, AK; Chandra, M; Xie, BY; Wan, W; Jackson, LP				Kendall, Amy K.; Chandra, Mintu; Xie, Boyang; Wan, William; Jackson, Lauren P.			Improved mammalian retromer cryo-EM structures reveal a new interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARGO-RECOGNITION; COAT COMPLEX; TRANSPORT; FOLD; ARCHITECTURE; MOLPROBITY; ENDOSOMES; MECHANISM; PROTEINS; DOMAINS	Retromer (VPS26/VPS35/VPS29 subunits) assembles with multiple sorting nexin proteins on membranes to mediate endosomal recycling of transmembrane protein cargoes. Ret-romer has been implicated in other cellular processes, including mitochondrial homeostasis, nutrient sensing, auto-phagy, and fission events. Mechanisms for mammalian retro-mer assembly remain undefined, and retromer engages multiple sorting nexin proteins to sort cargoes to different destinations. Published structures demonstrate mammalian retromer forms oligomers in vitro, but several structures were poorly resolved. We report here improved retromer oligomer structures using single-particle cryo-EM by combining data collected from tilted specimens with multiple advancements in data processing, including using a 3D starting model for enhanced automated particle picking in RELION. We used a retromer mutant (3KE retromer) that breaks VPS35-mediated interfaces to determine a structure of a new assembly interface formed by the VPS26A and VPS35 N-termini. The inter-face reveals how an N-terminal VPS26A arrestin saddle can link retromer chains by engaging a neighboring VPS35 N-terminus, on the opposite side from the well-characterized C-VPS26/N-VPS35 interaction observed within heterotrimers. The new interaction interface exhibits substantial buried surface area (similar to 7000 angstrom(2)) and further suggests that metazoan retromer may serve as an adaptable scaffold.	[Kendall, Amy K.; Chandra, Mintu; Xie, Boyang; Jackson, Lauren P.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Kendall, Amy K.; Chandra, Mintu; Wan, William; Jackson, Lauren P.] Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37235 USA; [Wan, William; Jackson, Lauren P.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Jackson, LP (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.; Jackson, LP (corresponding author), Vanderbilt Univ, Ctr Struct Biol, Nashville, TN 37235 USA.; Jackson, LP (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37235 USA.	lauren.p.jackson@vanderbilt.edu	Kendall, Amy/F-6780-2013; CHANDRA, MINTU/GLQ-8529-2022	Kendall, Amy/0000-0002-6176-9177; CHANDRA, MINTU/0000-0003-2382-5024; Jackson, Lauren/0000-0002-3705-6126	National Institutes of Health Common Fund Transformative High Resolution Cryo-Electron Microscopy program [U24 GM129539]; Simons Foundation [SF349247]; NY State Assembly	National Institutes of Health Common Fund Transformative High Resolution Cryo-Electron Microscopy program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NY State Assembly	We thank Kevin Chen and Brett Collins for generously providing the RT-L4 peptide used in 3KE retromer sample preparation and data collection. Screening was conducted at the Center for Structural Biology Cryo-EM Facility at Vanderbilt University. Data collection was performed at the National Center for CryoEM Access and Training and the Simons Electron Microscopy Center located at the New York Structural Biology Center, supported by the National Institutes of Health Common Fund Transformative High Resolution Cryo-Electron Microscopy program (U24 GM129539) and by grants from the Simons Foundation (SF349247) and NY State Assembly.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bean BDM, 2017, TRAFFIC, V18, P110, DOI 10.1111/tra.12459; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077; Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314; Chandra M, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.642378; Chandra M, 2020, BIOCHEM SOC T, V48, P2261, DOI 10.1042/BST20200552; Chen KE, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg4007; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choy RWY, 2014, NEURON, V82, P55, DOI 10.1016/j.neuron.2014.02.018; Collins BM, 2005, NAT STRUCT MOL BIOL, V12, P594, DOI 10.1038/nsmb954; Collins BM, 2008, TRAFFIC, V9, P366, DOI 10.1111/j.1600-0854.2007.00688.x; Courtellemont T, 2022, EMBO J, V41, DOI 10.15252/embj.2021109646; Curtis ME, 2020, ANN NEUROL, V88, P137, DOI 10.1002/ana.25752; Daniloski Z, 2021, CELL, V184, P92, DOI 10.1016/j.cell.2020.10.030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farmer T, 2019, MOL BIOL CELL, V30, P1138, DOI 10.1091/mbc.E19-01-0044; Farmer T, 2018, TRAFFIC, V19, P569, DOI 10.1111/tra.12573; Filippone A, 2021, ANN NEUROL, V90, P4, DOI 10.1002/ana.26042; Fjorback AW, 2012, J NEUROSCI, V32, P1467, DOI 10.1523/JNEUROSCI.2272-11.2012; Greber BJ, 2021, BIOPHYS J, V120, P677, DOI 10.1016/j.bpj.2020.12.030; Harrison MS, 2014, P NATL ACAD SCI USA, V111, P267, DOI 10.1073/pnas.1316482111; Hesketh GG, 2020, SCIENCE, V370, P351, DOI 10.1126/science.aaz0863; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Kendall AK, 2020, STRUCTURE, V28, P393, DOI 10.1016/j.str.2020.01.009; Kovtun O, 2018, NATURE, V561, P561, DOI 10.1038/s41586-018-0526-z; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kvainickas A, 2019, J CELL BIOL, V218, P3019, DOI 10.1083/jcb.201812110; Kvainickas A, 2017, J CELL BIOL, V216, P3677, DOI 10.1083/jcb.201702137; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lu L, 2014, SEMIN CELL DEV BIOL, V31, P30, DOI 10.1016/j.semcdb.2014.04.024; Lucas M, 2016, CELL, V167, P1623, DOI 10.1016/j.cell.2016.10.056; McNally KE, 2017, NAT CELL BIOL, V19, P1214, DOI 10.1038/ncb3610; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mecozzi VJ, 2014, NAT CHEM BIOL, V10, P443, DOI [10.1038/NCHEMBIO.1508, 10.1038/nchembio.1508]; Morris KL, 2019, NAT STRUCT MOL BIOL, V26, P890, DOI 10.1038/s41594-019-0292-0; Norwood SJ, 2011, TRAFFIC, V12, P56, DOI 10.1111/j.1600-0854.2010.01124.x; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Paraan M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8397; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reitz C, 2011, ANN NEUROL, V69, P47, DOI 10.1002/ana.22308; Romano-Moreno M, 2017, P NATL ACAD SCI USA, V114, pE11151, DOI 10.1073/pnas.1715361115; Roy S, 2017, MOL CELL, V67, P84, DOI 10.1016/j.molcel.2017.05.020; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Simonetti B, 2019, NAT CELL BIOL, V21, P1219, DOI 10.1038/s41556-019-0393-3; Simonetti B, 2018, CURR BIOL, V28, pR1350, DOI 10.1016/j.cub.2018.10.040; Simonetti B, 2017, J CELL BIOL, V216, P3695, DOI 10.1083/jcb.201703015; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Sztul E, 2019, MOL BIOL CELL, V30, P1249, DOI 10.1091/mbc.E18-12-0820; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Wan W, 2017, NATURE, V551, P394, DOI 10.1038/nature24490; Wang DQ, 2005, J BIOL CHEM, V280, P22962, DOI 10.1074/jbc.M500464200; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yin J, 2016, TRAFFIC, V17, P1286, DOI 10.1111/tra.12451; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	69	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102523	10.1016/j.jbc.2022.102523	http://dx.doi.org/10.1016/j.jbc.2022.102523			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36174678	Green Submitted, Green Published, gold			2022-12-26	WOS:000886086000007
J	Yuan, HW; Zhu, YT; Cheng, YL; Hou, JJ; Jin, FJ; Li, ML; Jia, W; Cheng, ZZ; Xing, HM; Liu, MK; Han, T				Yuan, Hongwei; Zhu, Yutong; Cheng, Yalong; Hou, Junjie; Jin, Fengjiao; Li, Menglin; Jia, Wei; Cheng, Zhenzhen; Xing, Haimei; Liu, Mike; Han, Ting			BTK kinase activity is dispensable for the survival of diffuse large B-cell lymphoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUTONS TYROSINE KINASE; RECEPTOR ENGAGEMENT; OPEN-LABEL; IBRUTINIB; ACTIVATION; MECHANISMS; RESISTANCE; RECOGNITION; RESPONSES; LEUKEMIA	Inhibitors targeting Bruton's tyrosine kinase (BTK) have revolutionized the treatment for various B-cell malignancies but are limited by acquired resistance after prolonged treat-ment as a result of mutations in BTK. Here, by a combination of structural modeling, in vitro assays, and deep phospho-tyrosine proteomics, we demonstrated that four clinically observed BTK mutations-C481F, C481Y, C481R, and L528W -inactivated BTK kinase activity both in vitro and in diffused large B-cell lymphoma (DLBCL) cells. Paradoxically, we found that DLBCL cells harboring kinase-inactive BTK exhibited intact B cell receptor (BCR) signaling, unperturbed transcrip-tion, and optimal cellular growth. Moreover, we determined that DLBCL cells with kinase-inactive BTK remained addicted to BCR signaling and were thus sensitive to targeted BTK degradation by the proteolysis-targeting chimera. By per-forming parallel genome-wide CRISPR-Cas9 screening in DLBCL cells with WT or kinase-inactive BTK, we discovered that DLBCL cells with kinase-inactive BTK displayed increased dependence on Toll-like receptor 9 (TLR9) for their growth and/or survival. Our study demonstrates that the kinase ac-tivity of BTK is not essential for oncogenic BCR signaling and suggests that BTK's noncatalytic function is sufficient to sus-tain the survival of DLBCL.	[Yuan, Hongwei; Zhu, Yutong; Han, Ting] Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Yuan, Hongwei; Cheng, Yalong; Han, Ting] Natl Inst Biol Sci, Beijing, Peoples R China; [Zhu, Yutong; Cheng, Zhenzhen; Xing, Haimei; Liu, Mike] BeiGene Beijing Co Ltd, Beijing, Peoples R China; [Hou, Junjie; Jin, Fengjiao; Li, Menglin; Jia, Wei] Deepkinase Co Ltd, Beijing, Peoples R China; [Han, Ting] Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing, Peoples R China	Beijing Normal University; National Institute of Biological Sciences, Beijing; Tsinghua University	Han, T (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China.; Han, T (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.; Han, T (corresponding author), Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing, Peoples R China.	hanting@nibs.ac.cn			Chinese Ministry of Science and Technology, Beijing Municipal Commission of Science and Tech-nology; Tsinghua Institute of Multidisciplinary Biomedical Research;  [Z201100005320010];  [Z211100003321009]	Chinese Ministry of Science and Technology, Beijing Municipal Commission of Science and Tech-nology; Tsinghua Institute of Multidisciplinary Biomedical Research; ; 	Funding and additional information-This work was supported by institutional grants from the Chinese Ministry of Science and Technology, Beijing Municipal Commission of Science and Tech-nology (Z201100005320010 and Z211100003321009) , and Tsinghua Institute of Multidisciplinary Biomedical Research to T. H. The funders had no role in study design, data collection and interpre-tation, or the decision to submit the work for publication.	Bian YY, 2016, NAT CHEM BIOL, V12, P959, DOI [10.1038/NCHEMBIO.2178, 10.1038/nchembio.2178]; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Burger JA, 2015, NEW ENGL J MED, V373, P2425, DOI 10.1056/NEJMoa1509388; Burger JA, 2018, NAT REV CANCER, V18, P148, DOI 10.1038/nrc.2017.121; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; de Rooij MFM, 2012, BLOOD, V119, P2590, DOI 10.1182/blood-2011-11-390989; Dhami K, 2022, SCI SIGNAL, V15, DOI 10.1126/scisignal.abg5216; Dimopoulos MA, 2017, LANCET ONCOL, V18, P241, DOI 10.1016/S1470-2045(16)30632-5; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Dreyling M, 2016, LANCET, V387, P770, DOI 10.1016/S0140-6736(15)00667-4; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Furman RR, 2014, NEW ENGL J MED, V370, P2352, DOI 10.1056/NEJMc1402716; Guo YH, 2019, J MED CHEM, V62, P7923, DOI 10.1021/acs.jmedchem.9b00687; Hamasy A, 2017, LEUKEMIA, V31, P177, DOI 10.1038/leu.2016.153; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hu X, 2020, BIOORG CHEM, V97, DOI 10.1016/j.bioorg.2020.103695; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Jiang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13875; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Kong AT, 2017, NAT METHODS, V14, P513, DOI [10.1038/NMETH.4256, 10.1038/nmeth.4256]; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Krug A, 2004, BLOOD, V103, P1433, DOI 10.1182/blood-2003-08-2674; Kung JE, 2016, STRUCTURE, V24, P7, DOI 10.1016/j.str.2015.10.020; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee KG, 2008, J BIOL CHEM, V283, P11189, DOI 10.1074/jbc.M708516200; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liu QH, 2005, J IMMUNOL, V174, P68, DOI 10.4049/jimmunol.174.1.68; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Maddocks KJ, 2015, JAMA ONCOL, V1, P80, DOI 10.1001/jamaoncol.2014.218; Marcucci F, 2011, BLOOD, V117, P1792, DOI 10.1182/blood-2010-06-275818; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Phelan JD, 2018, NATURE, V560, P387, DOI 10.1038/s41586-018-0290-0; Phillips A. J., 2018, N O LINKED DEGRONS D, Patent No. WO2018237026A1; Podar K, 2004, J BIOL CHEM, V279, P21658, DOI 10.1074/jbc.M305783200; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Reekie TA, 2017, CHEM-EUR J, V23, P6357, DOI 10.1002/chem.201700043; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Sharma S, 2016, ONCOTARGET, V7, P68833, DOI 10.18632/oncotarget.11932; Sun YH, 2018, CELL RES, V28, P779, DOI 10.1038/s41422-018-0055-1; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Tomlinson M G, 2001, BMC Immunol, V2, P4, DOI 10.1186/1471-2172-2-4; Tomlinson MG, 1999, J BIOL CHEM, V274, P13577, DOI 10.1074/jbc.274.19.13577; Wang E, 2022, NEW ENGL J MED, V386, P735, DOI 10.1056/NEJMoa2114110; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Young RM, 2015, P NATL ACAD SCI USA, V112, P13447, DOI 10.1073/pnas.1514944112; Yu FC, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1016/j.mcpro.2021.100077; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; ZIEGLER SF, 1987, MOL CELL BIOL, V7, P2276, DOI 10.1128/MCB.7.6.2276	59	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102555	10.1016/j.jbc.2022.102555	http://dx.doi.org/10.1016/j.jbc.2022.102555			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36183831	gold, Green Published			2022-12-26	WOS:000882199400008
J	Akram, Z; Mahjabeen, I; Umair, M; Fahim, M; Kayani, MA; Fatima, L; Ahmad, MW; Jahan, S; Afsar, T; Almajwal, A; AlruwailiID, NW; Khawar, IA; Razakid, S				Akram, Zertashia; Mahjabeen, Ishrat; Umair, Muhammad; Fahim, Muhammad; Kayani, Mahmood Akhter; Fatima, Lulu; Ahmad, Malik Waqar; Jahan, Sarwat; Afsar, Tayyaba; Almajwal, Ali; AlruwailiID, Nawaf W.; Khawar, Iftikhar Ali; Razakid, Suhail			Expression variation of OGG1 and HPRT gene and DNA damage in arsenic exposed industrial workers	PLOS ONE			English	Article							MUTANT FREQUENCY; OXIDATIVE STRESS; EXCISION-REPAIR; POLYMORPHISMS; TOXICITY; MECHANISMS; BIOMARKERS; METALS; NICKEL; HEALTH	Arsenic exposure alters redox balance, induces DNA damage, and deregulates many genes. OGG1 gene involved in base repair mechanism, for excision of 8-oxoguanine (8oxoG) from DNA formed as a result of accumulation of ROS in cell. HPRT gene encode transferase enzymes involved in purine recycling mechanism. The main focus of the study was to evaluate the expression variation in HPRT, OGG1 gene expression, and DNA damage of industrial workers. Blood samples of 300 occupational workers were collected from welding, brick kiln, furniture, pesticide, and paint industry (n = 60/industry) to evaluate the expression variation in HPRT, OGG1 gene expression, and DNA damage in blood cells by comet assay along with age and gender matched 300 control individuals. Blood arsenic content was higher (P<0.001) in an industrial group compared to the control. OGG1 and HPRT expression were (P< 0.05) downregulated in exposed workers compared to controls. Spearman correlation analysis showed a significant positive correlation between HPRT vs OGG1 (P< 0.0001) in exposed workers compared to controls. Altered expression of both genes was observed between workers with < 25years and > 25years of age as well as between workers with <10years and >10year exposure. Reduced expression (P<0.05) of both genes and a high extent of DNA damage was evident in exposed smokers compared to respective non-smokers. DNA fragmentation was higher (P< 0.05) in the furniture, welding and brick kiln group compared to control, and other industries. The present study suggests that altered expression of OGG1 and HPRT gene induce oxidative stress, showed a negative impact on the recycling of purines leading to DNA damage which increase the vulnerability of workers to carcinogenicity.	[Akram, Zertashia; Mahjabeen, Ishrat; Umair, Muhammad; Fahim, Muhammad; Kayani, Mahmood Akhter; Fatima, Lulu; Ahmad, Malik Waqar] COMSATS Univ, Canc Genet & Epigenet Res Grp, Dept Biosci, Islamabad, Pakistan; [Jahan, Sarwat] Quaid I Azam Univ, Dept Anim Sci, Fac Biol Sci, Islamabad, Pakistan; [Afsar, Tayyaba; Almajwal, Ali; AlruwailiID, Nawaf W.; Razakid, Suhail] King Saud Univ, Dept Community Hlth Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia; [Khawar, Iftikhar Ali] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA	COMSATS University Islamabad (CUI); Quaid I Azam University; King Saud University; Washington University (WUSTL)	Akram, Z (corresponding author), COMSATS Univ, Canc Genet & Epigenet Res Grp, Dept Biosci, Islamabad, Pakistan.; Razakid, S (corresponding author), King Saud Univ, Dept Community Hlth Sci, Coll Appl Med Sci, Riyadh, Saudi Arabia.	zertashia.akram@comsats.edu.pk; smarazi@ksu.edu.sa						Ahmad I, 2009, ENVIRON MONIT ASSESS, V158, P139, DOI 10.1007/s10661-008-0576-z; Ahmad S, 2020, ENVIRON SCI POLLUT R, V27, P11425, DOI 10.1007/s11356-019-07422-x; Ahmed MK, 2011, CHEMOSPHERE, V84, P143, DOI 10.1016/j.chemosphere.2011.02.025; Akram Z, 2019, ARCH ENVIRON OCCUP H, V74, P171, DOI 10.1080/19338244.2018.1428523; Angel BM, 2018, ENVIRON POLLUT, V238, P607, DOI 10.1016/j.envpol.2018.03.095; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Bach J, 2014, ARCH TOXICOL, V88, P585, DOI 10.1007/s00204-013-1151-0; Boiteux S, 2000, ARCH BIOCHEM BIOPHYS, V377, P1, DOI 10.1006/abbi.2000.1773; Chen Y, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2431; Chung CJ, 2019, ARCH TOXICOL, V93, P2155, DOI 10.1007/s00204-019-02500-y; COLE J, 1994, MUTAT RES, V304, P33, DOI 10.1016/0027-5107(94)90320-4; Collins A, 2014, MUTAT RES-REV MUTAT, V759, P27, DOI 10.1016/j.mrrev.2013.10.001; De Vizcaya-Ruiz A, 2009, MUTAT RES-GEN TOX EN, V674, P85, DOI 10.1016/j.mrgentox.2008.09.020; Ebert F, 2011, MUTAT RES-FUND MOL M, V715, P32, DOI 10.1016/j.mrfmmm.2011.07.004; Fasullo M, 2015, INT J MOL SCI, V16, P9431, DOI 10.3390/ijms16059431; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hartwig A, 1997, CARCINOGENESIS, V18, P399, DOI 10.1093/carcin/18.2.399; Hirano T, 2006, ENV FRAGMENTATION DN, V28, P62; Hirano T, 2008, J RADIAT RES, V49, P329, DOI 10.1269/jrr.08049; Hodges NJ, 2002, CARCINOGENESIS, V23, P55, DOI 10.1093/carcin/23.1.55; Hollenbach S, 1999, CARCINOGENESIS, V20, P1863, DOI 10.1093/carcin/20.9.1863; Hou SM, 1999, CARCINOGENESIS, V20, P437, DOI 10.1093/carcin/20.3.437; Huang HW, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152746; Jahan S, 2016, ENVIRON SCI POLLUT R, V23, P12932, DOI 10.1007/s11356-016-6454-2; Kadioglu E, 2010, TOXICOL IND HEALTH, V26, P67, DOI 10.1177/0748233709359278; Kang TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074967; Kim Hyun Soo, 2015, J Cancer Prev, V20, P232, DOI 10.15430/JCP.2015.20.4.232; Kumar MR, 2018, HUM EXP TOXICOL, V37, P295, DOI 10.1177/0960327117698540; Kumar M, 2016, BIOL TRACE ELEM RES, V170, P84, DOI 10.1007/s12011-015-0448-7; Lee C-H, 2016, ROLE MITOCHONDRIA RO, V8, P312; Leon-Mejia G, 2014, ECOTOX ENVIRON SAFE, V107, P133, DOI 10.1016/j.ecoenv.2014.05.023; Li HQ, 2015, ENVIRON MOL MUTAGEN, V56, P684, DOI 10.1002/em.21958; Mendez-Gomez J, 2008, ANN NY ACAD SCI, V1140, P358, DOI 10.1196/annals.1454.027; Michalska MM, 2015, TUMOR BIOL, V36, P9457, DOI 10.1007/s13277-015-3707-5; Nallanthighal S, 2017, NANOTOXICOLOGY, V11, P996, DOI 10.1080/17435390.2017.1388863; Normohammadi M, 2016, SAF HEALTH WORK-KR, V7, P251, DOI 10.1016/j.shaw.2015.12.006; Palus J, 2005, ENVIRON MOL MUTAGEN, V46, P81, DOI 10.1002/em.20132; Quetglas RB, 2017, BIOPHYS J, V112, p132A; Raza M, 2018, ENVIRON SCI POLLUT R, V25, P33381, DOI 10.1007/s11356-018-3274-6; Remoundou K, 2009, INT J ENV RES PUB HE, V6, P2160, DOI 10.3390/ijerph6082160; Saha JC, 1999, CRIT REV ENV SCI TEC, V29, P281, DOI 10.1080/10643389991259227; Saint-Jacques N, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-44; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Sardas S, 2010, TOXICOL IND HEALTH, V26, P601, DOI 10.1177/0748233710374463; Shen H, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020205; Shinmura K, 2001, ANTIOXID REDOX SIGN, V3, P597, DOI 10.1089/15230860152542952; Singh Z, 2016, TOXICOL IND HEALTH, V32, P1817, DOI 10.1177/0748233715590518; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Smith MT, 2016, ENVIRON HEALTH PERSP, V124, P713, DOI 10.1289/ehp.1509912; Townsend MH, 2017, ELEVATED EXPRESSION, V6, P19; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Villarini M, 2015, ANN IG MED PREV COMU, V27, P511, DOI 10.7416/ai.2015.2041; Vuyyuri SB, 2006, ENVIRON MOL MUTAGEN, V47, P562, DOI 10.1002/em.20229; Waalkes MP, 2014, ARCH TOXICOL, V88, P1619, DOI 10.1007/s00204-014-1305-8; Wu S, 2015, BIOMED ENVIRON SCI, V28, P679, DOI 10.3967/bes2015.095; Yahaya M, 2013, EFFICIENCY EXTRACTIO, V17, P365; Zhou Q, 2018, REGUL TOXICOL PHARM, V99, P78, DOI 10.1016/j.yrtph.2018.09.010	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2022	17	9							e0273211	10.1371/journal.pone.0273211	http://dx.doi.org/10.1371/journal.pone.0273211			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6N4IT	36178927	Green Published, gold			2022-12-26	WOS:000889522300001
J	Than, N; Chik, Z; Bowers, A; Bozano, L; Adebiyi, A				Than, Nam; Chik, Zamri; Bowers, Amy; Bozano, Luisa; Adebiyi, Aminat			Quantitation of ethanol in UTI assay for volatile organic compound detection by electronic nose using the validated headspace GC-MS method	PLOS ONE			English	Article							TUBE MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; PROSTATE-CANCER; WHOLE-BLOOD; URINE; SYSTEM; DIAGNOSIS; DISCRIMINATION; BIOMARKERS; MECHANISMS	Disease detection through gas analysis has long been the topic of many studies because of its potential as a rapid diagnostic technique. In particular, the pathogens that cause urinary tract infection (UTI) have been shown to generate different profiles of volatile organic compounds, thus enabling the discrimination of causative agents using an electronic nose. While past studies have performed data collection on either agar culture or jellified urine culture, this study measures the headspace volume of liquid urine culture samples. Evaporation of the liquid and the presence of background compounds during electronic nose (e-nose) device operation could introduce variability to the collected data. Therefore, a headspace gas chromatography-mass spectrometry method was developed and validated for quantitating ethanol in the headspace of the urine samples. By leveraging the new method to characterize the sample stability during e-nose measurement, it was revealed that ethanol concentration dropped more than 15% after only three measurement cycles, which equal 30 minutes for this study. It was further shown that by using only data within the first three cycles, better accuracies for between-day classification were achieved, which was 73.7% and 97.0%, compared to using data from within the first nine cycles, which resulted in 65.0% and 81.1% accuracies. Therefore, the newly developed method provides better quality control for data collection, paving ways for the future establishment of a training data library for UTI.	[Than, Nam] San Jose State Univ, Dept Biomed Engn, San Jose, CA USA; [Chik, Zamri] Univ Malaya, Univ Malaya Bioequivalence Testing Ctr UBAT, Fac Med, Dept Pharmacol, Kuala Lumpur, Malaysia; [Bowers, Amy; Bozano, Luisa; Adebiyi, Aminat] IBM Almaden Res Ctr, San Jose, CA 95120 USA; [Than, Nam] Univ Texas Austin, Dept Biomed Engn, Austin, TX USA	California State University System; San Jose State University; Universiti Malaya; International Business Machines (IBM); University of Texas System; University of Texas Austin	Adebiyi, A (corresponding author), IBM Almaden Res Ctr, San Jose, CA 95120 USA.	aminat.adebiyi@ibm.com		Than, Nam/0000-0002-1947-6530	Ministry of Higher Education Malaysia as part of the Sub-Specialty Training Program	Ministry of Higher Education Malaysia as part of the Sub-Specialty Training Program	NT completed this research as part of graduate studies with San Jose State University. ZC participated with financial grant support from the Ministry of Higher Education Malaysia as part of the Sub-Specialty Training Program. IBM Research provided support in the form of salary for AA, AB & LB, and material funding for experiments, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aathithan S, 2001, J CLIN MICROBIOL, V39, P2590, DOI 10.1128/JCM.39.7.2590-2593.2001; Adebiyi A, 2019, SENS TRANSDUCERS, V238, P94; Asimakopoulos AD, 2014, PROSTATE CANCER P D, V17, P206, DOI 10.1038/pcan.2014.11; Bax C, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103622; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Capelli L, 2021, SCI REP-UK, V11, P1; Capelli L, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16101708; Chun HJ, 2016, J ANAL TOXICOL, V40, P653, DOI 10.1093/jat/bkw075; Craven MA, 1997, THESIS U WARWICK; Dospinescu VM, 2020, BIOSENSORS-BASEL, V10, DOI 10.3390/bios10080083; Esfahani S, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040121; Esfahani S, 2016, BIOSENSORS-BASEL, V6, DOI 10.3390/bios6010004; FDA F and DA, 2018, FOOD DRUG ADM, V1043, P25; Filianoti A, 2022, CANCERS, V14, DOI 10.3390/cancers14122927; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Gardner JW, 2000, SENSOR ACTUAT B-CHEM, V70, P19, DOI 10.1016/S0925-4005(00)00548-7; Gibson TD, 1997, SENSOR ACTUAT B-CHEM, V44, P413, DOI 10.1016/S0925-4005(97)00235-9; Khodadadi M, 2020, METABOLOMICS, V16, DOI 10.1007/s11306-020-01687-x; Kristoffersen L, 2006, FORENSIC SCI INT, V161, P151, DOI 10.1016/j.forsciint.2006.03.034; Kwak J, 2011, CURR PHARM BIOTECHNO, V12, P1067, DOI 10.2174/138920111795909050; Meinardi S, 2013, BBA-GEN SUBJECTS, V1830, P2531, DOI 10.1016/j.bbagen.2012.12.006; Mihretu LD, 2020, COGENT CHEM, V6, DOI 10.1080/23312009.2020.1760187; Pavlou AK, 2002, BIOSENS BIOELECTRON, V17, P893, DOI 10.1016/S0956-5663(02)00078-7; PERSAUD K, 1982, NATURE, V299, P352, DOI 10.1038/299352a0; Roine A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114279; Saude EJ, 2007, METABOLOMICS, V3, P19, DOI 10.1007/s11306-006-0042-2; Seesaard T, 2016, 2016 9 BIOMEDICAL EN, P1; Seesaard T, 2020, ANAL METHODS-UK, V12, P5671, DOI 10.1039/d0ay01255f; Smith D, 1999, RAPID COMMUN MASS SP, V13, P724, DOI 10.1002/(SICI)1097-0231(19990430)13:8<724::AID-RCM548>3.0.CO;2-E; Storer MK, 2011, J MICROBIOL METH, V87, P111, DOI 10.1016/j.mimet.2011.06.012; Tangerman A, 1997, CLIN CHEM, V43, P1003; Xiao HT, 2014, J CLIN LAB ANAL, V28, P386, DOI 10.1002/jcla.21698; Yumang Analyn N., 2020, ICBET 2020: Proceedings of the 2020 10th International Conference on Biomedical Engineering and Technology, P40, DOI 10.1145/3397391.3397411; Zhang SC, 2012, METABOLOMICS, V8, P323, DOI 10.1007/s11306-011-0315-2	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2022	17	10							e0275517	10.1371/journal.pone.0275517	http://dx.doi.org/10.1371/journal.pone.0275517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6Q9VM	36201443	Green Published, gold			2022-12-26	WOS:000891956900001
J	Bogaards, FA; Gehrmann, T; Beekman, M; Ben van den Akker, E; van de Rest, O; Hangelbroek, RWJ; Noordam, R; Mooijaart, SP; de Groot, LCPGM; Reinders, MJT; Slagboom, PE				Bogaards, Fatih A.; Gehrmann, Thies; Beekman, Marian; Ben van den Akker, Erik; van de Rest, Ondine; Hangelbroek, Roland W. J.; Noordam, Raymond; Mooijaart, Simon P.; de Groot, Lisette C. P. G. M.; Reinders, Marcel J. T.; Slagboom, P. Eline			PLIS: A metabolomic response monitor to a lifestyle intervention study in older adults	FASEB JOURNAL			English	Article						bioinformatics; healthy ageing; lifestyle intervention; machine learning; metabolomics; response monitor	IMMUNE-SYSTEM; PROTEIN; OBESE; INFLAMMATION; OUTCOMES	The response to lifestyle intervention studies is often heterogeneous, especially in older adults. Subtle responses that may represent a health gain for individuals are not always detected by classical health variables, stressing the need for novel biomarkers that detect intermediate changes in metabolic, inflammatory, and immunity-related health. Here, our aim was to develop and validate a molecular multivariate biomarker maximally sensitive to the individual effect of a lifestyle intervention; the Personalized Lifestyle Intervention Status (PLIS). We used H-1-NMR fasting blood metabolite measurements from before and after the 13-week combined physical and nutritional Growing Old TOgether (GOTO) lifestyle intervention study in combination with a fivefold cross-validation and a bootstrapping method to train a separate PLIS score for men and women. The PLIS scores consisted of 14 and four metabolites for females and males, respectively. Performance of the PLIS score in tracking health gain was illustrated by association of the sex-specific PLIS scores with several classical metabolic health markers, such as BMI, trunk fat%, fasting HDL cholesterol, and fasting insulin, the primary outcome of the GOTO study. We also showed that the baseline PLIS score indicated which participants respond positively to the intervention. Finally, we explored PLIS in an independent physical activity lifestyle intervention study, showing similar, albeit remarkably weaker, associations of PLIS with classical metabolic health markers. To conclude, we found that the sex-specific PLIS score was able to track the individual short-term metabolic health gain of the GOTO lifestyle intervention study. The methodology used to train the PLIS score potentially provides a useful instrument to track personal responses and predict the participant's health benefit in lifestyle interventions similar to the GOTO study.	[Bogaards, Fatih A.; Gehrmann, Thies; Beekman, Marian; Ben van den Akker, Erik; Slagboom, P. Eline] Leiden Univ, Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Bogaards, Fatih A.; Gehrmann, Thies; Ben van den Akker, Erik; Reinders, Marcel J. T.] Leiden Computat Biol Ctr, Leiden, Netherlands; [Bogaards, Fatih A.; van de Rest, Ondine; Hangelbroek, Roland W. J.; de Groot, Lisette C. P. G. M.] Wageningen Univ & Res, Human Nutr & Hlth, Wageningen, Netherlands; [Ben van den Akker, Erik; Reinders, Marcel J. T.] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Noordam, Raymond; Mooijaart, Simon P.] Leiden Univ, Sect Gerontol & Geriatr, Internal Med, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research; Delft University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Slagboom, PE (corresponding author), Leiden Univ, Mol Epidemiol, Med Ctr, Leiden, Netherlands.	p.slagboom@lumc.nl	; Beekman, Marian/L-3004-2019	Bogaards, Fatih/0000-0003-2553-5346; van den Akker, Erik/0000-0002-7693-0728; Beekman, Marian/0000-0003-0585-6206; Reinders, Marcel/0000-0002-1148-1562; de Groot, Lisette/0000-0003-2778-2789; Hangelbroek, Roland/0000-0002-0442-5378; Noordam, Raymond/0000-0001-7801-809X; Mooijaart, Simon/0000-0003-3106-3568	BBMRI-NL [NWO 184.021.007, NWO 184.033.111]; Horizon 2020 ERC advanced grant; Netherlands Consortium for Healthy Ageing [050-060-810]; ZonMw project VOILA	BBMRI-NL; Horizon 2020 ERC advanced grant; Netherlands Consortium for Healthy Ageing; ZonMw project VOILA	BBMRI-NL, Grant/Award Number: NWO 184.021.007 and NWO 184.033.111; Horizon 2020 ERC advanced grant, Grant/Award Number: GEROPROTECT; Netherlands Consortium for Healthy Ageing, Grant/ Award Number: NWO grant 050-060-810; ZonMw project VOILA	Aderemi AV, 2021, METABOLITES, V11, DOI 10.3390/metabo11070418; Akram M, 2020, ROLE PHENYLALANINE I; Aktas MF, 2019, EUR J CLIN NUTR, V73, P805, DOI 10.1038/s41430-018-0371-z; Anisimova AS, 2020, P NATL ACAD SCI USA, V117, P15581, DOI 10.1073/pnas.2001788117; Aucott L, 2011, OBES REV, V12, pe412, DOI 10.1111/j.1467-789X.2010.00819.x; Azevedo MR, 2007, INT J PUBLIC HEALTH, V52, P8, DOI 10.1007/s00038-006-5062-1; Balagopal P, 2003, INT J OBESITY, V27, P1250, DOI 10.1038/sj.ijo.0802388; Barrett PHR, 2003, CURR OPIN LIPIDOL, V14, P61, DOI 10.1097/01.mol.0000052851.26236.75; Bartke A, 2021, WORLD J MENS HEALTH, V39, P222, DOI 10.5534/wjmh.200112; Beetham KS., 2018, BMC NEPHROL, V19, P1; Burgess E, 2017, CLIN OBES, V7, P123, DOI 10.1111/cob.12183; Campbell KL, 2017, OBESITY, V25, pS40, DOI 10.1002/oby.22010; Cirulli ET, 2019, CELL METAB, V29, P488, DOI 10.1016/j.cmet.2018.09.022; Colleluori G, 2019, CELL METAB, V30, P261, DOI 10.1016/j.cmet.2019.06.008; Crimmins E, 2008, ADV CLIN CHEM, V46, P161, DOI 10.1016/S0065-2423(08)00405-8; Cruzat V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111564; Deelen J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11311-9; Delanaye P, 2017, NEPHRON, V136, P302, DOI 10.1159/000469669; Dorling JL, 2020, EUR J CLIN NUTR, V74, P1210, DOI 10.1038/s41430-020-0593-8; Duan YH, 2016, AMINO ACIDS, V48, P41, DOI 10.1007/s00726-015-2067-1; Erickson KI, 2019, MED SCI SPORT EXER, V51, P1242, DOI 10.1249/MSS.0000000000001936; Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998; Fisher R.A., 1992, BREAKTHROUGHS STAT, P66, DOI DOI 10.1007/978-1-4612-4380-9_6; Fitzgerald KN, 2021, AGING-US, V13, P9419, DOI 10.18632/aging.202913; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hishikawa D, 2017, FEBS LETT, V591, P2730, DOI 10.1002/1873-3468.12825; Holecek M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030848; Iacobazzi V, 2014, BIOL CHEM, V395, P387, DOI 10.1515/hsz-2013-0271; Krumsiek J, 2015, METABOLOMICS, V11, P1815, DOI 10.1007/s11306-015-0829-0; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lai CQ, 2005, CURR OPIN LIPIDOL, V16, P153, DOI 10.1097/01.mol.0000162320.54795.68; LeVatte M, 2021, LIFESTYLE GENOM, DOI 10.1159/000518489; Li BB, 2017, MOLECULES, V22, DOI 10.3390/molecules22071173; Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684; Marseglia A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00349; Mensink M, 2005, OBES RES, V13, P1354, DOI 10.1038/oby.2005.164; Mierziak J, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030402; Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916; Paley CA, 2018, BMC SPORTS SCI MED R, V10, DOI 10.1186/s13102-018-0097-1; Parthasarathy A, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00029; Partridge L, 2018, NATURE, V561, P45, DOI 10.1038/s41586-018-0457-8; Phillips CM, 2013, J CLIN ENDOCR METAB, V98, pE1610, DOI 10.1210/jc.2013-2038; Puchades-Carrasco L, 2017, CURR TOP MED CHEM, V17, P2740, DOI 10.2174/1568026617666170707120034; Ravera S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46749-w; Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057; Rojas-Morales P, 2020, REDOX BIOL, V29, DOI 10.1016/j.redox.2019.101395; Salvioli S, 2013, CURR PHARM DESIGN, V19, P1675; Sander M, 2015, AGE AGEING, V44, P185, DOI 10.1093/ageing/afu189; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Soto-Heredero G, 2020, FEBS J, V287, P3350, DOI 10.1111/febs.15327; Suburu Janel, 2013, Food Biosci, V4, P1; Thomas DD, 2019, J ENDOCR SOC, V3, P1727, DOI 10.1210/js.2019-00065; van de Rest O, 2016, AGING-US, V8, P111, DOI 10.18632/aging.100877; van de Rest O, 2013, AMINO ACIDS, V45, P1035, DOI 10.1007/s00726-013-1583-0; van den Akker EB, 2020, CIRC-GENOM PRECIS ME, V13, P541, DOI 10.1161/CIRCGEN.119.002610; Villareal DT, 2006, AM J CLIN NUTR, V84, P1317, DOI 10.1093/ajcn/84.6.1317; Vroege DP, 2014, J MED INTERNET RES, V16, P19, DOI 10.2196/jmir.3643; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weyand CM, 2016, ANN AM THORAC SOC, V13, pS422, DOI 10.1513/AnnalsATS.201602-095AW; Weyh C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030622; Wing RR, 2021, OBESITY, V29, P1246, DOI 10.1002/oby.23158; Yang Y, 2011, J GERONTOL A-BIOL, V66, P493, DOI 10.1093/gerona/glr003	63	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22578	10.1096/fj.202201037R	http://dx.doi.org/10.1096/fj.202201037R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5A5RT	36183353	hybrid			2022-12-26	WOS:000862945400001
J	Ma, LJ; Wang, L; Gao, MD; Zhang, XJ; Zhao, XD; Xie, DB; Zhang, J; Wang, Z; Hou, LF; Zeng, FL				Ma, Lujie; Wang, Le; Gao, Mengdi; Zhang, Xinjie; Zhao, Xiangdong; Xie, Debao; Zhang, Jing; Wang, Zhen; Hou, Lifeng; Zeng, Fanli			Rtr1 is required for Rpb1-Rpb2 assembly of RNAPII and prevents their cytoplasmic clump formation	FASEB JOURNAL			English	Article						assembly factor; Gpn3; Npa3; RNA polymerase II; Rtr1	POLYMERASE-II; PHOSPHATASE RTR1; NUCLEAR IMPORT; SERINE 5; PHOSPHORYLATION; BIOGENESIS; SUBUNITS; GTPASES; RPB4; SER5	RNA polymerase II (RNAPII) is an essential machinery for catalyzing mRNA synthesis and controlling cell fate in eukaryotes. Although the structure and function of RNAPII have been relatively defined, the molecular mechanism of its assembly process is not clear. The identification and functional analysis of assembly factors will provide new understanding to transcription regulation. In this study, we identify that RTR1, a known transcription regulator, is a new multicopy genetic suppressor of mutants of assembly factors Gpn3, Gpn2, and Rba50. We demonstrate that Rtr1 is directly required to assemble the two largest subunits of RNAPII by coordinating with Gpn3 and Npa3. Deletion of RTR1 leads to cytoplasmic clumping of RNAPII subunit and multiple copies of RTR1 can inhibit the formation of cytoplasmic clump of RNAPII subunit in gpn3-9 mutant, indicating a new layer function of Rtr1 in checking proper assembly of RNAPII. In addition, we find that disrupted activity of Rtr1 phosphatase does not trigger the formation of cytoplasmic clump of RNAPII subunit in a catalytically inactive mutant of RTR1. Based on these results, we conclude that Rtr1 cooperates with Gpn3 and Npa3 to assemble RNAPII core.	[Ma, Lujie; Wang, Zhen; Zeng, Fanli] State Key Lab North China Crop Improvement & Regu, Baoding, Peoples R China; [Ma, Lujie; Wang, Le; Gao, Mengdi; Zhang, Xinjie; Zhao, Xiangdong; Xie, Debao; Zhang, Jing; Hou, Lifeng; Zeng, Fanli] Hebei Agr Univ, Coll Life Sci, Baoding, Peoples R China; [Wang, Zhen] Hebei Agr Univ, Coll Sci & Technol, Cangzhou, Peoples R China	Hebei Agricultural University; Hebei Agricultural University	Zeng, FL (corresponding author), State Key Lab North China Crop Improvement & Regu, Baoding, Peoples R China.	fanli.zeng@pku.edu.cn			National Natural Science Foundation of China [32070574]; Outstanding Youth Project from Natural Science Foundation of Hebei Province [C2020204109]; Hebei Provincial Department of Bureau of Science and Technology [360-0803-JSN-3YGS]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Project from Natural Science Foundation of Hebei Province; Hebei Provincial Department of Bureau of Science and Technology	We are grateful to Dr. Lilin Du and all lab members for helpful discussions and suggestions in this work. This work was supported by grants from the National Natural Science Foundation of China (no. 32070574), Outstanding Youth Project from Natural Science Foundation of Hebei Province (no. C2020204109) and Hebei Provincial Department of Bureau of Science and Technology (360-0803-JSN-3YGS).	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Calera MR, 2011, BBA-MOL CELL RES, V1813, P1708, DOI 10.1016/j.bbamcr.2011.07.005; Carre C, 2011, MOL CELL BIOL, V31, P3953, DOI 10.1128/MCB.05442-11; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer P, 2001, SCIENCE, V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2019, NATURE, V573, P45, DOI 10.1038/s41586-019-1517-4; Egloff S, 2012, MOL CELL, V45, P111, DOI 10.1016/j.molcel.2011.11.006; Fianu I, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02088-z; Forget D, 2013, NUCLEIC ACIDS RES, V41, P6881, DOI 10.1093/nar/gkt455; Garrido-Godino AI, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23042002; Garrido-Godino AI, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.669300; Gibney PA, 2008, EUKARYOT CELL, V7, P938, DOI 10.1128/EC.00042-08; Gomez-Navarro N, 2015, BBA-GENE REGUL MECH, V1849, P1354, DOI 10.1016/j.bbagrm.2015.10.003; Guerrero-Serrano G, 2017, BBA-MOL CELL RES, V1864, P451, DOI 10.1016/j.bbamcr.2016.12.010; Hsu PL, 2014, J MOL BIOL, V426, P2970, DOI 10.1016/j.jmb.2014.06.010; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hunter GO, 2016, MOL CELL BIOL, V36, P2236, DOI 10.1128/MCB.00870-15; Irani S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad4805; Ishihama A, 1981, Adv Biophys, V14, P1; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Li YX, 2018, PLANT CELL, V30, P466, DOI 10.1105/tpc.17.00380; Liu XQ, 2020, FASEB J, V34, P15547, DOI 10.1096/fj.202001523R; Ma LJ, 2022, INT J BIOL MACROMOL, V206, P837, DOI 10.1016/j.ijbiomac.2022.03.081; Minaker SW, 2021, CELL CYCLE, V20, P1361, DOI 10.1080/15384101.2021.1943879; Minaker SW, 2013, GENETICS, V193, P853, DOI 10.1534/genetics.112.148726; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Mosley AL, 2009, MOL CELL, V34, P168, DOI 10.1016/j.molcel.2009.02.025; Niesser J, 2016, MOL CELL BIOL, V36, P820, DOI 10.1128/MCB.01009-15; Osman S, 2020, ANNU REV CELL DEV BI, V36, P1, DOI 10.1146/annurev-cellbio-042020-021954; Smith-Kinnaman WR, 2014, MOL BIOSYST, V10, P1730, DOI 10.1039/c4mb00109e; Turowski TW, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.680090; Victorino JF, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008317; Wang XX, 2022, CELL REP, V39, DOI 10.1016/j.celrep.2022.110732; Wild T, 2012, TRENDS BIOCHEM SCI, V37, P99, DOI 10.1016/j.tibs.2011.12.001; Xiang KH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1947; Xie DB, 2022, INT J BIOL MACROMOL, V204, P565, DOI 10.1016/j.ijbiomac.2022.02.052; Zeng FL, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00091-18	38	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22585	10.1096/fj.202200698RR	http://dx.doi.org/10.1096/fj.202200698RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B0AU	36190433				2022-12-26	WOS:000863240400001
J	Petrillo, F; Chernyakov, D; Esteva-Font, C; Poulsen, SB; Edemir, B; Fenton, RA				Petrillo, Federica; Chernyakov, Dmitry; Esteva-Font, Cristina; Poulsen, Soren B.; Edemir, Bayram; Fenton, Robert A.			Genetic deletion of the nuclear factor of activated T cells 5 in collecting duct principal cells causes nephrogenic diabetes insipidus	FASEB JOURNAL			English	Article						AQP2; aquaporin-2; ELF5; ETS transcription factor; NDI; urinary concentration	PROTEIN-KINASE-A; VASOPRESSIN RECEPTOR; TRANSCRIPTION FACTOR; AQUAPORIN-2 EXPRESSION; EPIGENETIC REGULATION; ESSENTIAL REGULATOR; UREA TRANSPORTERS; BINDING PROTEIN; AQP2 EXPRESSION; KIDNEY	Water homeostasis is tightly regulated by the kidneys via the process of urine concentration. During reduced water intake, the antidiuretic hormone arginine vasopressin (AVP) binds to the vasopressin receptor type II (V2R) in the kidney to enhance countercurrent multiplication and medullary osmolality, and increase water reabsorption via aquaporin-2 (AQP2) water channels. The importance of this AVP, V2R, and AQP2 axis is highlighted by low urine osmolality and polyuria in people with various water balance disorders, including nephrogenic diabetes insipidus (NDI). ELF5 and nuclear factor of activated T cells 5 (NFAT5) are two transcription factors proposed to regulate Aqp2 expression, but their role is poorly defined. Here we generated two novel mouse lines with principal cell (PC)-specific deletion of ELF5 or NFAT5 and phenotyped them in respect to renal water handling. ELF5-deficient mice (ELF5(PC-KO)) had a very mild phenotype, with no clear differences in AQP2 abundance, and mild differences in renal water handling and maximal urinary concentrating capacity. In contrast, NFAT5 (NFAT5(PC-KO)) mice had significantly higher water intake and their 24 h urine volume was almost 10-fold greater than controls. After challenging with dDAVP or 8 h water restriction, NFAT5(PC-KO) mice were unable to concentrate their urine, demonstrating that they suffer from NDI. The abundance of AQP2, other AQPs, and the urea transporter UT-A1 were greatly decreased in NFAT5(PC-KO) mice. In conclusion, NFAT5 is a major regulator of not only Aqp2 gene transcription, but also other genes important for water homeostasis and its absence leads to the development of NDI.	[Petrillo, Federica; Esteva-Font, Cristina; Poulsen, Soren B.; Fenton, Robert A.] Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 3,Bldg 1233, DK-8000 Aarhus C, Denmark; [Chernyakov, Dmitry; Edemir, Bayram] Martin Luther Univ Halle Wittenberg, Dept Med Hematol & Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany; [Edemir, Bayram] Witten Herdecke Univ, Inst Physiol Pathophysiol & Toxicol, Witten, Germany	Aarhus University; Martin Luther University Halle Wittenberg	Fenton, RA (corresponding author), Aarhus Univ, Dept Biomed, Wilhelm Meyers Alle 3,Bldg 1233, DK-8000 Aarhus C, Denmark.; Edemir, B (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Med Hematol & Oncol, Ernst Grube Str 40, D-06120 Halle, Saale, Germany.	bayram.edemir@uk-halle.de; robert.a.fenton@biomed.au.dk		Petrillo, Federica/0000-0003-3297-4953	Independent Research Fund Denmark [1026-00063B]; Novo Nordisk Foundation [NNF21OC0067647, NNF17OC0028812, NNF20OC0063837, NNF19OC0058439]; Carlsberg Foundation; German Research Foundation [ED181-9/1]	Independent Research Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); German Research Foundation(German Research Foundation (DFG))	Support for this study was provided to Robert Fenton by the Independent Research Fund Denmark (Project No. 1026-00063B), the Novo Nordisk Foundation (NNF21OC0067647, NNF17OC0028812, NNF20OC0063837, NNF19OC0058439), and the Carlsberg Foundation. Support for Bayram Edemir was provided by the German Research Foundation (Project No. ED181-9/1).	Abraham S, 2021, AM J PHYSIOL-RENAL, V320, pF404, DOI 10.1152/ajprenal.00371.2020; Blasum BS, 2016, FASEB J, V30, P3588, DOI 10.1096/fj.201600319R; Bockenhauer D, 2013, AM J PHYSIOL-RENAL, V304, pF1037, DOI 10.1152/ajprenal.00639.2012; Castro-Mondragon JA, 2022, NUCLEIC ACIDS RES, V50, pD165, DOI 10.1093/nar/gkab1113; Centrone M, 2017, CELL PHYSIOL BIOCHEM, V44, P515, DOI 10.1159/000485088; Chen LH, 2021, J AM SOC NEPHROL, V32, P897, DOI 10.1681/ASN.2020101406; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; Dahl SC, 2001, AM J PHYSIOL-CELL PH, V280, pC248, DOI 10.1152/ajpcell.2001.280.2.C248; ECELBARGER CA, 1995, AM J PHYSIOL-RENAL, V269, pF663, DOI 10.1152/ajprenal.1995.269.5.F663; Fenton RA, 2004, P NATL ACAD SCI USA, V101, P7469, DOI 10.1073/pnas.0401704101; Fenton RA, 2002, AM J PHYSIOL-RENAL, V282, pF630, DOI 10.1152/ajprenal.00264.2001; Fenton RA, 2002, AM J PHYSIOL-RENAL, V283, pF817, DOI 10.1152/ajprenal.00263.2001; Fenton RA, 2007, PHYSIOL REV, V87, P1083, DOI 10.1152/physrev.00053.2006; Fenton RA, 2007, AM J PHYSIOL-RENAL, V293, pF748, DOI 10.1152/ajprenal.00316.2006; Grassmeyer J, 2017, DEV BIOL, V424, P77, DOI 10.1016/j.ydbio.2017.02.007; Hasler U, 2008, J BIOL CHEM, V283, P28095, DOI 10.1074/jbc.M801071200; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hinze C, 2021, J AM SOC NEPHROL, V32, P291, DOI 10.1681/ASN.2020070930; Hozawa Shigenari, 1996, American Journal of Physiology, V270, pC1695; Ju HJ, 2019, KIDNEY RES CLIN PRAC, V38, P145, DOI 10.23876/j.krcp.19.002; Jung HJ, 2018, J AM SOC NEPHROL, V29, P1490, DOI 10.1681/ASN.2017050545; Kandabarau S, 2020, CANCERS, V12, DOI 10.3390/cancers12010006; Kikuchi H, 2021, AM J PHYSIOL-RENAL, V321, pF389, DOI 10.1152/ajprenal.00204.2021; Kim JE, 2015, AM J PHYSIOL-RENAL, V308, pF749, DOI 10.1152/ajprenal.00334.2014; Kortenoeven MLA, 2014, BBA-GEN SUBJECTS, V1840, P1533, DOI 10.1016/j.bbagen.2013.12.002; Kortenoeven MLA, 2012, AM J PHYSIOL-RENAL, V302, pF1395, DOI 10.1152/ajprenal.00376.2011; Kortenoeven MLA, 2011, J BIOL CHEM, V286, P13002, DOI 10.1074/jbc.M110.207878; Kuper C, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00507; Lam AKM, 2004, J BIOL CHEM, V279, P48048, DOI 10.1074/jbc.M407224200; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Lin ST, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01308; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lopez-Rodriguez C, 2001, IMMUNITY, V15, P47, DOI 10.1016/S1074-7613(01)00165-0; MA TH, 1994, AM J PHYSIOL, V266, pC189, DOI 10.1152/ajpcell.1994.266.1.C189; Maric K, 1998, AM J PHYSIOL-RENAL, V275, pF796, DOI 10.1152/ajprenal.1998.275.5.F796; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Matsumura Y, 1997, J AM SOC NEPHROL, V8, P861; Moeller HB, 2014, J CELL SCI, V127, P3174, DOI 10.1242/jcs.150680; Moeller HB, 2013, ENDOCR REV, V34, P278, DOI 10.1210/er.2012-1044; Moeller HB, 2011, AM J PHYSIOL-RENAL, V300, pF1062, DOI 10.1152/ajprenal.00721.2010; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; Morancho B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-13; Mukherjee M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110692; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Olesen ETB, 2021, NAT REV NEPHROL, V17, P765, DOI 10.1038/s41581-021-00447-x; Petrillo F, 2021, J AM SOC NEPHROL, V32, P1339, DOI 10.1681/ASN.2020010031; Piggin CL, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-015-0666-0; Poulsen SB, 2018, CLIN SCI, V132, P1779, DOI 10.1042/CS20180060; Poulsen SB, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91042; Ransick A, 2019, DEV CELL, V51, P399, DOI 10.1016/j.devcel.2019.10.005; Ronzaud C, 2007, J AM SOC NEPHROL, V18, P1679, DOI 10.1681/ASN.2006090975; Rose R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91369-y; Sandoval PC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34863; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Stewart GS, 2004, AM J PHYSIOL-RENAL, V286, pF979, DOI 10.1152/ajprenal.00334.2003; Storm R, 2003, AM J PHYSIOL-RENAL, V284, pF189, DOI 10.1152/ajprenal.00245.2002; Umenishi F, 2006, BBA-BIOMEMBRANES, V1758, P1100, DOI 10.1016/j.bbamem.2006.06.001; Yasui M, 1997, AM J PHYSIOL-RENAL, V272, pF443, DOI 10.1152/ajprenal.1997.272.4.F443; Yde J, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00046; Yu L, 2014, MOL CELL BIOL, V34, P1929, DOI 10.1128/MCB.01659-13; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zhang XY, 2014, P NATL ACAD SCI USA, V111, P2277, DOI 10.1073/pnas.1323977111	65	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22583	10.1096/fj.202200856R	http://dx.doi.org/10.1096/fj.202200856R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5B9HX	36197017				2022-12-26	WOS:000863879000001
J	Deng, O; Dash, S; Nepomuceno, TC; Fang, B; Yun, SY; Welsh, EA; Lawrence, HR; Marchion, D; Koomen, JM; Monteiro, AN; Rix, U				Deng, Ou; Dash, Sweta; Nepomuceno, Thales C.; Fang, Bin; Yun, Sang Y.; Welsh, Eric A.; Lawrence, Harshani R.; Marchion, Douglas; Koomen, John M.; Monteiro, Alvaro N.; Rix, Uwe			Integrated proteomics identifies PARP inhibitor-induced prosurvival signaling changes as potential vulnerabilities in ovarian cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET ENRICHMENT ANALYSIS; DOUBLE-STRAND BREAKS; POLY(ADP-RIBOSE) POLYMERASE; OLAPARIB MONOTHERAPY; MAINTENANCE THERAPY; AKT ACTIVATION; MUTATION; GERMLINE; SURVIVAL; REPAIR	BRCA1/2-deficient ovarian carcinoma (OC) has been shown to be particularly sensitive to poly (ADP-ribose) polymerase inhibitors (PARPis). Furthermore, BRCA1/2 mutation status is currently used as a predictive biomarker for PARPi therapy. Despite providing a major clinical benefit to the majority of patients, a significant proportion of BRCA1/2-deficient OC tu-mors do not respond to PARPis for reasons that are incom-pletely understood. Using an integrated chemical, phospho-and ADP-ribosylation proteomics approach, we sought here to develop additional mechanism-based biomarker candidates for PARPi therapy in OC and identify new targets for combination therapy to overcome primary resistance. Using chemical prote-omics with PARPi baits in a BRCA1-isogenic OC cell line pair, as well as patient-derived BRCA1-proficient and BRCA1-deficient tumor samples, and subsequent validation by coimmunopreci-pitation, we showed differential PARP1 and PARP2 protein complex composition in PARPi-sensitive, BRCA1-deficient UWB1.289 (UWB) cells compared to PARPi-insensitive, BRCA1-reconstituted UWB1.289+BRCA1 (UWB+B) cells. In addition, global phosphoproteomics and ADP-ribosylation proteomics furthermore revealed that the PARPi rucaparib induced the cell cycle pathway and nonhomologous end joining (NHEJ) pathway in UWB cells but downregulated ErbB signaling in UWB+B cells. In addition, we observed AKT PARylation and prosurvival AKT-mTOR signaling in UWB+B cells after PARPi treatment. Consistently, we found the synergy of PARPis with DNAPK or AKT inhibitors was more pronounced in UWB+B cells, highlighting these pathways as actionable vulnerabilities. In conclusion, we demonstrate the combination of chemical proteomics, phosphoproteomics, and ADP-ribosylation prote-omics can identify differential PARP1/2 complexes and diverse, but actionable, drug compensatory signaling in OC.	[Deng, Ou; Yun, Sang Y.; Lawrence, Harshani R.; Rix, Uwe] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Dash, Sweta; Nepomuceno, Thales C.; Monteiro, Alvaro N.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Fang, Bin] H Lee Moffitt Canc Ctr & Res Inst, Prote & Metabol Core, Tampa, FL USA; [Yun, Sang Y.; Lawrence, Harshani R.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL USA; [Welsh, Eric A.] H Lee Moffitt Canc Ctr & Res Inst, Biostat & Bioinformat Shared Resource, Tampa, FL USA; [Marchion, Douglas] H Lee Moffitt Canc Ctr & Res Inst, Tissue Core, Tampa, FL USA; [Koomen, John M.] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Rix, U (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA.; Monteiro, AN (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA.	alvaro.monteiro@moffitt.org; uwe.rix@moffitt.org		Monteiro, Alvaro/0000-0002-8448-4801; Deng, Ou/0000-0002-9933-1832; Nepomuceno, Thales/0000-0002-1171-1030	NIH/NCI [R21 CA252373]; Rivkin Center for Ovarian Cancer; Moffitt Team Science; Moffitt Innovation and Technology Committee; Sarasota Innovation Fund/Moffitt Foundation; Miles for Moffitt; Ovarian Cancer Whisper Jacquie Liggett Fellowship; Ovarian Cancer Research Alliance - NIH/NCI [R50 CA211447]	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Rivkin Center for Ovarian Cancer; Moffitt Team Science; Moffitt Innovation and Technology Committee; Sarasota Innovation Fund/Moffitt Foundation; Miles for Moffitt; Ovarian Cancer Whisper Jacquie Liggett Fellowship; Ovarian Cancer Research Alliance - NIH/NCI	This project was supported by the NIH/NCI R21 CA252373 (to A. N. M. and U. R.) , the Rivkin Center for Ovarian Cancer (to A. N. M.) , as well as Moffitt Team Science (to A. N. M. and U. R.) , Moffitt Innovation and Technology Committee (to U. R. and J. M. K.) , the Sarasota Innovation Fund/Moffitt Foundation (to A. N. M. and U. R.) , and Miles for Moffitt (to U. R.) pilot funding. O.D. is the recipient of a Hearing the Ovarian Cancer Whisper Jacquie Liggett Fellowship and T.N. is the recipient of the Ann and Sol Schreiber Mentored Investigator Award from the Ovarian Cancer Research Alliance. The synthesis of compounds was in part funded by NIH/NCI grant R50 CA211447 (to H. R. L.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Becker JR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07855-x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Chandrasekaran A, 2021, MOL CANCER THER, V20, P2117, DOI 10.1158/1535-7163.MCT-21-0500; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Conrad LB, 2020, MOL CANCER THER, V19, P282, DOI 10.1158/1535-7163.MCT-19-0569; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Ctortecka C, 2018, MOL CELL PROTEOMICS, V17, P2434, DOI 10.1074/mcp.RA118.000713; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gallyas F, 2020, CANCERS, V12, DOI 10.3390/cancers12030532; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Jiang GC, 2013, J BIOL CHEM, V288, P8966, DOI 10.1074/jbc.M112.412650; Kalesh K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43154-1; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kim G, 2015, CLIN CANCER RES, V21, P4257, DOI 10.1158/1078-0432.CCR-15-0887; Knezevic CE, 2016, CELL CHEM BIOL, V23, P1490, DOI 10.1016/j.chembiol.2016.10.011; Krastev DB, 2022, NAT CELL BIOL, V24, P62, DOI 10.1038/s41556-021-00807-6; Kuenzi BM, 2017, NAT CHEM BIOL, V13, P1222, DOI [10.1038/NCHEMBIO.2489, 10.1038/nchembio.2489]; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lawlor MA, 2001, J CELL SCI, V114, P2903; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin KK, 2019, CANCER DISCOV, V9, P210, DOI 10.1158/2159-8290.CD-18-0715; Matulonis UA, 2016, ANN ONCOL, V27, P1013, DOI 10.1093/annonc/mdw133; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Mohyuddin GR, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06948-5; Oza AM, 2017, GYNECOL ONCOL, V147, P267, DOI 10.1016/j.ygyno.2017.08.022; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Pommier Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9246; Rix U, 2012, METHODS MOL BIOL, V803, P25, DOI 10.1007/978-1-61779-364-6_3; Sandhu SK, 2013, LANCET ONCOL, V14, P882, DOI 10.1016/S1470-2045(13)70240-7; Stronach EA, 2011, NEOPLASIA, V13, P1069, DOI 10.1593/neo.111032; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumi NJ, 2019, CELL CHEM BIOL, V26, P1240, DOI 10.1016/j.chembiol.2019.06.003; Tapodi A, 2005, J BIOL CHEM, V280, P35767, DOI 10.1074/jbc.M507075200; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Welsh EA, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-153; Westcott NP, 2017, NAT CHEM BIOL, V13, P302, DOI [10.1038/NCHEMBIO.2280, 10.1038/nchembio.2280]; Whicker ME, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2598-1; Xu F, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00416-0; Xu J, 2022, CANCER CHEMOTH PHARM, V89, P683, DOI 10.1007/s00280-022-04403-9; Yang G, 2018, NUCLEIC ACIDS RES, V46, P3446, DOI 10.1093/nar/gky088; Yap TA, 2020, CANCER DISCOV, V10, P1528, DOI 10.1158/2159-8290.CD-20-0163; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zhou P, 2020, PRECIS CLIN MED, V3, P187, DOI 10.1093/pcmedi/pbaa030; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	52	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102550	10.1016/j.jbc.2022.102550	http://dx.doi.org/10.1016/j.jbc.2022.102550			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36183837	gold, Green Published			2022-12-26	WOS:000882627400002
J	Monjes, NM; Wagner, PM; Guido, ME				Monjes, Natalia M.; Wagner, Paula M.; Guido, Mario E.			"Disruption of the molecular clock severely affects lipid metabolism in a hepatocellular carcinoma cell model"	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCADIAN CLOCK; CHOLINE KINASE; PHOSPHATIDYLCHOLINE BIOSYNTHESIS; GLYCEROPHOSPHOLIPID SYNTHESIS; DAILY RHYTHMS; PHOSPHATIDYLETHANOLAMINE; CANCER; SUSCEPTIBILITY; PHOSPHOLIPIDS; TRANSCRIPTION	Involved in triglyceride (TG) and glycerophospholipid metabolism, the liver plays a crucial physiological role in the human body both as a major metabolic integrator and a central hub for lipid and energy homeostasis. Metabolic disorders can be caused by various factors that promote abnormal lipid accumulation in storage organelles called lipid droplets (LDs), as in hepatic steatosis, a metabolic syndrome manifestation that can progress to a hepatocellular carcinoma, the most common primary liver malignancy worldwide. Modern life involves conditions that disrupt the biological clock, causing metabolic disorders and higher cancer risk. A circadian clock is present in the liver and in immortalized cell lines and temporally regulates physiological processes by driving transcriptional and metabolic rhythms. Here we investigated metabolic rhythms in HepG2 cells, a human hepatocellular carcinoma- derived cell line, and the link between these rhythms and the circadian clock in control (Bmal1-wildtype) and Bmal1-disrupted (B-D) cells having their molecular clock impaired. Rhythms in the expression of lipid-synthesizing enzymes ChoK alpha, Pcyt2, and Lipin1, in the metabolism of particular glycerophospholipids such as phosphatidylcholine (PC) and phosphatidylethanolamine, and in the phosphatidylcholine/ phosphatidylethanolamine ratio and TG and LD content were observed in Bmal1-wildtype cells. By contrast, in the B-D model, the whole hepatic metabolism was severely altered with a significant reduction in the TG and LD content as well as in ChoK alpha and other related lipid enzymes. Together, our results suggest a very strong crosstalk between the molecular clock and lipid metabolism, which exhibits an exacerbated pathological condition in B-D cells.	[Monjes, Natalia M.; Wagner, Paula M.; Guido, Mario E.] Univ Nacl Cordoba, CIQUIB CONICET, Cordoba, Argentina; [Monjes, Natalia M.; Wagner, Paula M.; Guido, Mario E.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina	National University of Cordoba; National University of Cordoba	Guido, ME (corresponding author), Univ Nacl Cordoba, CIQUIB CONICET, Cordoba, Argentina.; Guido, ME (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina.	mario.guido@unc.edu.ar			Agencia Nacional de Promocion Cientifica y Tecnica (FONCyT, PICT 2017) [631]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET) [PIP 2014]; Secretaria de Ciencia y Tecnologia de la Uni-versidad Nacional de Cordoba (SeCyT-UNC); John Simon Guggenheim Memorial Foundation for Latinoamerica and Caribe (2009) in Natural Sciences, USA	Agencia Nacional de Promocion Cientifica y Tecnica (FONCyT, PICT 2017); Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnologia de la Uni-versidad Nacional de Cordoba (SeCyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); John Simon Guggenheim Memorial Foundation for Latinoamerica and Caribe (2009) in Natural Sciences, USA	This work has been supported by Agencia Nacional de Promocion Cientifica y Tecnica (FONCyT, PICT 2017 No 631), Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET) (PIP 2014), and Secretaria de Ciencia y Tecnologia de la Uni-versidad Nacional de Cordoba (SeCyT-UNC) and John Simon Guggenheim Memorial Foundation for Latinoamerica and Caribe (2009) in Natural Sciences, USA.	Acosta-Rodriguez VA, 2013, J LIPID RES, V54, P1798, DOI 10.1194/jlr.M034264; Andersen LW, 2013, MAYO CLIN PROC, V88, P1127, DOI 10.1016/j.mayocp.2013.06.012; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Chao HC, 2017, ANAL CHIM ACTA, V971, P68, DOI 10.1016/j.aca.2017.03.033; Chen-Goodspeed M, 2007, J BIOL RHYTHM, V22, P291, DOI 10.1177/0748730407303387; Damato AR, 2022, SEMIN CELL DEV BIOL, V126, P27, DOI 10.1016/j.semcdb.2021.07.017; Dibner C, 2015, J INTERN MED, V277, P513, DOI 10.1111/joim.12347; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Garbarino-Pico E, 2005, NEUROCHEM INT, V47, P260, DOI 10.1016/j.neuint.2005.04.024; Garbarino-Pico E, 2004, J NEUROSCI RES, V76, P642, DOI 10.1002/jnr.20126; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gluchowski NL, 2017, NAT REV GASTRO HEPAT, V14, P343, DOI 10.1038/nrgastro.2017.32; Gorne LD, 2015, CHRONOBIOL INT, V32, P11, DOI 10.3109/07420528.2014.949734; Grechez-Cassiau A, 2015, CHRONOBIOL INT, V32, P774, DOI 10.3109/07420528.2015.1046601; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guido ME, 2022, MOL NEUROBIOL, V59, P326, DOI 10.1007/s12035-021-02595-4; Guido ME, 2001, J NEUROCHEM, V76, P835, DOI 10.1046/j.1471-4159.2001.00081.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kent C, 2005, BBA-MOL CELL BIOL L, V1733, P53, DOI 10.1016/j.bbalip.2004.12.008; Kiessling S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0349-7; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Krishnaiah SY, 2017, CELL METAB, V25, P1206, DOI 10.1016/j.cmet.2017.04.023; Lahti T, 2012, ANN MED, V44, P847, DOI 10.3109/07853890.2012.727018; Lahti TA, 2008, INT J CANCER, V123, P2148, DOI 10.1002/ijc.23566; Li ZY, 2008, J LIPID RES, V49, P1187, DOI 10.1194/jlr.R700019-JLR200; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Marcucci H, 2010, J BIOL CHEM, V285, P25382, DOI 10.1074/jbc.M110.139477; Mashek DG, 2013, ADV NUTR, V4, P697, DOI 10.3945/an.113.004648; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Niebergall LJ, 2012, BBA-MOL CELL BIOL L, V1821, P324, DOI 10.1016/j.bbalip.2011.10.018; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rios MN, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00376; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Sookoian S, 2019, ALIMENT PHARM THER, V49, P516, DOI 10.1111/apt.15163; Sztolsztener K, 2021, BIOCHEM BIOPH RES CO, V585, P132, DOI 10.1016/j.bbrc.2021.11.044; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61; Thaben PF, 2014, J BIOL RHYTHM, V29, P391, DOI 10.1177/0748730414553029; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Wagner PM, 2021, FASEB J, V35, DOI 10.1096/fj.202001753R; Wagner PM, 2019, ASN NEURO, V11, DOI 10.1177/1759091419892713; Wagner PM, 2019, MOL NEUROBIOL, V56, P1276, DOI 10.1007/s12035-018-1152-3; Wu G, 2021, BIOINFORMATICS, V37, P4581, DOI 10.1093/bioinformatics/btab731; Wu GS, 2010, BIOCHEM CELL BIOL, V88, P559, DOI 10.1139/O09-160; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Zhang Y, 2015, ACTA PHARMACOL SIN, V36, P71, DOI 10.1038/aps.2014.120	60	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102551	10.1016/j.jbc.2022.102551	http://dx.doi.org/10.1016/j.jbc.2022.102551			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36183836	gold, Green Published			2022-12-26	WOS:000882627400010
J	Liu, WW; Zhang, HM; Zhang, HC; Lyu, TZ; Yuan, SW				Liu, Wenwei; Zhang, Huimin; Zhang, Haichen; Lyu, Tongzhou; Yuan, Suwei			Prevalence and associated factors of inappropriate hospital admissions and days of children in a secondary hospital in Shanghai, China	PLOS ONE			English	Article							APPROPRIATENESS EVALUATION PROTOCOL; STAY; UNIT	Background Although the appropriateness of hospital utilization of adults and the elderly in China was audited by several studies, the appropriateness of hospital use by children in Shanghai remains to be determined. This study aims to assess the level of inappropriate hospital admissions and hospital days, to detect factors associated with inappropriateness, and to elucidate reasons for inappropriateness. Methods A retrospective review of the records of 291 admissions and 1449 hospital days of children inpatients from a secondary hospital in Shanghai was performed by two reviewers using the Chinese version Pediatric Appropriateness Evaluation Protocol (C-PAEP). Demographics, socio-economic characteristics, and other admission- or hospital stay-related information were collected and analyzed to determine factors associated with inappropriateness utilizing multivariate regression models. Results 38.5% (n = 112) of admissions and 9.5% (n = 137) of hospital days were categorized as inappropriate, according to the C-PAEP. Children who were non-Shanghai residents (p < 0.001), admitted through the emergency sector (p = 0.030), and/or received services in a surgical ward (p < 0.001) had a higher risk of being admitted inappropriately. Payment method (p = 0.006), service type (p < 0.001), comorbidity (p = 0.016), length of stay (p = 0.007), and appropriateness of admission (p < 0.001) were found to be associated with prevalence of inappropriate hospital days. Approximately three-fourths of the inappropriate admissions were premature admissions (75.9%, n = 85). The most frequent reasons for inappropriate hospital days were awaiting test results (34.3%, n = 47), awaiting surgery (19.7%, n = 27), awaiting test execution (10.9%, n = 15), and family unprepared for home care (10.9%, n = 15). Conclusions Although the extent of inappropriate hospital days was moderate compared with that found by previous investigations, the prevalence of inappropriateness of admission was considerable. To enhance the appropriateness of hospital care for children, interventions could be implemented according to the associated factors and identified causes.	[Liu, Wenwei] Shanghai Normal Univ, Coll Philosophy Law & Polit Sci, Shanghai, Peoples R China; [Zhang, Huimin] Shanghai Jiao Tong Univ, Sch Int & Publ Affairs, Shanghai, Peoples R China; [Zhang, Haichen] Shanghai Xuhui Mental Hlth Ctr, Shanghai, Peoples R China; [Lyu, Tongzhou] East China Normal Univ, Sch Polit & Int Relat, Shanghai, Peoples R China; [Yuan, Suwei] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai, Peoples R China; [Yuan, Suwei] Shanghai Jiao Tong Univ, China Hosp Dev Inst, Shanghai, Peoples R China	Shanghai Normal University; Shanghai Jiao Tong University; East China Normal University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yuan, SW (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Shanghai, Peoples R China.; Yuan, SW (corresponding author), Shanghai Jiao Tong Univ, China Hosp Dev Inst, Shanghai, Peoples R China.	yuansuwei@sjtu.edu.cn			National Natural Science Foundation [72004136]; Shanghai Public Health Excellent Talent Project [GWV-10.2-YQ51]; Postdoctoral Research Foundation of China [2019M661537]; Philosophy and Social Science Foundation of Hunan Province [2019EZZ003]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Public Health Excellent Talent Project; Postdoctoral Research Foundation of China(China Postdoctoral Science Foundation); Philosophy and Social Science Foundation of Hunan Province	The study was funded by the National Natural Science Foundation (number: 72004136), the Shanghai Public Health Excellent Talent Project (number: GWV-10.2-YQ51), the Postdoctoral Research Foundation of China (number: 2019M661537), and the Philosophy and Social Science Foundation of Hunan Province (number: 2019EZZ003).	Al-Tehewy M., 2009, Eastern Mediterranean Health Journal, V15, P1126; Angelillo IF, 2000, PUBLIC HEALTH, V114, P9, DOI 10.1038/sj.ph.1900609; Arab-Zozani M, 2020, VALUE HEALTH REG ISS, V21, P105, DOI 10.1016/j.vhri.2019.07.011; Bianco A, 2003, PEDIATRICS, V112, P124, DOI 10.1542/peds.112.1.124; BINDMAN AB, 1995, JAMA-J AM MED ASSOC, V274, P305, DOI 10.1001/jama.274.4.305; Brabrand M, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-152; Rodriguez FC, 2006, ARCH BRONCONEUMOL, V42, P440, DOI 10.1016/S1579-2129(06)60566-1; Esmail A, 2000, J PUBLIC HEALTH MED, V22, P231, DOI 10.1093/pubmed/22.2.231; Esmaili A, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.16602; GERTMAN PM, 1981, MED CARE, V19, P855, DOI 10.1097/00005650-198108000-00005; Ghods Ali Asghar, 2014, Glob J Health Sci, V7, P82, DOI 10.5539/gjhs.v7n3p82; GLOOR JE, 1993, PEDIATRICS, V91, P70; Hu XM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026443; Huang G, 2016, CHINESE HLTH EC, P64; Katz M, 2001, ISRAEL MED ASSOC J, V3, P501; KEMPER KJ, 1988, NEW ENGL J MED, V318, P1033, DOI 10.1056/NEJM198804213181605; KREGER BE, 1989, PEDIATRICS, V84, P242; Li F, 2012, CHINESE HLTH EC, V31, P42; Liu WW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208146; Liu WW, 2017, INT J QUAL HEALTH C, V29, P699, DOI 10.1093/intqhc/mzx091; Liu WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136498; Morrison AK, 2013, ACAD PEDIATR, V13, P421, DOI 10.1016/j.acap.2013.03.001; National Health and Family Planning Commission of the People's Republic of China, 2017, CHIN HLTH STAT YB 20; National Health and Family Planning Commission of the People's Republic of China, 2019, CHIN HLTH STAT YB 20; OhAiseadha C, 2016, INT J HEALTH POLICY, V5, P643, DOI 10.15171/ijhpm.2016.53; Pileggi C, 2004, PUBLIC HEALTH, V118, P284, DOI 10.1016/j.puhe.2003.06.002; Restuccia J D, 1987, Health Care Manage Rev, V12, P17; RESTUCCIA JD, 1995, INT J QUAL HEALTH C, V7, P253, DOI 10.1093/intqhc/7.3.253; Shafik MH, 2012, MED PRIN PRACT, V21, P516, DOI 10.1159/000339084; Soria-Aledo V, 2009, AM J MED QUAL, V24, P321, DOI 10.1177/1062860609337252; Vincitorio D, 2010, J PUBLIC HEALTH-HEID, V18, P497, DOI 10.1007/s10389-010-0325-y; Werneke U, 1997, ARCH DIS CHILD, V77, P294, DOI 10.1136/adc.77.4.294; Zhang Y, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0649-3	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2022	17	10							e0275645	10.1371/journal.pone.0275645	http://dx.doi.org/10.1371/journal.pone.0275645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6P6RS	36201444	gold, Green Published			2022-12-26	WOS:000891056500001
J	Wen, Y; Wang, XQ; Meng, W; Guo, WL; Duan, CY; Cao, JJ; Kang, LF; Guo, NF; Lin, Q; Lv, P; Zhang, R; Xing, LX; Zhang, XH; Shen, HT				Wen, Yue; Wang, Xiuqing; Meng, Wei; Guo, Wenli; Duan, Chenyang; Cao, Jingjing; Kang, Lifei; Guo, Ningfei; Lin, Qiang; Lv, Ping; Zhang, Rong; Xing, Lingxiao; Zhang, Xianghong; Shen, Haitao			TNF-alpha-dependent lung inflammation upregulates PD-L1 in monocyte-derived macrophages to contribute to lung tumorigenesis	FASEB JOURNAL			English	Article						chronic inflammation; lung tumorigenesis; Monocyte-derived macrophages; PD-L1; TNF-alpha	TUMOR-ASSOCIATED MACROPHAGES; TISSUE-RESIDENT; HOST-CELLS; EXPRESSION; BLOCKADE; CANCER; INFECTION; PROFILES; IDENTITY; DEVELOP	Chronic inflammation, which is dominated by macrophage-involved inflammatory responses, is an instigator of cancer initiation. Macrophages are the most abundant immune cells in healthy lungs, and associated with lung tumor development and promotion. PD-L1 is a negative molecule in macrophages and correlated with an immunosuppressive function in tumor environment. Macrophages expressing PD-L1, rather than tumor cells, exhibits a critical role in tumor growth and progression. However, whether and how PD-L1 in macrophages contributes to inflammation-induced lung tumorigenesis requires further elucidation. Here, we found that higher expression of PD-L1 in CD11b(+)CD206(+) macrophages was positively correlated with tumor progression and PD-1(+)CD8(+) T cells population in human adenocarcinoma patients. In the urethane-induced inflammation-driven lung adenocarcinoma (IDLA) mouse model, the infiltration of circulating CD11b(high)F4/80(+) monocyte-derived macrophages (MoMs) was increased in pro-tumor inflamed lung tissues and lung adenocarcinoma. PD-L1 was mainly upregulated in MoMs associated with enhanced T cells exhaustion in lung tissues. Anti-PD-L1 treatment can reduce T cells exhaustion at pro-tumor inflammatory stage, and then inhibit tumorigenesis in IDLA. The pro-tumor lung inflammation depended on TNF-alpha to upregulate PD-L1 and CSN6 expression in MoMs, and induced cytokines production by alveolar type-II cells (AT-II). Furthermore, inflammatory AT-II cells could secret TNF-alpha to upregulate PD-L1 expression in bone-marrow driven macrophages (BM-M0). Inhibition of CSN6 decreased PD-L1 expression in TNF-alpha-activated macrophage in vitro, suggesting a critical role of CSN6 in PD-L1 upregulation. Thus, pro-tumor inflammation can depend on TNF-alpha to upregulate PD-L1 in recruited MoMs, which may be essential for lung tumorigenesis.	[Wen, Yue; Wang, Xiuqing; Meng, Wei; Guo, Wenli; Duan, Chenyang; Cao, Jingjing; Guo, Ningfei; Xing, Lingxiao; Zhang, Xianghong; Shen, Haitao] Hebei Med Univ, Lab Pathol, 361 East Zhongshan Rd, Shijiazhuang, Hebei, Peoples R China; [Wen, Yue] Hebei Med Univ, Hosp 4, Dept Ultrasound, Shijiazhuang, Hebei, Peoples R China; [Wang, Xiuqing; Meng, Wei; Duan, Chenyang; Cao, Jingjing; Xing, Lingxiao; Zhang, Xianghong; Shen, Haitao] Hebei Med Univ, Ctr Metab Dis & Canc Res CMCR, Shijiazhuang, Hebei, Peoples R China; [Guo, Wenli; Zhang, Xianghong] Hebei Med Univ, Hosp 2, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Kang, Lifei] Hebei Chest Hosp, Dept Pathol, Shijiazhuang, Hebei, Peoples R China; [Lin, Qiang] Hebei Med Univ, North China Petr Bur Gen Hosp, Dept Oncol, Renqiu, Peoples R China; [Lv, Ping] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China; [Zhang, Rong] Hebei Med Univ, Sch Publ Hlth, Dept Toxicol, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhang, XH; Shen, HT (corresponding author), Hebei Med Univ, Lab Pathol, 361 East Zhongshan Rd, Shijiazhuang, Hebei, Peoples R China.	zhangxianghong2008@163.com; haitaoshen78@hotmail.com			National Natural Science Foundation of China [31570894, 81670939, 81672706]; Foundation of Hebei Science and Technology Department, China [216G7707Z]; Natural Science Foundation of Hebei Province (key program), China [H2021206351]; Natural Science Foundation for Distinguished Young Scholars of Hebei Province, China [H2018206120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Hebei Science and Technology Department, China; Natural Science Foundation of Hebei Province (key program), China; Natural Science Foundation for Distinguished Young Scholars of Hebei Province, China	This work was supported by the National Natural Science Foundation of China (31570894; 81670939; 81672706), Foundation of Hebei Science and Technology Department, China (216G7707Z), Natural Science Foundation of Hebei Province (key program), China (H2021206351), and Natural Science Foundation for Distinguished Young Scholars of Hebei Province, China (H2018206120).	Allard B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01777; Almatroodi SA, 2016, CANCER MICROENVIRON, V9, P1, DOI 10.1007/s12307-015-0174-x; Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Dey A, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00683; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Eldredge LC, 2016, AM J RESP CELL MOL, V54, P273, DOI 10.1165/rcmb.2014-0395OC; Gabrusiewicz K, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1412909; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Guilbaud E, 2019, CANCERS, V11, DOI 10.3390/cancers11030298; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guo NF, 2020, FASEB J, V34, P12197, DOI 10.1096/fj.202000166RR; Han XJ, 2020, MOL CARCINOGEN, V59, P1088, DOI 10.1002/mc.23239; Hartley G, 2017, CANCER IMMUNOL IMMUN, V66, P523, DOI 10.1007/s00262-017-1955-5; Hartley GP, 2018, CANCER IMMUNOL RES, V6, P1260, DOI 10.1158/2326-6066.CIR-17-0537; Helm O, 2014, INT J CANCER, V135, P843, DOI 10.1002/ijc.28736; Houghton AM, 2008, NAT MED, V14, P1023, DOI 10.1038/nm1008-1023; Jia YL, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01455-y; Kannan S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004891; Karabela SP, 2011, NEOPLASIA, V13, P1143, DOI 10.1593/neo.111224; Krieg C, 2018, NAT MED, V24, P144, DOI 10.1038/nm.4466; Lahmar Q, 2016, BBA-REV CANCER, V1865, P23, DOI 10.1016/j.bbcan.2015.06.009; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lin H, 2018, J CLIN INVEST, V128, P805, DOI 10.1172/JCI96113; Liu C, 2020, CELL DEATH DIFFER, V27, P1765, DOI 10.1038/s41418-019-0460-0; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Lu CH, 2018, ONCOGENE, V37, P6327, DOI 10.1038/s41388-018-0411-0; Mandai M, 2016, CLIN CANCER RES, V22, P2329, DOI 10.1158/1078-0432.CCR-16-0224; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Mazzaschi G, 2018, CLIN CANCER RES, V24, P407, DOI 10.1158/1078-0432.CCR-17-2156; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Nguyen LT, 2015, NAT REV IMMUNOL, V15, P45, DOI 10.1038/nri3790; Noguchi T, 2017, CANCER IMMUNOL RES, V5, P106, DOI 10.1158/2326-6066.CIR-16-0391; Petty AJ, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.146707; Pollari M, 2018, HAEMATOLOGICA, V103, P1908, DOI 10.3324/haematol.2018.197194; Quandt D, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-151; Rana T, 2020, AM J RESP CELL MOL, V62, P319, DOI 10.1165/rcmb.2019-0071OC; Sanfilippo AM, 2015, INFECT IMMUN, V83, P2976, DOI 10.1128/IAI.00142-15; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Su LR, 2020, MOL CARCINOGEN, V59, P520, DOI 10.1002/mc.23176; Sumitomo R, 2019, LUNG CANCER, V136, P136, DOI 10.1016/j.lungcan.2019.08.023; Sun F, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000294; Tang HD, 2018, J CLIN INVEST, V128, P580, DOI 10.1172/JCI96061; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; van de Laar L, 2016, IMMUNITY, V44, P755, DOI 10.1016/j.immuni.2016.02.017; Van Overmeire E, 2016, CANCER RES, V76, P35, DOI 10.1158/0008-5472.CAN-15-0869; Wang X, 2017, IMMUNOL LETT, V184, P7, DOI 10.1016/j.imlet.2017.02.006; Watanabe S, 2019, J CLIN INVEST, V129, P2619, DOI 10.1172/JCI124615; Xiao M, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0815-2; Zerdes I, 2018, ONCOGENE, V37, P4639, DOI 10.1038/s41388-018-0303-3; Zong ZY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01643; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	55	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2022	36	11							e22595	10.1096/fj.202200434RR	http://dx.doi.org/10.1096/fj.202200434RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	5D1HL	36205325				2022-12-26	WOS:000864700900001
J	Meyer, MB; Benkusky, NA; Lee, SM; Yoon, SH; Mannstadt, M; Wein, MN; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Lee, Seong Min; Yoon, Sung-Hee; Mannstadt, Michael; Wein, Marc N.; Pike, J. Wesley			Rapid genomic changes by mineralotropic hormones and kinase SIK inhibition drive coordinated renal Cyp27b1 and Cyp24a1 expression via CREB modules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; GENE-EXPRESSION; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN D-3; WIDE ANALYSIS; TARGET GENES; ACTIVATION; CALCIUM; COACTIVATOR; METABOLISM	Vitamin D metabolism centers on kidney regulation of Cyp27b1 by mineralotropic hormones, including induction by parathyroid hormone (PTH), suppression by fibroblast growth factor 23 (FGF23) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), and reciprocal regulations for Cyp24a1. This coordinated genomic regulation results in production of endocrine 1,25(OH)2D3, which, together with PTH and FGF23, controls mineral homeostasis. However, how these events are coordi-nated is unclear. Here, using in vivo chromatin immunoprecip-itation sequencing in mouse kidney, we demonstrate that PTH activation rapidly induces increased recruitment of phosphory-lated (p-133) CREB (pCREB) and its coactivators, CBP (CREB-binding protein) and CRTC2 (CREB-regulated transcription coactivator 2), to previously defined kidney-specific M1 and M21 enhancers near the Cyp27b1 gene. At distal enhancers of the Cyp24a1 gene, PTH suppression dismisses CBP with only minor changes in pCREB and CRTC2 occupancy, all of which correlate with decreased genomic activity and reduced transcripts. Treatment of mice with salt-inducible kinase inhibitors (YKL-05-099 and SK-124) yields rapid genomic recruitment of CRTC2 to Cyp27b1, limited interaction of CBP, and a transcriptional response for both Cyp27b1 and Cyp24a1 that mirrors the actions of PTH. Surprisingly, we find that 1,25(OH)2D3 suppression in-creases the occupancy of CRTC2 in the M1 enhancer, a novel observation for CRTC2 and 1,25(OH)2D3 action. Suppressive actions of 1,25(OH)2D3 and FGF23 at the Cyp27b1 gene are associated with reduced CBP recruitment at these CREB-module enhancers that disrupts full PTH induction. Our findings show that CRTC2 contributes to transcription of both Cyp27b1 and Cyp24a1, demonstrate salt-inducible kinase inhibition as a key modulator of vitamin D metabolism, and provide molecular insight into the coordinated mechanistic actions of PTH, FGF23, and 1,25(OH)2D3 in the kidney that regulate mineral homeostasis.	[Meyer, Mark B.; Benkusky, Nancy A.; Lee, Seong Min; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Yoon, Sung-Hee; Mannstadt, Michael; Wein, Marc N.] Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA USA	University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Massachusetts General Hospital	Meyer, MB (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	markmeyer@wisc.edu		LEE, Seong Min/0000-0001-5017-5456	National Institutes of Health;  [DK117475];  [DK116716];  [DK011794];  [AR075042]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; 	Funding and additional information-Our funding came from the National Institutes of Health grants DK117475 to J. W. P. and DK116716, DK011794, AR075042 to M. N. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; BOYLE IT, 1971, P NATL ACAD SCI USA, V68, P2131, DOI 10.1073/pnas.68.9.2131; Brenza HL, 2000, ARCH BIOCHEM BIOPHYS, V381, P143, DOI 10.1006/abbi.2000.1970; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; GARABEDIAN M, 1972, P NATL ACAD SCI USA, V69, P1673, DOI 10.1073/pnas.69.7.1673; Goodman RH, 2000, GENE DEV, V14, P1553; Haussler M R, 1980, Prog Biochem Pharmacol, V17, P134; Hill MJ, 2016, MOL ENDOCRINOL, V30, P104, DOI 10.1210/me.2015-1237; Homer-Bouthiette C, 2014, J BIOL CHEM, V289, P36303, DOI 10.1074/jbc.M114.619569; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Lee SM, 2015, J BIOL CHEM, V290, P30573, DOI 10.1074/jbc.M115.693614; Lee SM, 2015, J BIOL CHEM, V290, P18199, DOI 10.1074/jbc.M115.665794; Louet JF, 2010, CELL METAB, V12, P606, DOI 10.1016/j.cmet.2010.11.009; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2020, J STEROID BIOCHEM, V196, DOI 10.1016/j.jsbmb.2019.105500; Meyer MB, 2019, J BIOL CHEM, V294, P14467, DOI 10.1074/jbc.RA119.010173; Meyer MB, 2019, J BIOL CHEM, V294, P9518, DOI 10.1074/jbc.RA119.008760; Meyer MB, 2017, J BIOL CHEM, V292, P17541, DOI 10.1074/jbc.M117.806901; Meyer MB, 2016, J BIOL CHEM, V291, P17829, DOI 10.1074/jbc.M116.736538; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2014, J STEROID BIOCHEM, V144, P19, DOI 10.1016/j.jsbmb.2013.09.005; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Nishimori S, 2019, J CLIN INVEST, V129, P5187, DOI 10.1172/JCI130126; OMDAHL JL, 1972, NATURE-NEW BIOL, V237, P63, DOI 10.1038/newbio237063a0; Pike JW, 2021, JBMR PLUS, V5, DOI 10.1002/jbm4.10433; Pike JW, 2017, J CLIN INVEST, V127, P1146, DOI 10.1172/JCI88887; Pike JW, 2016, VITAM HORM, V100, P21, DOI 10.1016/bs.vh.2015.10.011; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sundberg TB, 2016, ACS CHEM BIOL, V11, P2105, DOI 10.1021/acschembio.6b00217; Tagami T, 1998, BIOCHEM BIOPH RES CO, V253, P358, DOI 10.1006/bbrc.1998.9799; Tang C. C., 2021, J BONE MINER RES, V36, P1; Tang CC, 2021, ELIFE, V10, DOI 10.7554/eLife.67772; Van de Velde S, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00200-19; Veldurthy V, 2016, VITAM HORM, V100, P137, DOI 10.1016/bs.vh.2015.10.005; Wein MN, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031237; Wein MN, 2018, TRENDS ENDOCRIN MET, V29, P723, DOI 10.1016/j.tem.2018.08.004; Wein MN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13176; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675	52	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102559	10.1016/j.jbc.2022.102559	http://dx.doi.org/10.1016/j.jbc.2022.102559			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36183832	gold, Green Published			2022-12-26	WOS:000882627400011
J	Guo, YM; He, JF; Zhang, HL; Chen, R; Li, L; Liu, XJ; Huang, CH; Qiang, Z; Zhou, ZH; Wang, YL; Huang, J; Zhao, X; Zheng, JK; Chen, GQ; Yu, JX				Guo, Yanmin; He, Jianfeng; Zhang, Hailong; Chen, Ran; Li, Lian; Liu, Xiaojia; Huang, Caihu; Qiang, Zhe; Zhou, Zihan; Wang, Yanli; Huang, Jian; Zhao, Xian; Zheng, Junke; Chen, Guo-Qiang; Yu, Jianxiu			Linear ubiquitination of PTEN impairs its function to promote prostate cancer progression	ONCOGENE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; TUMOR-SUPPRESSOR; COWDEN DISEASE; NUCLEAR PTEN; LIGASE; BREAST; LUBAC; STABILITY; OTULIN; NEMO	PTEN is frequently mutated in human cancers, which leads to the excessive activation of PI3K/AKT signaling and thus promotes tumorigenesis and drug resistance. Met(1)-linked ubiquitination (M1-Ubi) is also involved in cancer progression, but the mechanism is poorly defined. Here we find that HOIP, one important component of linear ubiquitin chain assembly complex (LUBAC), promotes prostate cancer (PCa) progression by enhancing AKT signaling in a PTEN-dependent manner. Mechanistically, PTEN is modified by M1-Ubi at two sites K144 and K197, which significantly inhibits PTEN phosphatase activity and thus accelerates PCa progression. More importantly, we identify that the high-frequency mutants PTENR173H and PTENR173C in PCa patients showed the enhanced level of M1-Ubi, which impairs PTEN function in inhibition of AKT phosphorylation and cell growth. We also find that HOIP depletion sensitizes PCa cells to therapeutic agents BKM120 and Enzalutamide. Furthermore, the clinical data analyses confirm that HOIP is upregulated and positively correlated with AKT activation in PCa patient specimen, which may promote PCa progression and increase the risk of PCa biochemical relapse. Together, our study reveals a key role of PTEN M1-Ubi in regulation of AKT activation and PCa progression, which may propose a new strategy for PCa therapy.	[Guo, Yanmin; He, Jianfeng; Zhang, Hailong; Chen, Ran; Li, Lian; Liu, Xiaojia; Huang, Caihu; Qiang, Zhe; Zhou, Zihan; Wang, Yanli; Huang, Jian; Zhao, Xian; Yu, Jianxiu] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China; [Zheng, Junke] Shanghai Jiao Tong Univ, Sch Med, Chinese Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200025, Peoples R China; [Chen, Guo-Qiang] Shanghai Jiao Tong Univ, Ren Ji Hosp, State Key Lab Oncogenes & Related Genes, Sch Med, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, JX (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China.	Jianxiu.Yu@gmail.com			China's National Key R&D Programmes (NKP) [2019YFE0110600]; National Natural Science Foundation of China [81630075, 82103082, 81721004, 81902866, 82002712, 81972585]; Shanghai Science and Technology Commission [20JC1410100]	China's National Key R&D Programmes (NKP); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from China's National Key R&D Programmes (NKP) (No. 2019YFE0110600), the National Natural Science Foundation of China (81630075, 82103082, 81721004, 81902866, 82002712, 81972585) and Shanghai Science and Technology Commission (20JC1410100).	Armstrong AJ, 2017, EUR J CANCER, V81, P228, DOI 10.1016/j.ejca.2017.02.030; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Chen Chang-fu, 2015, China Journal of Highway and Transport, V28, P1; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; de Almagro MC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.158; Deng R, 2021, MOL ONCOL, V15, P279, DOI 10.1002/1878-0261.12844; Dittmar G, 2020, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00915; Dou JZ, 2020, MOL ONCOL, V14, P2288, DOI 10.1002/1878-0261.12694; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Fu YS, 2021, MOL CELL, V81, P3187, DOI 10.1016/j.molcel.2021.05.031; Ge MK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15578-1; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Goto E, 2017, BIOCHEM BIOPH RES CO, V485, P152, DOI [10.1016/J.bbrc.2017.02.040, 10.1016/j.bbrc.2017.02.040]; Gu TT, 2011, CANCER RES, V71, P2821, DOI 10.1158/0008-5472.CAN-10-3399; Guo J, 2015, BIOCHEM BIOPH RES CO, V464, P1302, DOI 10.1016/j.bbrc.2015.07.127; He LZ, 2010, J CLIN INVEST, V120, P2094, DOI 10.1172/JCI40778; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Jamaspishvili T, 2018, NAT REV UROL, V15, P222, DOI 10.1038/nrurol.2018.9; Kharman-Biz A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197183; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kliza K, 2017, NAT METHODS, V14, P504, DOI [10.1038/NMETH.4228, 10.1038/nmeth.4228]; Lee YR, 2018, NAT REV MOL CELL BIO, V19, P547, DOI 10.1038/s41580-018-0015-0; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; Marsh DJ, 1998, GENE CHROMOSOME CANC, V21, P61, DOI 10.1002/(SICI)1098-2264(199801)21:1<61::AID-GCC8>3.0.CO;2-6; Noad J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.63; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Qiu P, 2018, ONCOL LETT, V15, P789, DOI 10.3892/ol.2017.7431; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Sakamoto H, 2015, ACS CHEM BIOL, V10, P675, DOI 10.1021/cb500653y; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Serebriiskii IG, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29227-2; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shi YJ, 2014, NAT STRUCT MOL BIOL, V21, P522, DOI 10.1038/nsmb.2828; Singh G, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-490; Smith IN, 2016, PROTEINS, V84, P1625, DOI 10.1002/prot.25105; Takiuchi T, 2014, GENES CELLS, V19, P254, DOI 10.1111/gtc.12128; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Thompson HGR, 2004, EXP CELL RES, V295, P448, DOI 10.1016/j.yexcr.2004.01.019; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; van Well EM, 2019, EMBO J, V38, DOI 10.15252/embj.2018100730; Vanhaesebroeck B, 2021, NAT REV DRUG DISCOV, V20, P741, DOI 10.1038/s41573-021-00209-1; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang W, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17770-9; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wong CW, 2018, AUTISM RES, V11, P1098, DOI 10.1002/aur.1950; Wu PJ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.641469; Xie P, 2021, CELL RES, V31, P291, DOI 10.1038/s41422-020-00443-z; Yang M, 2017, ONCOGENE, V36, P3673, DOI 10.1038/onc.2016.493; Yu J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3248-y; Zhang HL, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25739-5; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhu J, 2016, ONCOGENE, V35, P1955, DOI 10.1038/onc.2015.260; Zhu J, 2014, ONCOGENE, V33, P4340, DOI 10.1038/onc.2013.573; Zuo YB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14948-z	65	0	0	10	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2022	41	44					4877	4892		10.1038/s41388-022-02485-6	http://dx.doi.org/10.1038/s41388-022-02485-6		OCT 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5U1RX	36192478				2022-12-26	WOS:000865226400002
J	Hohberger, B; Pruss, H; Mardin, CY; Laemmer, R; Muller, J; Wallukat, G				Hohberger, Bettina; Pruess, Harald; Mardin, Christian Y.; Laemmer, Robert; Mueller, Johannes; Wallukat, Gerd			Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic dysbalance	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Meeting Abstract									[Hohberger, Bettina; Mardin, Christian Y.; Laemmer, Robert] Univ Erlangen Nurnberg, Ophthalmol, Erlangen, Germany; [Pruess, Harald] Charite Univ Med Berlin, Berlin, Germany; [Mueller, Johannes; Wallukat, Gerd] Berlin Cures GmbH, Berlin, Germany	University of Erlangen Nuremberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin									0	0	0	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	JUN	2022	63	7				929								3	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	3Z4QH	36201426	Green Published, Green Submitted, gold			2022-12-26	WOS:000844401302256
J	Garrigues, RJ; Thomas, S; Leong, JM; Garcia, BL				Garrigues, Ryan J.; Thomas, Sheila; Leong, John M.; Garcia, Brandon L.			Outer surface lipoproteins from the Lyme disease spirochete exploit the molecular switch mechanism of the complement protease C1s	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BORRELIA-BURGDORFERI; FACTOR-H; STRUCTURAL BASIS; SERINE-PROTEASE; COMPONENT C4; ERP PROTEINS; EVASION; BINDING; FAMILY; INHIBITION	Proteolytic cascades comprise several important physiolog-ical systems, including a primary arm of innate immunity called the complement cascade. To safeguard against complement -mediated attack, the etiologic agent of Lyme disease, Borre-liella burgdorferi, produces numerous outer surface-localized lipoproteins that contribute to successful complement evasion. Recently, we discovered a pair of B. burgdorferi surface lipoproteins of the OspEF-related protein family-termed ElpB and ElpQ-that inhibit antibody-mediated complement acti-vation. In this study, we investigate the molecular mechanism of ElpB and ElpQ complement inhibition using an array of biochemical and biophysical approaches. In vitro assays of complement activation show that an independently folded homologous C-terminal domain of each Elp protein maintains full complement inhibitory activity and selectively inhibits the classical pathway. Using binding assays and complement component C1s enzyme assays, we show that binding of Elp proteins to activated C1s blocks complement component C4 cleavage by competing with C1s-C4 binding without occluding the active site. C1s-mediated C4 cleavage is dependent on activation-induced binding sites, termed exosites. To test whether these exosites are involved in Elp-C1s binding, we performed site-directed mutagenesis, which showed that ElpB and ElpQ binding require C1s residues in the anion-binding exosite located on the serine protease domain of C1s. Based on these results, we propose a model whereby ElpB and ElpQ exploit activation-induced conformational changes that are normally important for C1s-mediated C4 cleavage. Our study expands the known complement evasion mechanisms of mi-crobial pathogens and reveals a novel molecular mechanism for selective C1s inhibition by Lyme disease spirochetes.	[Garrigues, Ryan J.; Thomas, Sheila; Garcia, Brandon L.] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA; [Leong, John M.] Tufts Univ, Tufts Sch Med, Dept Mol Biol & Microbiol, Boston, MA USA	University of North Carolina; East Carolina University; Tufts University	Garcia, BL (corresponding author), East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, Greenville, NC 27858 USA.	garciabr18@ecu.edu		Thomas, Sheila/0000-0001-6584-6240; Garrigues, Ryan/0000-0002-5923-3250; Garcia, Brandon/0000-0002-6724-8700; Leong, John/0000-0003-0240-6402	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01-AI146930]; NIAID, NIH [R01-AI121401]	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by Public Health Service grant R01-AI146930 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (to B. L. G.) and R01-AI121401 from the NIAID, NIH (to J. M. L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akins DR, 1999, INFECT IMMUN, V67, P1526, DOI 10.1128/IAI.67.3.1526-1532.1999; Amdahl H, 2013, J IMMUNOL, V191, P1775, DOI 10.4049/jimmunol.1300638; Bhattacharjee A, 2013, J BIOL CHEM, V288, P18685, DOI 10.1074/jbc.M113.459040; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Booth C. E., 2022, FRONT IMMUNOL, V13; Brangulis K, 2015, BBA-PROTEINS PROTEOM, V1854, P349, DOI 10.1016/j.bbapap.2014.12.025; Brissette CA, 2008, INT J MED MICROBIOL, V298, P257, DOI 10.1016/j.ijmm.2007.09.004; Brissette CA, 2009, MICROBIOL-SGM, V155, P863, DOI 10.1099/mic.0.024604-0; Bykowski T, 2008, INT J MED MICROBIOL, V298, P249, DOI 10.1016/j.ijmm.2007.10.002; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Clark EA, 2011, MOL IMMUNOL, V48, P452, DOI 10.1016/j.molimm.2010.09.017; Coburn J, 2021, CURR ISSUES MOL BIOL, V42, P473, DOI 10.21775/cimb.042.473; Dowdell AS, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00658-16; Duncan RC, 2012, J IMMUNOL, V189, P2365, DOI 10.4049/jimmunol.1201085; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; Gaboriaud C, 2000, EMBO J, V19, P1755, DOI 10.1093/emboj/19.8.1755; Gaboriaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067962; Garcia BL, 2016, J IMMUNOL, V197, P2051, DOI 10.4049/jimmunol.1600863; Garcia BL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005404; Garrigues RJ, 2021, J IMMUNOL, V207, P2856, DOI 10.4049/jimmunol.2100815; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Hallstrom T, 2013, MBIO, V4, DOI 10.1128/mBio.00481-13; Hammel M, 2007, J BIOL CHEM, V282, P30051, DOI 10.1074/jbc.M704247200; Hammel M, 2007, NAT IMMUNOL, V8, P430, DOI 10.1038/ni1450; Hart TM, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009801; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kenedy MR, 2009, INFECT IMMUN, V77, P2773, DOI 10.1128/IAI.00318-09; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Kraiczy P, 2001, INT IMMUNOPHARMACOL, V1, P393, DOI 10.1016/S1567-5769(00)00041-2; Kraiczy P, 2013, TICKS TICK-BORNE DIS, V4, P26, DOI 10.1016/j.ttbdis.2012.10.039; Kugeler KJ, 2021, EMERG INFECT DIS, V27, P616, DOI 10.3201/eid2702.202731; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lin YP, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00001; Madeira F, 2022, NUCLEIC ACIDS RES, V50, pW276, DOI 10.1093/nar/gkac240; Marconi RT, 1996, J BACTERIOL, V178, P5615, DOI 10.1128/jb.178.19.5615-5626.1996; McDowell JV, 2006, INFECT IMMUN, V74, P3030, DOI 10.1128/IAI.74.5.3030-3034.2006; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Nagy ZA, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101985; Pereira Michael J, 2022, Proc Natl Acad Sci U S A, V119, pe2117770119, DOI 10.1073/pnas.2117770119; Perry AJ, 2013, J BIOL CHEM, V288, P15821, DOI 10.1074/jbc.M113.464545; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; Ricklin D, 2008, J IMMUNOL, V181, P7463, DOI 10.4049/jimmunol.181.11.7463; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rogers EA, 2009, INFECT IMMUN, V77, P4396, DOI 10.1128/IAI.00393-09; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Rossi V, 1998, J BIOL CHEM, V273, P1232, DOI 10.1074/jbc.273.2.1232; Rushing BR, 2020, MOLECULES, V25, DOI 10.3390/molecules25174016; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmidt CQ, 2016, IMMUNOL REV, V274, P152, DOI 10.1111/imr.12475; Skare JT, 2020, TRENDS MICROBIOL, V28, P889, DOI 10.1016/j.tim.2020.05.004; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; Stevenson B, 1996, J BACTERIOL, V178, P3508, DOI 10.1128/jb.178.12.3508-3516.1996; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; Stevenson B, 2022, J BACTERIOL, V204, DOI 10.1128/jb.00606-21; Takacs CN, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.02519-20; Troisi R, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910803; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Xie JL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007659; Zuckert WR, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.PSIB-0026-2019; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022	66	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102557	10.1016/j.jbc.2022.102557	http://dx.doi.org/10.1016/j.jbc.2022.102557			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G4BI	36183830	gold, Green Submitted, Green Published			2022-12-26	WOS:000884698500002
